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Abstract 
With the realization that mechanical signals are important in controlling cancer cell 
behaviours, a new in vitro model has been developed to incorporate physical signals in 
laboratory studies. Here, we developed a system to fabricate hard polymers with imprinted 
cell topography, which we called a Bioimprint, and then we used the Bioimprint as the 
platform to culture endometrial cancer cells on. With Bioimprint high resolution of cell 
replicas were produced with cell-like features that retain all the micro- and nanoscale details 
of the cells. This enabled us, importantly, to study the effect of surface physical topography 
on endometrial cancer cell behaviours. The physical topography we used here was the cell-
like topography that the cells encounter in real cell microenvironments.  
 
We fabricated the Bioimprint of cells onto polymethacrylate (pMA) and compared the cells 
cultured on it to the cells on flat pMA. pMA is not a common cell culture material, therefore, 
we compared cell culture on pMA with the conventional cell culture materials: glass and 
polystyrene (pST). We then fabricated the Bioimprint onto pST, and compared the response 
of cells cultured on the replica with that cultured on the flat pST. Moreover, on pST, the 
Bioimprint was made in two forms: pit-like (negative) versus hump-like (positive) 
topographies, which enabled us to further investigate the effect of distinct topographies on 
cell behaviours. We also extended our study on flat and pST Bioimprints to study the effect 
of culture serum, fetal bovine serum (FBS), on cell responses to surface physical topography. 
 
In this report, we characterized the behaviours of endometrial cancer cells and studied the 
biological changes in response to culture substrate materials and culture substrate with cell-
like topography. We examined cell adhesion, morphology, spreading, expression of adhesion 
molecules and growth. The studies of pST Bioimprints were extended to examine the cell 
protein profile, and cell responses to anticancer agents, in serum-supplemented or serum-free 
culture media.  
 
The comparison between glass, tissue culture grade pST and pMA showed that substrate 
material modulated cell behaviours. Additionally, imprinting with cell-like topography also 
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altered cell behaviours. Here, we showed that Ishikawa endometrial cancer cells spread wider 
and grew faster on glass and pST compared to pMA. Further, on the pMA surface that was 
imprinted with cell-like topography, the cells spread and grew better compared to cells on flat 
pMA. On the other hand, when pST, which is a favourable cell culture surface, was imprinted 
with the cell-like topography, the topographical effect was to restrict cell spreading and 
growth.  
 
Most importantly, the change in cell growth behaviour was modulated through different 
proliferation biomolecules on each of these pMA and pST Bioimprints, indicating again the 
interaction of chemical and physical topography in regulating cell behaviours. In addition, the 
comparison between pST hump-like versus the pit-like topographies showed that the cells on 
the hump-like topography showed a greater response of an alteration of cell growth, 
expression of adhesion molecules when compared to cells on flat substrate. Furthermore, 
relative to cells on (f)pST proteomics analysis similarly showed that cells on hump-like 
topography had more alteration in protein expression than cells on pit-like topography. Most 
of these identified proteins were involved in cell energy homeostasis, growth and structural 
modulation.  
 
Additionally, the extended studies with culture serum without FBS again showed that 
endometrial cancer cells responded to physical topography. The cell responses were different 
from those in culture medium supplemented with FBS. This again indicated that the 
topographical influences on cells were in turn affected by chemical factors (the biological 
source of serum chemical factors). Notably, cell culture in serum free medium similarly 
showed a greater tropographical response to the hump-like topography compared to cells on a 
flat substrate. 
 
Here, we reveal the potential of targeting cell mechano-signalling as cancer treatment, and 
also this project describes a culture platform that inherently incorporates physical signals in 
laboratory cell culture studies. This is the first report that showed that Ishikawa endometrial 
cancer cells respond to the culture substrate material and cell-like physical topography. 
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Chapter 1 Introduction 
 
1.1 An Overview of Cancer Occurrence  
 
Cancer is a disease in which cells can grow infinitely and immortally forming a tumour, and 
in malignant cases, cancer cells can spread to different parts of a body. Cancer remains the 
main cause of death for both males and females in New Zealand and accounted for one-third 
of deaths in 2011. In 2011, 21,050 cases of cancer were registered in New Zealand, and 
8891 deaths were reported. Maori cancer registration rate is 391.8 per 100,000 and mortality 
rate of 206.4 per 100,000 population, which are higher than non-Maori population 
(registration rate 360.8 per 100,000 and mortality rate 137.7 per 100,000 non-Maori) 
according to the Ministry of Health (Ministry of Health, 2014). Besides, gynaecological 
cancer in New Zealand constitutes 10% of all cancer cases. Endometrial cancer is the most 
common gynaecological cancer, with about 315 new cases and 80 deaths reported every 
year (The New Zealand Gynaecological Cancer Foundation, no date). Also, endometrial 
cancer rates are higher in Maori women compared to European women in New Zealand, 
with the rate of 19.8 and 13.6 per 100,000, respectively (Ministry of Health, 2014). Among 
the identified risk factors for endometrial cancer are obesity, nulliparity, late menopause, 
consumption of Tamoxifen and family history. In this project, the Ishikawa endometrial 
cancer cell line was used as the model for endometrial cancer study. 
 
Due to the complexity of cancer, finding a complete effective cure is a challenge for 
scientists. Surgical removal of a tumour was traditionally the only treatment for cancer yet it 
is limited to the localized tumour. Later in the mid-20th century, the first chemotherapy drug, 
chlormethine, was used to treat lymphoma (Gilman, 1963). Then, with the introduction of 
radiation therapy, surgery or chemotherapy was often used in combination with radiation 
therapy to treat cancer. Although these treatments could kill cancer cells successfully, they 
also killed normal cells and patients often experienced side effects such as hair loss, appetite 
loss, diarrhoea, nausea and vomiting or even an increased risk of developing a second 
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cancer. For this reason, treatments that cause less adverse side effects have been developed 
such as gene therapy, hormone therapy, immunotherapy or a combination of each with any 
other form of treatments. Though the side effects are less harmful, patients would still 
experience problems like depression, weight gain, hair loss and memory problems, to name 
a few. Also, these therapies are limited to certain types of cancers. Despite the limitations of 
these discussed cancer therapies, they still modestly lengthen the lives of patients, but 
clearly, more cancer research is needed in order to develop new therapies or improve the 
available therapies to optimize the treatment effects with minimized risk to patients.  
 
The field of cancer research has been changing along with the expansion of knowledge in 
biochemistry, proteomics and biomolecular research. Cancer research has been focusing on 
finding the self-sustaining growth signals and anti-apoptotic characteristic of cancer cells 
and targeting relevant pathways aiming to eradicate them. Then, with an advance in 
molecular study technologies, scientists have started to hypothesize that these failing 
biochemistry functions of cancer cells are due to genetic defects. For instance, the risk of 
colorectal cancer increases with the presence of common gene variation near Cyclin-
Dependent Kinase Inhibitor 1A (CDKN1A), polymerase (DNA-directed), delta 3(POLD3) 
and shroom family member 2(SHROOM2) genes (Dunlop et al., 2012). In addition to that, 
mutation of inheritable cancer susceptibility genes, like breast cancer 1 (BRCA1) or breast 
cancer 2 (BRCA2), has been known to increase risk of breast cancer and ovarian cancer 
(Welcsh & King, 2001).  
 
Moreover, recent advancement in cancer genome sequencing enables further 
characterization of different types of tumour tissues, both primary and secondary tumours, 
and also the normal tissues adjacent to the tumours. With the whole genome analysis, 
tumours’ genome sequence data, copy number and sequence variants, chromosomal 
translocations and fusion genes, gene expression, miRNA expression, and alternative 
splicing events can be profiled. Indeed, there is now a more defined characterization for 
different types of tumours with this technique, for instance, the use of whole genome 
sequencing has identified subtypes in 100 patients with pancreatic ductal adenocarcinomas 
(Waddell et al., 2015) and whole genome sequencing has been used to differentiate between 
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chemotherapy sensitive and resistant genotypes among 92 advanced ovarian cancer patients 
(Patch et al., 2015).  
 
Many studies have identified the genes that can put a person at high risk of cancer, and this 
helps in cancer prevention, diagnosis and developing personalised medicine or helping in 
developing new treatments targeting the biological pathways that are affected by these 
genes. Yet recently it was realized that genetic and biochemical pathway defects are not the 
only explanations. To support this idea, a person can have multi-mutated cells without 
developing a tumour. For instance, a person with inherited mutated BRCA oncogene will 
have the gene in all cells but it will only increase risk of developing a tumour in breast tissue 
or ovary (Bissell & Hines, 2011). Moreover, another study that investigated chromosomal 
rearrangement of the normal lobules adjacent to breast tumours reported that the normal 
lobules with normal structure adjacent to tumour cells had an abnormal chromosomal 
rearrangement (Deng et al., 1996). This study shows that tissue cells with abnormal 
chromosomal arrangement can still have normal phenotype. It may be suggested that, 
according to the interpretation (Bissell & Hines, 2011) underlying this thesis, these pre-
malignant cells may develop into cancerous cells when the microenvironment permits. For 
example, in addition to having normally functioning mutated cells, the human body could 
also have high percentage of tumours that are termed ‘occult tumours’, which exist as part 
of the tissue and will not develop into malignant tumour (Bissell & Hines, 2011). It has been 
suggested that a mutated cell will only turn into a cancerous cell or an occult tumour will 
only become a malignant tumour when their microenvironments are permissive (Bissell & 
Hines, 2011).  Moreover, a series of hallmarks as steps in cancer progression has been 
postulated (Hanahan and Weinberg, 2000; 2011) and these have been used to underpin 
many studies. However this approach has resulted in only incremental improvements in 
treatments, which suggests other factors may be involved. Pickup et al. (Pick up et al., 2014) 
used the hallmark categories to present a discussion in favour of a pivotal role for the 
physical environment. For example, adhesion of cells to the ECM activated Ras, Rac 
GTPases and ERK and PI3K pathways (Schwartz & Assoian, 2001; Pylayeva et al., 2009) 
which enabled cancer cells to acquire self-sustained growth. Further, interaction of cells 
with the ECM and stiffening of tumour ECM inhibited growth suppressors (Kim et al., 
2008; O’Connell et al., 2000; Mouw et al., 2014) and apoptosis (Lim et al., 2008; Lewis et 
al., 2002), increased the expression of telomerase (Kunimura et al., 1998), which is essential 
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for immortal growth and metastasis (Yu et al., 2009).  Further, stiffened ECM enhanced 
angiogenesis (Montesano et al., 1983; Mammoto et al., 2009; Liu & Agarwal, 2010) and 
restructuring of the ECM promoted metastasis (Pathak & Kumar, 2012; Pickup et al., 2013). 
In addition, stiffening of the ECM may play a role in preventing immune destruction on 
cancer cells (O’Connor et al. 2012) by regulating cancer cell metabolism through PI3K 
signalling (Grassian et al., 2011; Zhang & Hochwald, 2014). Also, dysregulation of the 
ECM may promote genetic instability and mutations that ultimately contribute to cancer 
development (Radisky et al., 2005; Zhou et al., 1993).  
 
The lack of attention in looking at cancer biomechanical features may explain why current 
cancer research is having a relatively low success rate. There appears to be a few gaps that 
need more attention when undertaking cancer research in order to improve or speed up the 
process of developing new cancer treatments. One of the issues would be to realize the 
importance of biomechanical modulation in cancer initiation and development and to 
incorporate this concept into the existing biochemical knowledge. Secondly, an in vitro 
model with incorporation of the concept of biomechanical signals should be developed.   
 
Before emphasizing the need of studying the cancer cell microenvironment in tumour 
development and progression, the role of mechanical signals in normal tissue development 
and homeostasis is discussed first, followed by discussion of how a change in mechanical 
signals leads to tumorigenesis. And then some studies that investigated this area both in 
normal tissue and cancerous tissue are presented. And lastly, the outline of this thesis is 
included.  
 
1.2 Role of Mechanical Signals in Normal Tissue Development 
 
Mechanobiology is the study of mechanical signalling in the biological system whereas 
mechanotransduction is the cellular process of detecting mechanical stimuli and conveying 
them into intracellular biochemical signals. Biological tissues and cells are surrounded by 
extracellular matrix (ECM), neighbouring cells, basement membrane, fluids or 
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biomolecules. The interactions and contacts with surroundings expose the tissues and cells 
to mechanical stimuli. The ECM, which is the main mechanical mediator between cells and 
the surroundings, is a collection of structural biomolecules secreted by cells. Cells receive 
mechanical loads from the surrounding ECM or neighbouring cells and respond by changes 
in cell behaviours and structures, which subsequently affects the cytoskeletal generated 
force that acts on ECM, or affects the secretion of ECM proteins. Remodelling of ECM on 
the other hand further alters the force that acts on cells. This feedback-loop continues until a 
force balance between the cell and the ECM compartment is reached. The reciprocal force 
interaction between cell and ECM components is named mechanoreciprocity. 
Mechanoreciprocity remodelling of ECM was demonstrated in a study done by Lee et al. in 
which mechanical force but not growth factors triggered ECM restructuring (Lee et al., 
2003). The reciprocal relationship is crucial for ensuring optimal cell and tissue growth and 
function and can be seen in many circumstances, e.g., changing the structure and the 
components of ECM during wound healing, tissue homeostasis maintenance (Bell et al., 
1979; Ehrlich et al., 1991; Schiro et al., 1991) and during tissue formation as cells migrate 
through ECM (Grinnell & Lamke, 1984; Harris et al., 1981; Klein et al., 1991). The 
mechanical forces that act on tissues and cells exist in different forms; these include 
compression and tensional force, hydrostatic load and shear force. Compression and 
tensional forces are forces that are applied perpendicular to the surface, such as the force 
acting on or from neighbouring cells or ECM; whereas shear forces are forces that are 
parallel to the surface such as the force of blood flow that acts on endothelial cells of blood 
vessels.  
 
Though biochemistry, molecular biology and genetics explain a lot about the development 
of biological systems, mechanical signalling is also an important mechanism to manipulate 
tissue development and homeostasis, maintain cell uniform growth and regulate cell 
migration or differentiation. Physical forces have been actually appreciated to be important 
in organ or tissue development and tissue shape regulation since early in 1945 (Thompson, 
1945).  The ECM structure that determines its mechanical properties must be spatially and 
temporally well-controlled because optimum tissue function and morphology development 
requires different stiffness and arrangement of ECM fibres. One of the examples of 
mechanical signal regulation of biological structure formation can be seen in the growth of 
Drosophila melanogaster wing imaginal disc; slower growing cells in the vicinity of faster-
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growing cells would undergo apoptosis to maintain uniform growth. The mechanism behind 
this distance regulation was proposed to be through mechanical feedback (Shraiman, 2005). 
More examples of mechanical cues in the regulation of tissue development can be seen in 
lung development in which mechanical forces resulting from lung expansion determines 
fetal lung structure development (Hooper & Wallace, 2006), and the types of mechanical 
force (distension or contraction) determines the phenotypic expression of alveolar cells 
(Dobbs & Gutierrez, 2001). Another example is the formation of vessels such as blood 
vessels and lymph vessels; it has been observed that under high unidirectional fluid shear 
force, the cytoskeleton of the vascular endothelial cells (ECs) formed a uniform structure 
aligned with the flow direction, which resulted in ECs elongation, and formed tube-like 
structures. Oppositely, ECs arranged themselves randomly under low shearing force (Dai et 
al., 2004; Tzima et al., 2002; Tzima et al., 2001).  
 
Not only initial tissue development and formation are influenced by environmental forces. 
Throughout the lifetime of an organism, tissue homeostasis is also manipulated by forces. 
For example, through frequent exercises, bone tissues would experience compression stress 
constantly which subsequently resulted in high hyaluronan in articular cartilage that gave a 
stronger bone structure; on the contrary, less motility could cause loss of hyaluronan and 
aggrecan, which was the main cause of arthritis-associated joint degeneration (Haapala et 
al., 1996). Also, the muscle built up resulting from frequent exercise, was the result of 
mechanical tension stimulation of the formation of myofibrils of skeletal muscle (Weitkunat 
et al., 2014). The need of mechanical signals in tissue homeostasis also can be seen in an 
acute tendon injury mouse model. In a normal physiological situation, mechanical forces 
regulated the expression of Scleraxis (Scx) which was required for the formation of tendon 
tissue, whereas when injury occurred, in which the mechanical signals were disrupted, 
force-regulated secretion of TGF-β led to tenocyte death (Maeda et al., 2011). Also, in cases 
of acute injury such as bone fracturing, biomechanical signals were needed for bone 
repairing (Chao et al, 2003). 
 
In addition to tissue development and homeostasis, physical signals are also important in 
cellular development and maintenance, in which cells interact dynamically and bi-
directionally with the surrounding biomechanical signals. Cell responses to external 
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biomechanical signals depend on the nature of the mechanical signal such as the type, 
magnitude, direction or duration of the experienced force signal. Different influences of 
different biomechanical signals can be seen in a study which showed that cyclic force 
stimulated higher protein tyrosine phosphorylation than continuous force in an osteoblastic 
cell line (Schmidt et al., 1997). Besides, cell features that are regulated by mechanical forces 
are cell shape, motility, growth and differentiation. An example in mechanical signal 
regulation of cell shape and cell motility is in the regulation of PC-12 neurite morphology 
and motility, which involved compression force alignment of neurite microtubules (Dennerll 
et al., 1988). On the other hand, it has been shown that the early phase of axon growing 
required an exertion of forces to the surroundings from the growing cones at axon tips (Betz 
et al., 2011; Lamoureux et al., 1989); then in the late phase, it required a pulling force from 
target tissue, a process that has been termed stretch growth (Weiss, 1941). Furthermore, by 
using a stretchable substrate, Chang and his colleague showed that the extension of neural 
stem cell’s neurite and axon was enhanced with increased substrate stretching and neurite 
outgrowth was oriented along with substrate stretching, moreover, neural stem cell 
differentiation depended on the direction of stretching, i.e. parallel or perpendicular 
stretching (Chang et al., 2013). Other examples of biomechanical signal regulation of cell 
fate were the force-stimulated differentiation of keratinocytes (Gormar et al., 1990), and 
also differentiation of  breast epithelial cells into tubules, which were found to be modulated 
by the collagen density and rigidity in ECM (Wozniak et al., 2003). 
 
Clearly, mechanical signals are important in regulating tissue and cell development and 
homeostasis. In fact, in the past decades, collaborations between engineers and biologists 
have enabled an incorporation of mechanical studies in laboratory cell studies. Different 
culture substrates and culture models have been developed and cells are observed to behave 
differently in the presence of different mechanical signals. 
 
1.3 In Vitro Culture Substrate and Its Influence on Cultured Cells 
 
In vitro cell culture was first done in 1907 by Ross Harrison (Harrison, 1907). Thereafter 
cultures were grown as an explant culture, as hanging drop or at the bottom of glass flasks 
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and petri dishes. In the mid-1900s, due to the disadvantages of using glass as culture 
substrates because of low cell attachment for primary cell lines and the need of careful 
cleaning, disposable polystyrene (pST) started to be used as cell culture substrate. In 
addition to the ease of handling, pST is easy to mould and can be surface treated by either 
corona discharge or by gas plasma treatment to enhance cell attachment. However, both 
glass and pST culture substrates are unnatural flat and hard surfaces for cells to attach and 
grow on; and following the appreciation that mechanical signals from the cell 
microenvironment is one of the factors that controls cell behaviours, the making of 
biomimetic substrates that have the same or similar physical features to the cell 
microenvironment is especially important in tissue engineering, tissue implantation and in 
understanding the role of these forces in cell development. 
 
The most studied aspects of physical microenvironments that change cell behaviours are 
stiffness and surface topography. The stiffness of the cell microenvironment determines the 
compression force that acts on cells. In the laboratory setting it has been observed that 
motility of cells is dependent on the microenvironment stiffness in which fibroblasts and 
smooth muscle cells move and migrate towards a stiffer culture environment (Wang et al., 
2001; Wong et al., 2003). Furthermore, in an absence of cell-cell adhesion, fibroblasts and 
endothelial cells can only spread on stiff but not on soft surfaces (Yeung et al., 2005). 
Culture substrates with tailor-made stiffness can be produced by using biocompatible 
materials such as polydimethylsiloxane (PDMS), polyacrylamide (PAM) gel, hydrogel and 
so on. Alternatively, cells are grown as a cluster or as a 3D Matrigel model in which the 
cells are in a 3D microenvironment with stiffness similar to the real tissue environment. 
Evidence has shown that cells cultured in the 3D model behaved differently to cells cultured 
on a flat surface. Cells growing in 3D culture showed different adhesion patterns 
(Cukierman et al., 2001), shape, proliferation and gene expression (Gruber & Hanley, 2000). 
Though 3D culture is the most physiologically relevant in vitro cell culture model, it has 
relatively high cost, and complex handling compared to conventional 2D cell culture 
making it not an ideal model to be used for investigating elementary biochemical questions 
such as preliminary investigation of cell responses to drugs, secretion level of cytokines and 
high throughput screening assays. Hence, a model that is simpler than the 3D model but an 
improved 2D culture that incorporates the physical factors would be ideal for ‘preliminary’ 
drug studies before moving on to the 3D culture.   
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On the other hand, the surface topography is another physical feature that gives cells 
mechanical signals, and the cell responses to surface geometry are termed topographic cell 
responses. Topographic influence on cells will be discussed in more detail below because 
this is the main focus of this project. The ECM surrounding cells consists of curvature, 
grooves, ridges, holes or lattice structures. These different geometries would influence the 
cell adhesion, spreading, orientation, polarity, migration, growth and functions. In fact, 
topographic cell responses were described early in cell culture history as contact guidance of 
cell growth (Weiss, 1941).  
 
New advances of nanofabrication techniques such as soft lithography (Liliensiek, et al., 
2006), micro-photopatterning (Gilchrist et al., 2014), capillary force lithography (Kwon et 
al., 2011), microscope projection photolithography (Kwon et al., 2011), electron beam 
lithography (Teixeira et al., 2003; Tsimbouri et al.,2013; Wood, 1988), photo lithography 
(Hamilton et al., 2007; Murugan et al. 2010), and self-assembly monolayers (Murugan et al., 
2010; Mrksich et al.,1996) enable the making of substrates with controlled topography. 
Substrates with controlled and designed topography; such as grooves (Hamilton et al., 2007; 
Nikkhah et al., 2012; Rovensky, 2011; Wood, 1998), columns (Rovensky, 2011), pitch 
(Hamilton et al., 2007; Nikkhah et al., 2012), pillars (Nomura et al., 2006), pores (Zinger et 
al.,2004) and surface roughness (Dalby et al., 2007; Kawahara et al., 2004) have started to 
be used in guiding cell position and differentiation.  
 
However due to the diversity of scales, materials and the cell types studied, the precise 
mechanism of how cells sense and respond to surface topography remains unclear. The 
current idea is that cell spreading is constrained by the topography which then changes the 
distribution of adhesion molecules and the alignment of actin filaments that are connected to 
signalling molecules, thence triggering signalling pathways according to the spatial and 
temporal distribution and activation of the adhesion molecules (Anselme et al, 2010; Chen 
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A well-designed study done by Chen and his co-workers showed how adhesion area 
affected cell behaviours. They created substrate surfaces designed with adhesive islands of 
different sizes, which allowed control over the cell adhesion surface areas. They elegantly 
showed that spreading on a larger area was required for cells to survive and grow, and cells 
could not survive when their spreading and shape formation were restricted on substrate 
surfaces (Chen et al., 1997). Further, because cells adhere to their microenvironment 
through transmembrane receptors and integrins, a study that modulated the cell integrin-
mediated adhesion showed that cell adhesion was linked to one of the three components of 
the cell cytoskeleton, actin filaments. In this study, integrin ligand spatial density and 
distribution were controlled and fabricated on culture substrate, and cells with different 
integrin clustering were seen to have different organization and motility of actin filaments 
(Maheshwari et al., 2000). The idea that cell response to topography is actin filament-
dependent is supported by the observations that different cell lines with various actin 
arrangements have different topographical responses. Fibroblasts, for example, are cells that 
have bundles of straight actin filaments; Dunn showed that fibroblasts failed to bend at an 
angle >16ᵒ degree because the actin bundles made them resistant to bending (Dunn & Heath, 
1976). This restriction in bending was not observed in endothelial cells because endothelial 
cells have less straight actin bundles and so they were shown to be more flexible in curving 
on surfaces (Rovensky, 2011). Hence, surface topography affects cell spreading and 
movement through modulating the cell’s actin structure. 
 
An alteration in actin filaments stretching or bending will activate the formation of focal 
adhesion (FA), which is an assembly of biomolecules that regulates transmission of 
mechanical signals between cells and their extracellular matrix. By culturing cells on nano-
scaled pattern substrates, cell actin microfilaments and FA were observed to align along 
with nano-scaled features; also, the width of ridge defined the width of FA formed (Teixeira 
et al., 2003). Another study that quantified the force applied from cells on patterned 
elastomer substrates reported that the force had linear dependency on the area and intensity 
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Eventually, the cell FA formation, distribution and activation (through phosphorylation of 
focal adhesion kinase (FAK)) determine the downstream signallings that are linked to FA 
and change the cell behaviours including cell proliferation, differentiation and cell secretion. 
For instance, cells adhered on surfaces with groove topography activated the mitogen-
activated protein kinase/extracellular signal-regulated kinases (MAPK/ERK)  pathway 
through phosphorylation of FAK-Proto-oncogene tyrosine-protein kinase (Src) complex, yet 
on flat substrates, MAPK/ERK activation was FAK-Src independent (Hamilton & Brunette, 
2007). Also, fibroblasts reduced growth on a rough surface (Pennisi et al., 2011) and 
epithelial cells decreased growth on grooved surfaces (Liliensiek et al., 2006). Furthermore, 
bone cell differentiation can be modulated by surface roughness (Dalby et al., 2007; 
Kawahara et al., 2004; Lim et al., 2005). For example, Dalby and his colleagues showed that 
mesenchymal stem cells can be stimulated to differentiate and produce bone mineral with 
osteoblastic morphology on nanotopography polymethylmethacrylate (PMMA), without any 
chemical stimulant. Also, the effect was regulated by the shape and distribution of the nano-
pattern (Dalby et al., 2007).  On the other hand, cell functional behaviours such as fibroblast 
secretion of tenascin decreased on grooved titanium surfaces (Goto & Brunette, 1998) and 
the half-life of the secreted matrix metalloproteinase (MMP)-2 messenger RNA (mRNA) 
was altered on grooved surfaces (Chou et al., 1998). A recent detailed study showed that 
nanotopography changed the mesenchymal stem cell adhesion and the cell nuclear 
architecture. Changes were observed at the chromosomal level in which the packing of 
chromosomal territories within the nucleus were altered, and this influenced the 
transcription activity and functional signalling of cells. They further showed that the 
alteration at the cellular and nuclear levels was depended on the arrangement of the nano-
scaled pits (Tsimbouri et al., 2014).  
 
In summary, cell behaviours can be modulated through modification of cell culture substrate 
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1.4 Mechanical Signals in Tumorigenesis 
 
Under normal circumstances, cells are in a balanced mechanical feedback loop with their 
surroundings. During different development stages or when cells are encountering 
pathological changes, there will be a change in the biomechanical signals acting from the 
microenvironment on cells or vice versa. When the mechanical feedback loop fails to reach 
a balance, cancer may develop. 
 
Normal cells can only grow and function normally in a microenvironment with appropriate 
stiffness and structure; transformed cells, on the other hand, lose the ability to probe their 
microenvironment stiffness and can spread and grow indefinitely regardless of abnormal 
environment stiffness. For example, Wang et al. showed that normal fibroblasts were able to 
sense alterations of stiffness of their environment and then exerted traction force and 
generated a force feedback loop with their environment. On the contrary, transformed 
fibroblasts lost the ability to probe the surrounding stiffness. The loss of this ability led to 
maintained growth, anti-apoptotic, enhancing spreading and continuous traction force 
generation of fibroblasts regardless of the stiffness of the environment (Wang et al., 2000). 
All these characteristics lead to the adhesion-independent growth of cancer cells. Cancer 
studies in the past decades have focused on biochemistry, proteomics and especially 
biomolecular properties. In fact, there is a need to include mechanobiology in tumorigenesis 
as there is increasing evidence showing that an alteration in mechanical properties of tissue 
and cell is part of tumorigenesis.  
 
There is evidence in laboratory studies that showed the role of microenvironment in tumour 
formation. Rous sarcoma virus (RSV), which is an oncovirus, has been shown to transform 
fibroblast culture derived from chick embryo and caused the formation of sarcomatous 
tumour in newly hatched chicks. Nevertheless, RSV was not tumorigenic when it was 
injected into chick embryos in ovo (Dolberg & Bissell, 1984; Stoker et al., 1990). 
Interestingly, the extracted cells from the in ovo chicken embryo injected with RSV showed 
transformed phenotypes  when cultured in a 2D laboratory setting (Dolberg & Bissell, 
1984). These studies may imply that the microenvironment of the embryos, which is lost in 
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culture conditions, is required to attenuate the oncovirus transformation. Also, the role of 
microenvironment in regulating cancer cell phenotype can be illustrated using HMT-3522 
human breast cancer cell series; these cells originated from breast luminal epithelial cells. 
The cells of < 200 passages are non-malignant, do not form tumours in nude mice and are 
called S1 cells; whereas T4-2, are cells derived from S1, are premalignant and form tumours 
in nude mice. Both of these cells, however, did not have a distinguishable phenotype when 
cultured on 2D tissue culture plastic, but only if they were cultured on 3D basement 
membrane, S1 cells formed functionally normal acinar structure whereas T4-2 cells formed 
irregular colonies (Howlett et al., 1995). Furthermore, Wang’s group observed coupled and 
bidirectional modulation of β1-integrin and epidermal growth factor receptor (EGFR) 
signalling in T4-2 cells; the expression level and activation of each β1-integrin and EGFR 
were observed to be correlated with each other. Most importantly, this was observed only in 
3D basement membrane models and not on 2D culture models, which implies that the 
structure or the chemical cues from the microenvironment of cells regulate the coordination 
of receptors (Wang et al., 1998). In agreement with this was the finding that senescent 
fibroblasts, the number of which increased with aging, stimulated preneoplastic and 
malignant fibroblasts growth, largely due to topography of ECM secreted from senescent 
fibroblasts, and only partly due to soluble secreted factors (Krtolica et al., 2001). In short, 
tumorigenesis is associated with defects in cell mechanical homeostasis. 
 
Mechanical defects found in tumorigenesis are stiffening of tumour microenvironment  
(Akiri et al., 2003; Levental et al., 2009; Paszek et al., 2005; Provenzano et al., 2006; Zhao 
et al., 2010), restructuring of ECM (Carey et al., 2013; Kraning-Rush et al., 2012), alteration 
of mechanical features of cancer cells themselves (Cross, et al., 2007; Lekka et al., 1999) 
and also malfunction of oncogenes that are responsible for cell mechanical signalling 
(Martin et al., 2012; Nelson et al., 2012; Rathje et al., 2014).  
 
Tumours are always more rigid than normal tissues, and so the mechanical signals acting 
from and on cancerous cells must be different from that of normal cells. For example, 
development of normal mammary gland to invasive cancer was associated with stiffening of 
the tissue and the stromal tissue surrounding it (Levental et al., 2009; Paszek et al., 2005; 
Provenzano et al., 2006). Tumour tissue was found to be stiff due to excessive fibrosis 
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(Akiri et al., 2003) and cross-linking between collagen and elastin (Decitre et al., 1998; 
Levental et al., 2009; Provenzano et al., 2006). Another illustration for stiffer tumour stroma 
can be seen in hepatic cirrhosis disease. Hepatic cirrhosis is a major cause of hepatocellular 
carcinoma (HCC). It was found that hepatic cirrhosis was always associated with higher 
fibre deposition in ECM before developing into HCC (Zhao et al., 2010). Furthermore, the 
observation of stiff tumorous microenvironments may explain why aging is one of the 
factors that increases the risk of cancer; in addition to accumulation of genetic defects, the 
loss of collagen resulted in increased stromal stiffness and promoted tumour development 
(Boyd et al., 2007; Wolfe, 1976). In addition, smoking-related lung cancer can also be 
linked to an alteration in tumour microenvironment. Nicotine, the main component of 
tobacco in cigarettes, was found to promote non-small cell lung carcinoma (NSCLC) cells 
proliferation, and one of the mechanisms of nicotine-stimulated NSCLC proliferation was 
through increasing expression of an ECM glycoprotein fibronectin that altered the ECM 
mechanical properties (Zheng et al., 2007).  
 
An alteration in the stiffness of the tumour microenvironment is a process that assists 
tumour development. Cells in a stiff environment could adhere better and spread wider than 
cells on soft tissue by forming greater number of FAs and increasing Rho-associated protein 
kinase (ROCK) and Ras homolog gene family (Rho)-generated actin cytoskeleton 
contraction (Paszek & Weaver, 2004; Paszek et al., 2005). Furthermore, overexpression of 
the proteases MMP such as MMP1, MMP2 and MMP26, all of which are markers of 
metastasis, has been observed in the stiff tumour stroma (Kajita et al., 2001; Marchenko et 
al., 2001; Milkiewicz et al., 2007; Park et al., 2000; Sato et al., 1994; Uria & Lopez-Otin, 
2000). Moreover, fluid shear stress, which is always elevated in a lump of tumour, has been 
shown to increase the cell secretion of insulin growth factor-1 (IGF-1) and vascular 
endothelial growth factor (VEGF) B and D that in turn induced cancer cell invasion (Wang 
et al., 2014). The secretion of growth factor promotes tumour growth whereas VEGF 
promotes abnormal angiogenesis in tumours. Further, an increase in compression force from 
ECM disrupted blood flow of existing vasculature around the tumour, which then caused a 
hypoxic condition in tumours that subsequently elevated cell VEGF secretion (Harris, 
2002). Additionally, the elevated compression force shrunk intercellular interstitial space 
and caused an increment in the local concentration of growth factor and cytokines. This 
facilitated and enhanced auto-and paracrine signalling pathways that promoted tumour 
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growth (Tschumperlin et al., 2004). Nevertheless, the requirement of a stiffer 
microenvironment on cancer invasion is not always the case and is varied for different 
cancer types. Ovarian cancer, for example, showed epithelial-to-mesenchymal (EMT) 
morphology, increased polarization, migration, proliferation and chemoresistance on a soft 
substrate (McGrail et al., 2014). Though ovarian cancer growth and invasion requires a 
softer microenvironment, the role of physical features in cancer development is undeniable.  
 
An alteration in the topography or the ECM physical structure is also an important factor 
that regulates cancer cell invasion. Cancer cells restructure their microenvironment to assist 
them to migrate through. For example, cancer cell remodelling of ECM increased the 
metastatic potential of cells (Kraning-Rush et al., 2012). Local invasion along the collagen 
fibres was observed when the collagen aligned perpendicularly to a tumour explant whereas 
invasion was suppressed when collagen alignment resembled the alignment in a non-
invasive region (Provenzano et al., 2008). A tumour explant cultured on a randomly 
organized collagen matrix realigned the collagen fibres in a contractility-dependent manner 
that involved the Rho/Rho kinase pathway, which then promoted local cell invasion along 
the aligned collagen fibres (Provenzano et al., 2006; Provenzano et al., 2008). The need for 
an ‘invasive’ ECM structure for metastasis cancer can also be shown by Carey’s lab study 
which showed that cell invasion was preceded by restructuring of ECM through cell-
contractility realignment of ECM and proteolytic track making (Carey et al., 2013). 
 
At the cellular level, cancerous cells are softer than non-cancerous cells. For example, the 
scanning force microscopic measurement of Young’s modulus (a measurement of elasticity 
of a material, which is defined as the ratio of stress to deformation along an axis) showed 
that cancerous cells had lower Young’s modulus than the normal cells (Lekka et al., 1999) 
and the softness of cells correlates to the metastatic state of cells in which metastatic cells 
are softer than benign cells. Cross found that metastatic cancer cells were 70% softer than 
the benign cells from a single patient’s body fluid sample (Cross et al., 2007). There are a 
few factors that may explain the observation of cancer cells softening; firstly, cells soften 
prior to proliferation (Fritsch et al., 2010) and this was reported to be partly because 
filamentous actin depolymerizes and globular actin diffuses throughout the cell body as cells 
are entering the mitotic phase from interphase (Sanger, 1975). The soft phenotype is maybe 
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just part of the cancerous transformation since cancer cells are cells that proliferate 
continuously. Secondly, metastatic cells are cells that invade different parts of the body by 
moving through small openings of the basement membrane, cell-cell gaps and so on; hence, 
soft cells can move and squeeze through easier than hard cells. 
 
Cancer has been related to mutations or enhanced oncogene expression; and one of the 
linkages between biomechanics and tumorigenesis is through activation of oncogenes that 
are responsible for the regulation of mechanobiology on the cytoskeleton of the cells. For 
instance, oncogenes such as simian virus 40 (SV40) large T antigen, c-Myc, and cyclin E 
were found to increase cell stiffness through up-regulating tubulin deacetylase histone 
deacetylase 6 (HDAC6) that increased the width of vimentin fibers and disrupted the 
structure of the vimentin network to a more entangled assemblage (Rathje et al., 2014). 
Moreover, these oncogenes also changed the spatial distribution of acetylated microtubules 
(Rathje et al., 2014). Oncogenes can also change the cell mechanical properties through 
regulating the cell actin cytoskeleton. An example of a mutated gene in cancer is the 
adenomatous polyposis coli (APC) tumour suppressor protein gene mutation that causes 
sporadic and hereditary colorectal cancer. Mutated APC was found to depolymerize actin 
filaments at the cell migration tip (Nelson et al., 2012). Hence, the presence of mutated APC 
disturbs directional cell migration as in normal gut maintenance and eventually puts cells in 
pre-cancerous state and increases the risk of colorectal cancer. Oncogene activation can also 
alter the cell sensitivity to mechanical stimuli from the surroundings, hence promoting 
cancer development. A specific example is the expression of receptor tyrosine-protein 
kinase erbB-2 (ERBB2), which is associated with a bad prognosis in breast cancer. The 
induction of ERBB2 increased the cell sensitivity to biomechanical stimuli and resulted in 
temporal up-regulation of 46 cytoskeletal genes; a further analyses of 766 breast cancer 
patients showed that 12 of these 46 cytoskeletal genes were associated with metastatic 
breast cancer (Martin et al., 2012).  
 
Tumour initiation and development is closely related to dysfunction in mechanical 
signalling. Hence, there is a need to incorporate mechanical studies in cancer research. 
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1.5 Tumour Mechanotransduction Studies 
 
The concept of mechanical effects on cancer initiation and development is relatively new 
and so fewer studies have investigated mechanotransduction in cancer cells compared to 
stem cells, fibroblasts and so on. But studies have now started aiming to alter the 
mechanical signals acting on cells by changing the tumour microenvironment or by actively 
exerting force on tumours. These studies show that tumour characteristics can be reversed 
back to normal just by altering the tumour microenvironment mechanical signals. The first 
example is a study that examined the influence of normal mesenchymal cells on neoplastic 
Dunning prostatic adenocarcinoma (DT) development. In this study, DT alone and 
recombinant of DT + seminal vesicle mesenchyma (SVM) were grafted in mice, and the 
tumorigenicity and growth of grafted cells were examined after 3 months. The presence of 
normal SVM cells was shown to reduce tumorigenicity and growth of DT (Hayashi & 
Cunha, 1991). Furthermore, another study showed that the compression force stopped the 
growth of malignant breast cancer tissue and changed the unorganized growth back to 
normal acini structure (Yang, 2012). Moreover, 3D culture which is less stiff than tumour 
microenvironment could revert cancer cells back to near normal phenotype (Howlett, 
Petersen, Steeg, & Bissell, 1994) and turned endometrial cancer cells to a less malignant 
appearance with slower growth behaviour (Chitcholtan et al., 2013). Also, by preventing 
ECM remodelling and stiffening such as through inhibiting lysyl oxidase (LOX)-dependent 
cross-linking of collagen, the chances of tumour formation and growth of an existing tumour 
were lowered (Wang et al., 1998; Weaver et al., 1997) and focal adhesion activation, PI3K 
activity and breast malignancy were also reduced (Levental et al., 2009).  
 
In addition to targeting the tumour vicinity or changing the tumour mechanical properties 
directly, scientists also started to target cell-ECM receptor, cell cytoskeleton or 
biomolecules that are known to be mechano-sensitive, for example, integrin, focal adhesion 
molecules and actin cytoskeleton. Integrin is the cell’s main adhesion molecule that anchors 
cells to the ECM. The total and surface expression of β1 integrin of cancerous cells has been 
found to be different from those of non-cancerous cells as cancer cells showed higher 
expression of β1 integrin (Weaver et al., 1997). In a study that blocked β1 integrin using 
antibody, T4-2 cells normalized their morphology and formed functional acini with normal 
 
18 | P a g e  
 
basement membrane structure, cell-cell contact, cell polarity and actin cytoskeleton 
arrangement. Moreover, these normalised cells reduced growth and became less tumorigenic 
when injected into nude mice (Weaver et al., 1997). Not only targeting integrin (Rucci et al., 
2015; Taga et al., 2002) but targeting other adhesion molecules such as FAK, which is the 
downstream molecule of β1 integrin (Shanthi et al., 2014) also showed promising results in 
reducing tumorigenesis of cancer cells. Also, Chondramide that acts to prevent cell actin 
contractility may potentially inhibit tumour cell invasion (Menhofer et al., 2014).  
 
The realization that cancerous cells have different mechanical features than normal cells led 
to studies that investigated cancer diagnosis and treatment monitoring based on 
measurement of cancer cell mechanical properties. For example, oral squamous cell 
compliance was quantified using microfluidic optical stretchers as a diagnosis of malignant 
change (Remmerbach et al., 2009). Moreover, examination of cell or tumour stiffness can be 
useful to predict drug responsiveness in patients. For instance, the drug transporter, human 
equilibrative nucleoside transporter-1 (hENT1), is correlated with patients’ response to 
chemotheraphy; meanwhile hENT1 is also related to the stiffness, morphology and EMT 
state of cancer cells. Hence quantification of cancer cell stiffness can be useful in predicting 
drug response (Lee et al., 2014).  
 
All these examples show that the tumour is an abnormal tissue structure, and the formation 
of it involves the defect of many components, hence cancer cells should be studied ‘in a 
context’ with their microenvironment. In other words, the microenvironment is important in 
the formation of a tumour. Though mechanical studies of cancer are at its early development 
stage, this field of study surely has many implications for finding new cancer therapies and 
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1.6 In Vitro Culture Substrate in Cancer Studies 
 
As illustrated above, where the non-malignant S1 and the malignant T4-2 cells do not show 
any morphological differences when cultured on 2D culture substrate, clearly the 
conventional cell culture on flat 2D surfaces is not a model similar enough to represent the 
real physiology of cells. Moreover, cells growing on fibronectin or collagen were less 
affected by doxorubicin compared to cells growing on flat plastic (Fourre et al., 2008; 
Millerot-Serrurot et al., 2010). Work from our laboratory showed that endometrial cancer 
cells in 3D culture were more resistant to drugs compared to cells grown on flat surfaces 
(Chitcholtan et al., 2012). This implies that the cell microenvironment can affect drug 
efficiency, which may explain why drugs that show promising results in 2D laboratory study 
fail in clinical studies. Furthermore, this also highlights that the physical features of the 
microenvironment should be considered in drug studies for a more accurate result. 
 
The mechanical factors that influence cancer have been mostly focused on stiffness since 
one of the abnormalities of tumours is their altered stiffness, and cells cultured in a 3D 
model are becoming more common in cancer studies. Relatively few studies have 
investigated the topographical effect on cancer. In fact, topography is also important in 
regulating cancer cell morphology, adhesion and motility. For instance, on poly(lactic-co-
glycolic) acid (PLGA) surfaces with nano-scaled spherical surface topographies, the lung 
cancer epithelial cancer cells reduced adherence at the low Root Mean Square (RMS) 
roughness surface compared to the surface with higher RMS surface roughness (Zhang et 
al., 2010a). Another study that was not intended to examine the effect of topography on 
cancer cells, but instead to study PDMS surface topography and wettability effects on 
cancer and non-cancerous cells in general, found that HeLa and 3T3 fibroblast attachment 
and growth were modulated by surface topography, independently from surface wettability 
(Kidambi et al., 2007). This behaviour of HeLa cells agreed with an earlier study, that found 
that HeLa cells adhered differently with different actin cytoskeleton arrangement on a 
surface of patterned nanopillars compared to a flat counterpart (Nomura et al., 2005). 
Moreover, human colon cancer cells showed preferential adherence and migrated towards 
the nanostructured area on a hierarchically patterned micro-and nano-structure (Kwon et al., 
2011). Also, prostate cancer cells had been shown to migrate along grooved substrates 
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(Sarna et al., 2009). All these studies pointed out that cancer cells do sense substrate 
topography and are responsive to it. 
 
A few studies that investigated the spreading of normal versus transformed cells on 
topographies such as cylindrical and grooved patterned surfaces showed that the responses 
of cells are cell type dependent and different on different topographies, and most 
importantly, transformed cell responses to topographic mechanical signals are different from 
normal cell responses. For example, a study that compared the effects of stiffness and 
topography on normal fibroblast (3T3) and transformed fibroblast (SaI/N) observed that the 
stimuli of substrate stiffness on normal fibroblast spreading and motility was more than the 
influences of substrate topography; yet transformed cells were nevertheless more sensitive 
and responsive to topography than stiffness (Tzvetkova-Chevolleau et al., 2008). 
Furthermore, on cylindrical topography, transformed fibroblasts were less elongated and lost 
the orientation along the cylinder compared to normal fibroblasts. On the other hand, 
opposite behaviours were observed for epithelial cells, where normal epithelial cells could 
bend and spread along the curvature of the cylinder, transformed epithelial cells showed 
increased elongation and guided alignment on the cylinder with the longitudinal 
arrangement of actin filaments (Rovensky, 2011). Besides, on surfaces with 15, 25 and 
40µm depth groove and 80, 155 and 200µm space between grooves, respectively, normal 
fibroblasts migrated directionally from the bottom of the grooves to the area between 
grooves, whereas transformed fibroblasts remained in the grooves with some showing 
random movement from the bottom of the grooves to the area between grooves (Rovensky 
et al., 1971; Veselý et al., 1981).  
 
The observation of distinct responses from normal and transformed fibroblasts and epithelial 
cells to substrate topography may be because fibroblasts and epithelial cells have different 
actin filaments alignment, and that transformed fibroblasts and epithelial cells similarly have 
altered their actin filaments differently from each other. Transformed fibroblasts were 
deprived of stress fibres compared to normal fibroblasts, hence they were less resistant to 
bending and spreading around the cylinder but transformed epithelial cells acquired more 
bundles of actin filaments, hence they were more reluctant to bend over cylinders 
(Rovensky, 2011). On the other hand, the groove side slope of 90ᵒ degree prevented 
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fibroblasts from bending in the bottom of the grooves and so normal fibroblasts 
preferentially migrated and stayed in the area between grooves, yet transformed fibroblasts 
with fewer actin bundles either stayed in the bottom or moved up to area between grooves 
(Rovensky, 2011). These observations suggest that transformed cells can alter the cell 
mechano-sensitive structures that change the cell responses to topography and that cancer 
cell topographic responses are different from normal cells. This indicates that topographical 
influences on cancer cells should also be considered to be as important as the influence of 
stiffness on cancer development.  
 
1.7 Bioimprint  
 
Though the above illustrations have shown that the use of patterns gives cells the 
mechanical signals that change the cell behaviours, yet these regular patterns are still not the 
topography that the cells would encounter in a real cell microenvironment. It has been 
observed that there is dynamic force interaction between cells and the structured 
microenvironment (Albert & Schwarz, 2014; Gilchrist et al., 2014), which in vivo, consists 
of neighbouring cells. Here a substrate imprinted with cell-like topography is used to 
examine topographic responses of Ishikawa endometrial cancer cells. This newly developed 
culture substrate is named a Bioimprint. A Bioimprint is made by a technique that combines 
biological cell culture with soft lithography imprint technology to produce a substrate that 
duplicates a biological cell surface and hence creates a hard copy of the cell surface (Muys 
et al., 2006; Muys et al., 2006; Samsuri et al., 2010). The Bioimprint contains the 
topography of cells, making it a culture substrate encoded with the real cell topography and 
more closely resembles the physical micro-and nano-environment of cells. 
 
The Bioimprint was first developed to make a substrate for the atomic force microscope 
(AFM) to examine exocytosis processes in cancer pathology (Muys et al., 2006). Exocytosis 
is a cellular process of secreting cytokines or hormones from intracellular to extracellular 
compartments; it involves the fusion of intracellular vesicular membrane with the cellular 
membrane, thence releasing the biomolecules contained in the vesicles. The examination of 
the membrane surface features regarding the rate and spatial distribution of exocytosis 
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process is thus useful to check on the cell physiological status. AFM is an extremely 
valuable tool in this regard due to the high resolution surface scanning ability to probe any 
invaginations across the membrane. However, AFM is not suitable for examining soft 
biological specimens as the scanning process of the probe will damage the soft biological 
structure. Hence, the Bioimprint was developed to make a hard substrate with captured cell 
surface topography down to the nano-scale so that it is stable enough for probing with an 
AFM scanning tip. The Bioimprint has been shown to have copied the fine structure on cell 
membrane down to 5nm (Samsuri et al., 2011).  
 
Bioimprint is a substrate with cell-like topography, and the imprinted topography contains 
features of the right scale, it therefore may carry more relevant and correct biophysical 
signals in cell culturing. Ishikawa endometrial cells were cultured on the Bioimprint in order 
to study the effect of the cell-like topography on cells. A previous study that cultured 
Ishikawa endometrial cancer cells on the polymethacrylate (pMA) Bioimprint showed 
preferential adherence of cells to areas where there was captured cell topography rather than 
to the flat areas (Figure 1) (Murray et al., 2014). This growing preference of cells on pMA 
substrate may be because pMA is not an optimised cell culture material (detailed discussion 
in chapter 4, section 4.1 and 4.6). The cell-like topography on a non-optimised cell culture 
substrate may have assisted cells to adhere better than on the surrounding flat surface. 
Furthermore, this result showed that endometrial cancer cells sensed the cell-like 























Figure 1 Ishikawa endometrial cancer cells grew preferentially on the Bioimprint surface. 
Adopted from (Murray, 2011,unpublished work). (A) Hoechst 33342 stained Ishikawa 
cell nuclei (B) Atto 594 phalloidin stained Ishikawa cell actin filaments (C) Fluorescein 
incorporated pMA Bioimprint (D) Overlay of fluorescently stained cells and pMA 
Bioimprint. 
Fluorescein (green) was added in the liquid pMA biopolymer mixture before curing. 
The adding of fluorescein made the Bioimprint topography visible. This fluorescein 
incorporated pMA was used as the cell culture platform. After certain culture time, 
the cells were fixed and stained for their actin filaments (red) and nuclei (blue). The 




1.8 Project Outline 
 
The Bioimprint is a culture substrate that enables us to study the influence of topography on 
endometrial cancer cells. First, we compared a Bioimprint made on pMA polymer to the flat 
pMA substrate (abbreviation (f)pMA). This pMA surface contained a negative/pit-like 
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3 Section 3.2.2 for details of making and definition of (f)pMA and (-ve)pMA). We also 
compared these pMA substrates to the conventional cell culture substrates: glass and tissue 
culture grade pST. 
 
Since pMA is not a commonly used cell culture substrate, we next developed the Bioimprint 
on a pST microscope slide. Besides making the Bioimprint on a more common cell culture 
material, the benefit of using pST to make the Bioimprint also allows us to make the 
topography as humps above the horizontal plane, which we call ‘positive’ Bioimprint, 
(+ve)pST, versus hollows below the horizontal, which is named ‘negative’ Bioimprint, (-
ve)pST (Figure 9 illustrates the making of (+ve) and (-ve)pST). We then compared these 
two topographies to the non-imprinted flat polystyrene, (f)pST.  Further, we extended our 
study on flat and Bioimprint pST to investigate the effect of FBS on cell responses to 
surface physical topography. In addition to the innovative use of the Bioimprint in this 
cancer cell study, this is also the first study that investigated endometrial cancer cell 
topographic responses. 
 
Here we hypothesized that endometrial cancer cell behaviours will be influenced by both 
chemical and surface topography factors. We postulated that the cell-like topography we 
used here provoked endometrial cancer cells with physical signals that altered cell 
behaviours compared to cell culture on a flat surface. We further hypothesised that culture 
surface materials (with different surface chemistry) and the serum in culture medium 
(biological source of chemical factors) also influenced cell behaviours, and that those 
factors were influential in modulating cell responses to the physical environment. In short, 
here we studied the influence of surface physical topography both independently and 
incorporated with influences of substrate material and culture medium serum.  
 
The topography alters the physical environment and the details of the mechanical forces that 
mediate its effects will be specific to that topography. In this project the mechanical forces 
have not been identified but this is the topic of another planned project in the laboratory. 
Nevertheless, it is reasonable to believe that the tensile and compressive forces and others 
that will be part of the interaction between cells and their nano- and micro-environments 
will be components of the integrin-mediated signalling. 
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1.9  Thesis Outline 
 
In this thesis, Chapter One addresses the background of mechanical stimuli studies in 
biology and the recent studies that investigated mechanical signal alteration in cancer 
initiation and development, followed by an introduction of the development of Bioimprint 
for cell culture.  
 
 
Next in Chapter Two, the experiment methodologies and materials used in this project are 
presented. Chapter Three gives a detailed discussion of the protocols for making of pMA 
and pST Bioimprints.  
 
 
Then we examined cell morphological changes in response to substrate topography; we 
examined cell morphology, spreading area and cell circularity on glass, tissue culture grade 
pST, pMA and pST Bioimprints and the cell preferential attachment on either flat or pST 
Bioimprints surface. These observations are presented in Chapter Four.  
 
 
Next, by using glass, tissue culture grade pST, pMA and pST Bioimprints, we investigated 
the changes in the expression and distribution of cell adhesion molecule, β1 integrin, the 
major mediator of the adhesion between a cell and the microenvironment (Bouvard et al., 
2013; Gehler et al., 2013). We also studied the expression and distribution of β1 integrin 
downstream effector molecules: cell cytoskeleton and FAK. Further, for pST Bioimprints, 
we examined cell nitric oxide (NO) secretion. Cell NO secretion levels were measured 
because their secretion is modulated by arrangement of actin filaments. All these results (β1 
integrin, cell cytoskeleton and FAK and NO secretion) are discussed in Chapter Five.  
 
 
We also examined cell adhesion, growth and expression of cell growth-related biomolecules 
in cells on glass, tissue culture grade pST, pMA and pST Bioimprints and we present these 
in Chapter Six.  
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For Ishikawa endometrial cancer cells on pST Bioimprints, we further our studies by 
looking at the protein profile of cells on different substrates which we measured using 
isobaric tags for relative and absolute quantitation (iTRAQ) and the results are presented in 
Chapter Seven.  
 
 
Then, as cancer cell vascular endothelial growth factor (VEGF) secretion and cell responses 
to cancer drugs in 3D model have been reported to be different from secretion of cells on 2D 
flat culture substrate (Chitcholtan et al., 2012) and VEGF is a key mediator of angiogenesis 
in cancer, we then examined if Ishikawa cell VEGF secretion was affected by culture 
substrate material and physical topography. For this, we quantified cell VEGF secretion on 
glass, tissue culture grade pST, pMA and pST Bioimprints, and the effect of EGCG and 
CoCl2 on the cell VEGF secretion. Moreover, for cells on pST Bioimprints, we examined 
the effect of the Bioimprint on cell responses to cancer drugs (cisplatin and paclitaxel) with 
regard to cell VEGF secretion and cell growth. We present these observations of VEGF 
secretion and cell response to chemotherapy drugs in Chapter Eight.  
 
 
Lastly, for cells that were grown on pST Bioimprints, we investigated the influences of the 
Bioimprint on cells in the absence of FBS in the culture medium. All the results including 
cell morphology, spreading, cell expression of adhesion biomolecules, cell growth, cell 
protein profile and cell responses to chemotherapy drugs, were examined and are discussed 













Chemotherapy has lengthened the lives of many patients. Yet quite often the effect is 
moderate and also always associated with deleterious side effects (Ouhtit et al., 2013).  
Though improvements have been seen with the use of combination therapy or personalised 
therapy that combats the dynamics and diversity of cancer progress, cancer still remains as 
one of the major causes of death globally. Also, reports have pointed out that drug 
treatments of cancer have only increased survival rates moderately yet often result in lower 
life quality (Fojo & Grady, 2009).  
 
 
One of the recent suggestions is that the physical environment of cancer cells should be 
given attention in finding more efficient treatment (Lee et al., 2013). It is already known that 
tumours have altered mechanical properties, and cancerous cells receive and give different 
mechanical signals compared to normal cells; hence mechanical factors should 
automatically be included in cancer research. The limited number of efficient treatments of 
cancer and the modest effects of treatments may be partly due to poor understanding of the 
physical environment. To illustrate this, a reduced response to drugs by cells in a 3D 
environment has been observed (Chitcholtan et al., 2012). Furthermore, the interaction of 
cancer with the microenvironment is a dynamic process, and chemotherapy and 
radiotherapy resistance have been linked to the interaction between cells and their 
microenvironments through integrin and FA (Storch & Cordes, 2012). In addition to that, 
one of the reasons for adverse side effects from chemotherapy is because the drug agents do 
not differentiate between cancerous cells and normal cells. Hence, the understanding of 
mechanical signals in tumours may help in structuring chemotherapy drugs or improving 
drug delivery systems that can specifically target the tumours with abnormal tissue and 
ECM structures. In short, cancer development and progression should be understood as a 
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Mechanical influences on cell development have been studied extensively on stem cells, 
fibroblasts and endothelial cells, with relatively few studies on cancerous cells. In addition 
to that, most mechanical effects on cancer initiation and development have been focused on 
the stiffness of the tissue microenvironment with few studies looking at the topographical 
effect on cancer cells (Kwon et al., 2011; Zhang et al., 2010b). Not only is this work the first 
study that investigates the topographical effects on endometrial cancer, our study is also 
unique in that features similar to cells themselves are used as substrate topography. 
Furthermore, the Bioimprint enables the separation of topographic effects from cell-cell 
adhesion and secretion as would happen in a 3D cluster. The outcome of this project will 
identify the influence of physical topography on endometrial cancer cells. If any effect is 
observed such activities should be considered when describing tumour development and 
developing tumour therapy. Treatment can be designed to target directly or indirectly the 
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Chapter 2  Methods and Materials 
 
This chapter will describe the materials, equipment (Table 1) and the recipe of the buffers 
used (Table 2) in this project followed by a discussion of the experiment protocols carried 
out in this project. 
 
2.1 Materials and Solution Recipe 
Materials and equipments are listed in Table 1 and the recipes of reagents used in this 
project are listed in Table 2. 
Table 1 Materials and equipment used in this project including the suppliers and locations 
of distributors in New Zealand.  
The list is grouped under separate experiments and is ordered alphabetically in each 
subgroup. 
Cell Lines 
Human dermal microvascular 
endothelial cells: HMEC-1 
A kind gift from the Gene Structure and 
Function Laboratory, Christchurch School of 
Medicine, New Zealand (NZ) 
Ishikawa endometrial cancer cells A gift from Dr Mishato Nishida, Ibraki-ken, 
Japan 
Murine myoblast cells: C2C12 A gift from collaborative partners at Plant and 
Food Research in Hamilton, NZ 








Bright-LineTM Haemocytometer Sigma Aldrich Auckland, NZ 





Centrifuge 5702 Eppendorf Hamburg, Germany 
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Coomassie brilliant blue Sigma Aldrich Auckland,NZ 
Cryotube Raylab Auckland, NZ 
Dimethyl sulfoxide (DMSO) Sigma Aldrich Auckland, NZ 
Dulbecco's modified eagle medium: 
nutrient mixture-F12 (DMEM-F12) 
medium powder 
Gibco, Invitrogen Auckland, NZ 
DMEM-F12 no phenol red Invitrogen Auckland, NZ 
Epidermal growth factor Gibco, Invitrogen Auckland, NZ 
Falcon® 25cm² rectangular canted 
neck cell culture flask 
Becton, Dickinson and 
Company 
Auckland, NZ 
Falcon® 75cm² rectangular canted 
neck cell culture flask  
Becton, Dickinson and 
Company 
Auckland, NZ 
Fetal bovine serum (FBS) GibcoR (via 
Invitrogen) 
Auckland, NZ 
Forma steri-cycle incubator Thermo Fisher 
Scientific  
Auckland, NZ 
Fungizone GibcoR (via 
Invitrogen) 
Auckland, NZ 
GlutaMAX (10x) GibcoR (via 
Invitrogen) 
Auckland, NZ 
Hydrocortisone Sigma Aldrich Auckland, NZ 
Intracellular (IC) fixation buffer Invitrogen Auckland, NZ 
MCDB 131  Gibco, Invitrogen Auckland, NZ 











Sodium bicarbonate Sigma Aldrich Auckland, NZ 
Steritop™ filter units MERCK Millipore North Shore City, NZ 
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Bioimprint 
Ethylene glycol dimethacrylate 
(EGDMA)  
 
Sigma Aldrich Auckland, NZ 




Sigma Aldrich Auckland, NZ 
IRGAcure 2022  CIBA Specialty 
Chemicals 
Basel, Switzerland 
Methacrylic acid  Acros Organics Fisher 
Scientific 
Auckland, NZ 
Omnicure S2000 Excelitas 
Technologies Corp. 
Waltham, MA, USA 
Sylgard® 184 silicone elastomer kit  Dow Corning 
Australia Pty Ltd 
Auckland, NZ 
Ted pella plastic microscope slide  ProSciTech CA, USA 
Western Blot 
40% Acrylamide/Bis solution Bio-Rad Laboratories Hercules, CA, USA 
Alliance 4.7 imaging system Unitec Cambridge, UK 
Ammonium persulfate Sigma Aldrich Auckland, NZ 
BenchMarkTM protein ladder Invitrogen Auckland, NZ 






Bovine anti-rabbit-HRP Sigma Aldrich Auckland, NZ 
Bromophenol blue Sigma Aldrich Auckland, NZ 
Donkey-anti-mouse-HRP Life Technologies, 
Inc., Invitrogen 
Auckland, NZ 
Dri-block heater Techne Staffordshire, UK 
Electrophoresis gel cast plate Bio-Rad Laboratories Hercules, CA, USA 
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Enhanced chemiluminescence (ECL) 
prime western blotting detection 
reagent plus mix  
GE Healthcare Amersham, UK 
EDTA Sigma Aldrich Auckland, NZ 
Glycerol Sigma Aldrich Auckland, NZ 
Glycine Sigma Aldrich Auckland, NZ 
MagicMarkTM XP western protein 
standard 
Invitrogen Auckland, NZ 
 Nonidet P-40 
(NP-40) 
Sigma Aldrich Auckland, NZ 
Orthovanadate Sigma Aldrich Auckland, NZ 
Pierce protein-free blocking buffer  Thermo Fisher Auckland, NZ 
Polyvinylidene difluoride (PVDF) 
membrane 
Bio-Rad Laboratories Hercules, CA, USA 
Power box Bio-Rad Laboratories Hercules, CA, USA 
Precision plus proteinTM standards Bio-Rad Laboratories Hercules, CA, USA 
Protease inhibitor tablet (complete 
mini) 
Roche Diagnostics  Mannheim, Germany 
Sodium deoxycholate Sigma Aldrich Auckland, NZ 
Sodium dodecyl sulphate (SDS) Sigma Aldrich Auckland, NZ 
Tetramethylethylenediamine 
(TEMED) 
Amresco Solon, Ohio 
Tris(hydroxymethyl)aminomethane 
(Tris) 
Sigma Aldrich Auckland, NZ 
 
Tween-20 Sigma Aldrich Auckland, NZ 
Immunofluorescent Staining 
Anti mouse fluorescein isothiocyanate 
(FITC)-488 
Invitrogen Auckland, NZ 
Anti-rabbit Atto 594 Sigma Aldrich Auckland, NZ 
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p-Phenylene-diamine Sigma Aldrich Auckland, NZ 
Texas Red-X phalloidin  Life Technologies, 
Inc., Invitrogen 
Auckland, NZ 
Triton-x Sigma Aldrich Auckland, NZ 
Primary Antibodies 
Cyclin B1,B2, D2, (proliferating cell 
nuclear antigen) PCNA, Cytokeratin-
18, actin (C-2), focal adhesion kinase 
(FAK), phosphorylated-FAK (pFAK), 
(protein kinase B) Akt, 
phosphorylated-Akt (pAkt), 
extracellular-signal-regulated kinases 








Detergent compatible (DC) protein 
assay kit  
Bio-Rad Laboratories Hercules, CA,USA 
DuoSet human VEGF enzyme-linked 
immuno assay (ELISA) development 
kit 
R&D System (via 
Pharmaco) 
Minneapolis, USA 
Nitric oxide kit Cayman Chemical 
Company (via 
Sapphire Bioscience) 









Nunc-immunoTM 96-well solid plate Sigma Aldrich Auckland, NZ 
Scanning Electron Microscope Specimen Fixation 
Glutaraldehyde Sigma Aldrich Auckland, NZ 
Hexamethyldisilazane Sigma Aldrich Auckland, NZ 
Osmium tetroxide Sigma Aldrich Auckland, NZ 
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iTRAQ specimen preparation 
Dithiothreitol (DTT)  Sigma Aldrich  Auckland, NZ 
Ethylene glycol tetraacetic acid 
(EGTA) 
Sigma Aldrich Auckland, NZ 
Hepes buffer Sigma Aldrich Auckland, NZ 
Sodium fluoride Sigma Aldrich Auckland, NZ 
Tris(2-carboxyethyl)phosphine 
(TCEP) 
Sigma Aldrich Auckland, NZ 
Microsope 
Inverted light microscope ACCU-SCOPE Commack, New York 




Zeiss Axio Imager epifluorescence 
microscope  
Carl Zeiss AG Oberkochen, Germany 
Micellaneous 
1.7mL Eppendorf tube Axygen (via Global 
Science) 
Auckland, NZ 
15mL centrifuge tubes  Becton, Dickinson and 
Company 
Auckland, NZ 
Aldosterone  Sigma Aldrich Auckland, NZ 




Cobalt chloride (CoCl2) Sigma Aldrich Auckland, NZ 
(−)-epigallocatechin-3-gallate 
(EGCG) 
Sigma Aldrich Auckland, NZ 





National Institutes of 
Health (NIH), 
Maryland, U.S. 
Microscope slide precleaned plain 
75x25mm 100pcs ground edges 
Fronine (via Thermo 
Fisher Scientific) 
Auckland, NZ 
Nunc® OmniTray Sigma Aldrich Auckland, NZ 
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36 | P a g e  
 
Table 2 Reagents and recipes used in this project. The list is ordered alphabetically. 
Reagents Recipe 
Cell Culture 
Cell freezing medium 90% v/v FBS 
10% v/v DMSO 
1x trypsin EDTA  
 
10% v/v 10x trypsin EDTA  
90% v/v sterilized PBS pH7.4 
Bioimprint 
0.1% HPMC 0.1% w/v HPMC in double distilled water 
Polymethacrylate (pMA) polymer mixture 6:3:1 mixture of ethylene glycol 
dimethacrylate (EGDMA): methacrylic acid: 
IRGAcure 2022 
10% SDS 10% w/v SDS in double distilled water 
5x trypsin EDTA 50% v/v 10x trypsin EDTA 
50% v/v double distilled water 
Western Blot 
10% Ammonium persulfate 10% w/v ammonium persulfate in double 
distilled water  
Coomassie blue destaining solution 50% v/v methanol 
10% v/v acetic acid 
40% v/v double distilled water 
Electrophoresis buffer pH8.3 25mM Tris 
192mM glycine 
0.1% w/v SDS 
5x Laemmli loading buffer 60mM 1M Tris-HCl pH6.8 
25% v/v glycerol 
2% w/v SDS 
0.2% w/v bromophenol blue 
Radio-immunoprecipitation assay (RIPA) 
buffer 
50mM Tris-HCl pH7.4 
100mM Sodium chloride (NaCl) 
5mM EDTA 
1 mM Sodium orthovanadate 
10% v/v glycerol 
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1% w/v NP-40 
0.5% w/v sodium deoxycholate 
0.1% w/v SDS 
1 tablet of phosphatase inhibitor cocktail 
12% Separating gel 3.5 mL water 
4 mL 40% acrylamide/bis solution  
2.5 mL solution B  
50 µL 10% ammonium persulfate 
5 µL TEMED 
Solution B (for western blot separating 
gel) 
1.5 M Tris-HCl (pH8.8) 
0.4% w/v SDS 
Solution C (for western blot stacking gel) 0.5M Tris-HCl  
0.4% w/v SDS 
5% Stacking gel  2.3 mL water 
0.67 mL 40% acrylamide/bis solution  
1.0 mL solution C  
30 µL 10% ammonium persulfate 
5 µL TEMED 
Transfer buffer  15.6 mM Tris base 
120 mM glycine 
Tris-buffered saline (TBS) 20 mM Tris-HCl pH7.5 
140 mM NaCl 
Tris-buffered saline –Tween®-20 (TBST) 0.1% v/v Tween®-20 in autoclaved TBS 
Western blot blocking solutions (the 
suitable antibodies for respective blocking 
solutions are in parenthesis) 
- 5% w/v non-fat dried milk in 0.1% 
v/v TBST (PCNA, Cytokeratin-18, 
Akt, pAkt,Erk1/2,pERK1/2,GAPDH) 
- 1% BSA w/v in 0.1% v/v Tween®-20 
in autoclaved TBS (Cyclin B1, actin 
(C-2), FAK, pFAK) 
- Thermo Fisher Pierce Protein-free 









90% v/v glycerol in PBS pH7.4 
1 g/L p-phenylene-diamine 
Adjusted pH to 8.5 and stored in -20 ºC 
Coomassie blue solvent  10% w/v SDS in 0.01 M hydrogen chloride 
(HCl) 
Coomassie blue staining solution  
 
0.2% w/v CBB stain  
10% v/v acetic acid  
40% v/v methanol  
49.8% v/v double distilled water. 
Phosphate-buffered saline-Tween®-20 
(PBST) 
0.05% v/v Tween®-20 in autoclaved PBS 
pH7.4 
Texas Red-X phalloidin 
 
200 units/mL Texas Red-X phalloidin 
In PBS pH7.4 
VEGF ELISA  
VEGF reagent diluent  1% w/v BSA in PBS pH7.4 
Scanning electron microscope  
Glutaraldehyde 2.5% v/v glutaraldehyde in double distilled 
water 
Osmium tetroxide 1% v/v osmium tetroxide in double distilled 
water 
Absolute ethanol 25%,50%,75% and 90% v/v absolute ethanol 
in double distilled water 
iTRAQ Specimen Lysing 
iTRAQ lysis buffer Phosphatase inhibitor (10 mM sodium 
fluoride and 1 mM orthovanadate) 
1 mM EDTA/EGTA 
0.1% w/v SDS 
50 mM DTT 
1 tablet of protease inhibitor 
5 mM TCEP 
In hepes buffer 
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2.2 Cell Culture Protocols and Reagents Preparation  
 
Cell cultures were done in sterilized conditions in a cell culture biological laminar flow 
cabinet and all the solutions, as well as equipment, used in cell culture were autoclaved and 
stored at an appropriate temperature. 
 
2.2.1 Cell Culture Medium Preparation 
 
The base media powder and sodium bicarbonate were dissolved in sterilized double distilled 
water with the aid of magnetic stirrer. Then the pH was adjusted with sodium hydroxide 
(NaOH) or HCl to pH 7.2. The solution was then filtered into a sterilized bottle and stored in 
a cold room at 4 ºC. The filtration step will bring the solution pH up to pH 7.4. This base 
medium was used within a month, or within a week if opened.  
 
 
2.2.2 Cell Culture 
 
Cells were cultured at 37 ºC in a 5/95 CO2/air incubator. For Ishikawa endometrial cancer 
cells and C2C12 murine myoblast cells, the cells were maintained in DMEM-F12 
supplemented with 10% v/v fetal bovine serum, penicillin (100 units/ml), streptomycin 
(100ug/ml), Fungizone (1 µg/mL) and GlutaMAX TM (2mM). On the other hand, HMEC-1 
cells were maintained in MCDB 131 supplemented with 10ng/mL Epidermal Growth Factor 
and 1ng/mL hydrocortisone in addition to FBS, penicillin, streptomycin, and GlutaMAX, all 
with concentrations stated above.  
 
 
Cells were maintained in 25cm2 or 75cm2 tissue culture flasks. The cell culture medium was 
changed every second day. Once the cells reached 70-80% confluence, the cells were 
harvested and used for experimental culture or for sub-culturing into a new flask. The cells 
used in all the experiments were all within passage 13-30. Further, the end point analysis of 
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To harvest the cells from a culture flask, after discarding the culture medium, the cells were 
washed with room temperature PBS pH7.4 to wash off any remaining medium since the 
FBS in the culture medium may inhibit trypsin activity. Next, sufficient 0.5% trypsin-EDTA 
was added to cover the cell monolayer and the flask was left in the incubator for 15-20mins 
until the cell-flask adhesion bonds were broken by trypsin. The cell suspension was then 
collected in 15 mL BD Falcon tube and spun down at a speed of 15000 rpm to get a cell 
pellet. This was followed by discarding of supernatant. The cells remained as a pellet at the 
bottom of the tube and were dispersed in an appropriate volume of culture medium. Cell 
counting was then performed on the re-suspension of this cell pellet. 
 
 
2.2.3 Cell Counting 
 
100 µL of cell suspension was moved into Eppendorf tubes and the cells were spun down, 
then the medium was removed, and the cells were resuspended with 100 µL PBS pH7.4 and 
100 µL of 0.4% Trypan Blue. The reason for re-suspending cells in PBS pH7.4 was because 
the protein rich cell culture medium may be stained by trypan blue. The mixture was left for 
3 minutes and then 10 µL of this 2x diluted cell suspension was pipetted into a Neubauer 
haemocytometer. The cell number was counted after 1 minute in order to allow cells to 
settle in the chambers.  
 
 
The cell number was counted fromf the four corner squares of the Neubauer 
haemocytometer. The volume of one large corner square was 1mm2 x 0.1mm = 0.1cm x 
0.1cm x 0.01cm =10-4cm3 or 10-4 ml (Figure 2). Therefore, the cell number/mL was 
calculated as average cell number per corner x dilution factor x 104/mL Only the live cells 
that were unstained with 0.4% Trypan Blue solution were included in the counting.  
 












Figure 2 Dimension of a haemocytometer 
Figure showing the dimension of a haemocytometer gridlines and the depth of space of the 
counting area.  
 
 
From the known cell concentration per mL, the volume of cell suspension that contains the 




2.2.4 Cell Freezing  
 
Cell freezing was done to keep cells as cell stock. For cell freezing, the cells in culture flask 
were trypsinized and collected in 15mL BD Falcon tube and spun down. Then cells were re-
suspended with cell freezing medium and counted. At least 1x106 cells must be allocated to 
one cryotube to ensure maximum survival of cells upon thawing. The cryotube was then 
transferred to Thermo Scientific™ Mr. Frosty™ Freezing Container and stored at -20 ºC 
freezer for an hour, and then Mr. Frosty™ Freezing Container was transferred to a -80 ºC 
freezer overnight. Mr Frosty was used to freeze the cells in cryotubes to achieve a rate of 
cooling closed to -1ᵒC/minute. Lastly, the cryotubes were transferred into liquid nitrogen 
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2.2.5 Cell Thawing 
 
Cell thawing was done to obtain cells for cell culture. For cell thawing, a cryotube was taken 
out from the liquid nitrogen tank and was warmed in an incubator for 1-3 minutes; the tube 
should be moved to the cell culture fume hood once the outer layer of the frozen cell 
suspension started to thaw. There must be some unthawed frozen cell suspension to ensure 
that the temperature of the cell suspension did not drop suddenly. The cell suspension was 
then pipetted out very carefully, not to disturb the cells too much and transferred into a 
15mL BD Falcon tube that had been filled with room temperature cell culture medium. The 
cells were then spun down followed by discarding of supernatant, and again the cells were 
re-suspended in new cell culture medium and were ready for re-seeding. 
 
 
The medium of the cell culture of freshly thawed cells was changed one day after re-
seedling to remove any dead cells and cell debris. The cells were passaged for at least 2 




2.3 PDMS gel and Bioimprint 
 
The process of curing PDMS from liquid elastomer and crosslinker is described in Chapter 3 
section 3.2.1.1.  
 
 
The making of pMA Bioimprint and pST Bioimprints and respective control culture 
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2.4 Cell Fixation 
2.4.1 Cell Fixation for Bioimprint or Immunofluorescent or Chemical Staining 
 
Cells ready for fixing were washed with warm PBS pH 7.4 for at least 2 times. Then IC 
fixation solution was added, the volume of which depended on the culture substrate surface 
area, but the cells must be fully covered by the fixative. Then the cells with the fixative were 
left at room temperature for 20 minutes. After the fixation step, the IC fixation solution was 
aspirated out and cells were washed with PBS pH7.4 for 3 times. The cells were now ready 
for experimental use. 
 
 
2.4.2 Cell Fixation for Scanning Electron Microscope Examination 
 
The cells were first rinsed twice with room temperature PBS pH7.5. Then the samples were 
incubated in 2.5% glutaraldehyde for 30 minutes, followed by rinsing twice with PBS 
pH7.4. The cells were then stained with 1% osmium tetroxide for 10 minutes, followed by 
rinsing with double distilled water three times. Then the samples were dehydrated using a 
series of absolute ethanol concentrations: 25%, 50%, 75% and 90%. Each dehydration step 
was for 10 minutes. Then the samples were chemically dried in hexamethyldisilizane 
overnight. All these procedures were carried out in a fume hood.  
 
 
2.5 Proliferation Assay 
 
In this project, two different methods were used to quantify the number of cells growing on 
glass, tissue culture grade pST and pMA substrates and also cells growing on (f)pST, (-
ve)pST and (+ve)pST. Trypan blue counting of trypsinized cells (as described in section 
2.2.3) was done on glass, tissue culture pST and pMA substrates, whereas the coomassie 
blue assay was done on (f), (-ve) and (+ve)pST.  
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For cells cultured on glass, tissue culture grade pST and pMA, cells were easily detached by 
trypsin since the glass and pST were both flat surfaces, and for cells on pMA substrates, the 
ease of trysinization was because of the weaker bonds formed between cells and pMA 
surface. Moreover, coomassie blue made a high background staining on a pMA material; 
hence trypan blue direct cell count was used for cells growing on the glass, tissue culture 
grade pST and pMA. On the other hand, for cells on flat and pST Bioimprints, trypan blue 
cell count was first used but it was then observed that some cells were trapped in the 
physical topography on the surface, and since coomassie blue does not leave a background 




2.5.1 Coomassie Blue Cell Number Standard curve  
 
After cell harvesting and cell counting, a cell suspension with the desired number of cells 
was transferred to triplicate Eppendorf tubes for standard curve cell counting. The number 
of cells depended on the experiment to be carried out, and the cell standard curve was 
constructed to cover 2x the expected cell number range of the relevant experiment.  
 
 
For standard curve cell counting, a serial dilution of cell suspension in 9 Eppendorf tubes, 
each in triplicate was prepared with PBS pH7.4. The cells were spun down and washed once 
with PBS pH7.4, then the cells were spun down again and the wash liquid was pipetted out 
from the cell pellet carefully so that the cell pellet remained in the tube bottom. The cells 
were fixed and washed as described above. Coomassie stain was then added and left for 15 
mins. After that, the stained cells were spun down and the stain was pipetted out, and then 
the stained cells were washed 3 times with double distilled water. Each washing involved 
adding of washing water, spinning down and pipetting out the washing solution. Lastly, the 
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To quantify coomassie blue staining, 150 µL coomassie blue solvent was used to dissolve 
coomassie blue staining, for 10 mins on a shaker, and then 100 µL of the solution was 
transferred into a 96 well plate and absorbance at 595nm was determined.  
 
 
The number of cells was estimated using a standard curve that relates coomassie blue 




The use of standard curve method for relating coomassie blue staining to cell count was 
based on the assumption that the amount of protein in cells was similar in each cell and 
hence the cell number was linearly related to the total protein.  
 
There was an uncertainty in this cell number measurement. The protein content may be 
varied between the spreading cells and the cells that were spun down in the Eppendorf tube 
(cells for standard curve’s cell number measurement). Nonetheless, this method suited the 
cell number measurement for the non-adhered cells in suspension as they were collected 
from the culture medium by spinning the cells down in the Eppendorf tube. 
 
 
2.5.2 Adherent Cell Quantitation 
 
For adherent cell staining, the cell culture medium was aspirated, and the cells were washed 
3 times with PBS pH7.4. This PBS wash solution must be transferred into respective 
labelled Eppendorf tubes for non-adherent cell counting as described in section 2.5.3. After 
washing, the cell monolayer was fixed. These fixed cells were washed three times with 
double distilled water and stained with coomassie blue for 15 mins at room temperature. 
The stained solution was then discarded, and the stained cells were washed by pipetting with 
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2.5.3 Non-adherent Cell Quantitation 
 
For non-adherent cell staining, first, the cell culture medium was transferred into an 
Eppendorf tube and mixed with the PBS pH7.4 wash solution of corresponding adherent 
cells. The suspending cells were spun down. Then the cells were washed three times with 
PBS pH7.4 and fixed. Last, the cells in the tube were stained with coomassie blue as 
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Figure 3 ImageJ measurement of cell spreading area. 
(a) An image of ImageJ toolbox. 
(b) An image of Ishikawa endometrial cancer cells with stained Cytokeratin-18. 
(c) Picture showing a selected cell enclosed with a yellow boundary at the top right corner. 
(d) The ‘Set Measurements’panel of ImageJ showing all parameters that the ImageJ can 
measure. 








48 | P a g e  
 
To measure cell spreading area, first, the ‘pixel to distance’ scale (from a measurement of a 
known distance) was set through Analyze>Set scale.  
 
To measure the cell size from an image, a freehand selection tool ( ) (Figure 3a) was used 
to enclose an area of a cell (Figure 3b: original cell image Figure 3c: a single cell area was 
selected and enclosed). And then from Analyze>Set Measurement, select the measurements 
of interest (Figure 3d). Then performed Analyze>Measure. The measurements were 
displayed in a new window (Figure 3e).  
 
2.7 Cell Preferential Attachment 
 
To examine cell preferential adhesion on flat or imprinted area on a culture surface, cells 
were seeded on a low-density Bioimprint. A low density Bioimprint was a Bioimprint 
culture substrate with both the flat area and the Bioimprint area. To seed the cells, the cells 
were suspended in culture medium and then was pipetted into the chamber The ‘before’ and 
‘after’ cell seeding pictures of pST Bioimprints were taken. In order to align the ‘before’ 
and the ‘after’ images, the back part of each Bioimprint chamber was drawn with a grid so 
that the points where images were taken were known (Figure 4). When the cells in the 
suspension deposited and adhered on the substrate surface, the cells were exposed to the flat 
area and the Bioimprint area. An assumption that cells had equal chance in their allocation 
between flat versus imprinted areas was made. A proposed cell area on each surface was 
calculated as cell confluence multiplied by density of respective area. The measured cell 
area on each flat and Bioimprint area was then compared to the proposed cell area. 
 
In this experiment, cells were seeded at low confluence to avoid cells from covering the 
Bioimprint and flat area altogether.  Also, images were taken at 100x magnification so that a 
large area was covered per image (except for Figure 4(A) which was taken at 200x 
magnification for illustration purposes). Notably, coomassie blue staining was not an ideal 
stain to observe individual cells as an individual cell boundary was hardly visualized. 
Hence, if there was any difference observed, either differential deposition or difference in 
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cell number may be the reason of the observed differences. To minimise this, the after 
image was taken a short duration (24 hours) after cell seeding.  
ImageJ was used to draw the outline of the Bioimprint, cell area on the Bioimprint and cell 
area on the flat surface. Then the respective areas were measured and a paired t-test was 


















Figure 4 Representative images of alignment of ‘before’ and ‘after’ cell culture on the 
substrate.  
(A) Grid was drawn at the back of culture substrate for aligning purposes. 
(B) A pST Bioimprint before cell seeding.  
(C) Coomassie blue stained cells on a pST Bioimprint.  
(D) Outline of cells (in red) drawn from (C) and aligned on (B). 
(E) Outlines of a pST Bioimprint area (black line) overlaid with the red cell outline. 
Area of cells grown on the pST Bioimprint and cells grown on the flat area were 
measured using ImageJ software (cell area measurement with ImageJ was detailed 
in section 2.6). 
‘Before’ Image  
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2.8 RGDS and RGES Treatments 
 
Ishikawa endometrial cancer cells were pre-mixed with 100 µM L-arginylglycyl-L-α-
aspartyl-L-serine (RGDS) or arginyl-glycyl-glutamyl-serine (RGES) or both before seeding 
on pST flat and Bioimprint substrates. After 3 hours seeding time, adherent cells and non-
adherent cells were counted with haemocytometer (section 2.2.3) and percentage of 
adherent cells was calculated. 
 
 
2.9 Total Protein Measurement 
 
For experiments that required quantitation of total protein, the protein content was measured 
using Bio-Rad DC protein assay kit. Protein concentration of each sample was determined 
from a standard curve of BSA. To perform this assay, 5 µL of each sample was added into a 
well of a 96-well plate. Each sample was done in triplicate. Then, 25 µL of solution A’ 
(mixture of 1:0.02 solution A to solution C, both provided by the kit) was added into each 
well, followed by 200 µL of solution B (provided by kit). The mixture was left at room 
temperature for 15 minutes, and the absorbance at 750nm was read. 
 
 
Total Protein was used as a normalisation in western blot protein loading, VEGF ELISA and 
NO assays. An analysis of average protein amount of all samples showed higher total 
protein on (f)pST than on pST Bioimprints, and lowest total protein on (+ve)pST, both in 
culture with or without FBS (Table 3). This was same as cell number analysis of cultures on 
(f), (-ve) and (+ve)pST (Figure 49), indicating a direct relation between cell number and 
total cell protein.  
 
Table 3 A table showing average of total cell protein (mg/mL) of samples (f), (-ve) 
and (+ve)pST, in medium with or without FBS. Data are presented as mean (SEM) of 
measurements of 3 independent experiments in quadruplicate. 
 (f)pST (-ve)pST (+ve)pST 
In Medium with FBS 2.00 (0.60) 1.80 (0.57) 1.67 (0.48) 
In Medium without FBS 1.15 (0.57) 1.06 (0.50) 0.83 (0.39) 
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2.10 Western Blot 
2.10.1 Cell Lysing for Western Blot 
 
Cell culture media were aspirated, and the cells growing on respective substrates were 
washed with PBS pH7.4 three times. Cells were lysed with RIPA buffer containing protease 
inhibitor cocktail tablets for 20 minutes at 4 ºC and were then scraped off surfaces using 
blue tips. The collected cell lysate was then centrifuged at 12,000 rpm for 7 minutes to spin 
down cell DNA or cell debris. The supernatant was transferred to a new Eppendorf tube. 
The cell lysates collected were used immediately or stored at -20 °C. All samples were 
analysed for total protein concentration using BioRad DC protein assay kit (assay protocol 
was described in section 2.9). Following protein concentration determination, the loading 
volume of samples for each lane in sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) gel was adjusted to contain 10ug of protein, and the total 
loading volume was made up to 15µL with 5x Laemmli loading buffer. Then, the mixtures 
were boiled in a 99 ºC heat block for 5 minutes to denature the proteins. All denatured 
samples were quickly cooled on ice for about 1 minute followed by brief centrifugation. The 
samples were adjusted to room temperature just prior to loading.   
 
The only exception was β1 integrin cell lysate, which was not boiled at 99 ºC, but instead it 
was left at 37 ºC for 15 minutes. The reason behind this was that β1 integrin is a 
transmembrane receptor, and the cell lipid bilayer can easily unfold upon heating which may 
have an impact on β1 integrin protein structure. Hence to sufficiently harvest β1 integrin 
protein without destroying it, the sample was left at 37 ºC.  
 
2.10.2 Gel Preparation and Electrophoresis 
 
An electrophoresis SDS-PAGE gel cast plate was set up and 12% separating gel was cast 
within the cast plate for one hour at 37 ºC. Next, 5% stacking gel with 10 wells was made on 
top of this separating gel at room temperature for 30 minutes.  
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After the SDS-PAGE gel was set up, and samples were loaded into each well. Gel 




Before protein was transferred from SDS-PAGE gel onto PVDF membrane, the PVDF 
membrane was pre-incubated in methanol for at least 10 minutes. Next, together with clean 
sponge and blotting paper, the membrane was soaked in transfer buffer for at least 30 
minutes before transferring.  
 
After 30 minutes, a sandwich of SDS-PAGE gel, blotting paper and sponge was assembled, 
and the proteins on the gel were transferred onto PVDF membrane by the wet electroblot 
technique for 1 hour at 100 V constant. After immunoblotting, the membrane was incubated 
in blocking solution: Pierce protein-free blocking buffer, 1% or 4% BSA w/v in 0.1% TBST 
or 5% w/v skim milk in 0.1% TBST was used as blocking solution; the choice of blocking 
solution depended on the protein of interest to be detected. The blocking step was at least 1 
hour at room temperature on a plate shaker. 
 
2.10.4 Antibodies Binding and Protein Bands Visualization 
 
Following blocking, the membrane was incubated in diluted primary antibody solution 
overnight at 4 ºC followed by washing four times, each of 10 minutes duration, and with 
approximately 25 mL of 0.1% TBST. Meanwhile, diluted anti-rabbit or anti-mouse HRP-
conjugated secondary antibody was prepared. The primary and secondary antibody dilution 
solution was 50% blocking solution mixed with 50% TBS-T. The membrane was then 
incubated with the secondary antibody for 90 minutes at room temperature with slow 
shaking on a plate shaker. Next, the membrane was washed four times, each for 10 minutes 
long, and each with roughly 25 mL 0.1% TBST. The last wash was with double distilled 
water for 5 minutes. 
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ECL Plus reagent was prepared just prior to the signal development step to avoid reaction 
between signal development reagents. The signal development solution was made by mixing 
1 part of reagent A and reagent B provided in the ECL Plus kit. Then, the membrane was 
covered with this solution for 7 minutes and the chemiluminescent image was then 
developed with Alliance 4.7 imaging system. The densities of bands were determined using 
ImageJ. The densitometry measurement is not quantitatively linearly related to protein 
amount. It is a semi-quantitation measurement of protein amount (the protein amount is 
more or it is less than a control sample). The background intensity was not included in the 
densitometry measurement using ImageJ (discussed in section 2.10.6). 
 
2.10.5  Western blot densitometry normalisation 
 
In western blot analysis of protein expression, different samples are loaded into different 
lanes and the protein of interest is detected with HRP-conjugated antibody. First the loading 
needs to be normalised to ensure that a same amount of total protein is loaded into each 
lane. From the same amount of total proteins, the relative amount of protein of our interest 
can then be identified.  
 
Also, conventionally western blot experiment would further normalise the densitometry of 
protein of interest with a densitometry of a housekeeping protein. 
 
For western blot of experiments involving comparison between cells cultured on glass, 
tissue culture grade pST and pMA substrates, some commonly-used reference proteins such 
as actin, Cytokeratin-18 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were 
sensitive to the substrate materials (differences in actin and Cytokeratin-18 expression levels 
are discussed in Chapter 5, and for GAPDH is shown in Figure 5). Therefore, western blot 
data for cells on experiments involving material comparison were presented using the same 
sample loading, ensured by total protein measurement, and also with coomassie blue gel 
staining on an additional gel running with the same loading for each sample (methods 
described in next section). An average of coomassie stain densitometry (arbitrary unit) of 
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glass, tissue culture grade pST, (f)pMA and (-ve)pMA were 24203, 22482, 22458 and 
24193, respectively (coomassie blue stained gels are not shown). This similar densitometry 
reading confirmed similar loading amounts for each sample.  
 
For western blot involving the (f), (-ve) and (+ve)pST culture substrates, the analysis used 
both total protein and housekeeping protein’s densitometry normalisation methods. 
 
Figure 5 GAPDH expression in cells 
cultured on glass, tissue culture grade 
pST, (f)pMA and (-ve)pMA. 
(A) (From left to right:  glass, tissue 
culture grade pST, (f)pMA, (-ve)pMA) an 
example of GAPDH western blot protein 
band. 
(B) Densitometry of GAPDH of cells 
cultured on glass, tissue culture grade 
pST, (f)pMA, (-ve)pMA. 
Data are presented as densitometry 
mean ± standard error of the mean 
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(b)               (c)       (d)  
 
 
           
 





Figure 6 ImageJ measurement of densitometry 
(a) An image of ImageJ toolbox. 
(b) Picture showing western blot gel bands with the selected band on the left enclosed with 
a yellow rectangle.  
(c) An image of a band’s profile plot. 
(d) Picture showing the profile plot in (c) is enclosed with a straight line at the base of the 
peak. 
(e) The enclosed plot in (d) is selected and highlighted. 
(f) The ‘Results’ window of ImageJ showing the measured area and the percent (intensity) 
of the western blot band.  
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To measure western blot gel band’s densitometry. First a gel image was opened with ImageJ 
software. Then a rectangle selection tool ( ) (Figure 6a) was used to select a band 
followed by the selection Analyze>Gels>Select First Lane. The rectangle was now set in 
place with a 1 in the middle of it (Figure 6b). And then, the rectangle was clicked and hold 
and dragged over to the second band. Then performed Analyze>Gels>Select Next Lane. 
The step was repeated for all the subsequent bands. After all bands were selected, performed 
Analyze>Gels>Plot Lanes and a profile plot of each lane was presented in a new window 
(Figure 6c). 
 
The profile plot contained the relative density of the bands in the rectangle. A higher peak 
represented a darker band while a wider peak indicated a band with a bigger size. The peak 
did not reach down the baseline of the profile plot (perfect white) because of the background 
signal in the western blot gel images.  
 
To analyse the profile plot, a straight line was drawn across the base of the peak ( ) to 
enclose the peak hence to exclude the background signal from the measurement [(Figure 
6d), red arrow points out the enclosing of the peak]. Then, the Wand tool ( ) was used to 
select and highlight the peak (Figure 6e). The step was repeated for all peaks. While 
highlighting the peaks, densitometry measurements were shown in a new Results window 
(Figure 6f). The measurements in the Results window were then copied into Excel 
spreadsheet.  
 
2.10.7 Coomassie gel staining 
 
After the electrophoresis step, instead of proceeding to the electro-blotting step, the gel was 
transferred to a small container and then the gel was stained for 20 minutes with coomassie 
staining solution on a plate shaker. After that, the stain solution was discarded and a 
destaining solution was added. The gel was left in destaining solution on a plate shaker for 
an hour, and the image was then developed with the Alliance 4.7 imaging system.  
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2.11 Immunofluorescent Staining 
 
Cells were grown on respective substrates until 70-80% confluent and were fixed as 
described above. The fixed cells were washed with cold PBS pH 7.4 for 3 times. For 
Cytokeratin-18 staining, cells were permeabilized with cold methanol for 10 minutes at -
20ºC and for actin, β1 integrin and pFAK staining cells were permeabilized with 0.5% v/v 
Triton X-100 in PBS pH7.4 for 5 minutes at room temperature. After permeabilization, cells 
were washed four times with cold PBS pH7.4, each of 5 minutes duration. Then samples 
were blocked with 5 % w/v BSA in PBS pH7.4 for 60 min at room temperature followed by 
washing with cold PBS pH 7.4 for 4 times, each with 5 mins. For actin filament staining, the 
cells were incubated with 1/40 diluted Texas Red-X phalloidin in 2.5% BSA in PBS pH7.4. 
For β1 integrin and pFAK staining, the cells were incubated with the first antibody (1/100 
dilution with 2.5% BSA in PBS pH7.4). Both incubations were done at 4 °C overnight.  
 
 
For Texas Red-X phalloidin staining, following the overnight incubation, the cells were 
washed with cold PBS pH7.4 for 3 times, each for 10min, and the last wash with cold 0.1% 
v/v PBST for 10 minutes, followed by adding of anti-fading solution. The cells cultured on 
glass and tissue culture grade pST surfaces were then covered by glass cover slips and the 
samples were examined with epifluorescent microscope.  
 
 
For β1 integrin and pFAK staining, after the primary antibody incubation, the cells were 
washed 4 times, each for 5 mins, with cold PBS pH7.4 prior to secondary antibody 
incubation. The samples were left with secondary antibody solution (1/500 dilution with 
2.5% BSA in PBS pH7.4) for an hour at 37 ºC in the dark. After that, 10ug/mL Hoechst 
33342 solution replaced the secondary antibody solution and incubated at 37 ºC for 20 
minutes in the dark. Lastly, the samples were washed with cold PBS pH7.4 for 3 times, each 
for 10min, and the last wash with cold 0.1% v/v PBST for 10 minutes, followed by adding 
of anti-fading solution. The cells cultured on glass and tissue culture grade pST surfaces 
were then covered by glass cover slips, whereas the cells on pMA substrates were examined 
straight after staining since putting on a glass coverslip was technically difficult on the 
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curved surface. The samples were visualized with a Zeiss Axio Imager epifluorescence 
microscope. The stained samples can be stored at -20 ºC for later microscopy examination. 
 
 
2.12 Cell Morphology, Area and Circularity Measurements 
  
Ishikawa cell morphology was examined with an inverted light microscope. The cells 
examined with the inverted light microscope were live cells without any fixation involved. 
Further, the cell morphology was also examined by studying the cell actin filaments and 
Cytokeratin-18 structures with an epifluorescent microscope (the staining of the cell actin 
filaments and Cytokeratin-18 was detailed in section 2.11).  
 
 
Some of the figures presented in this thesis include arrows that point out certain cell 
features, the arrows are pointing out the representative examples in the images and there are 
many instances in the relevant figures. 
 
 
For cell area and circularity measurements, cells were immunofluorescently stained for 
cytoskeleton-18 and were examined under an epifluorescent microscope. Pictures from 4 
corners of the culture chambers were taken, and the sizes and circularities were measured 
using ImageJ from at least 20 cells in each of the 4 corners. 
 
 
2.13 iTRAQ analysis (cell lysing and data analysis) 
 
Cells were cultured for 60 hours, then the cell culture medium was aspirated out and the 
cells were washed 3 times with PBS pH7.4. Next iTRAQ lysis buffer was added into each 
well (100 µL each well) and left in a 4 ºC room for 20 minutes. The cells were then scraped 
off the surface, and the lysate was collected in an Eppendorf tube. The lysate was spun 
down at 12,000 rpm for 7 min to get rid of cell debris. The remaining cell lysate supernatant 
was transferred to a new Eppendorf tube, and the total protein was quantified using a protein 
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assay kit. Sixteen wells of cultures were pooled to become one sample so that the total 
protein reached at least 30 ug/mL for iTRAQ analysis. The need of at least 30ug/mL protein 
was to ensure that there was sufficient amount of protein for total protein measurement and 
for protein processing. The final protein amount loaded for iTRAQ analysis was the same 
for all samples of protein. The samples were transported to Dunedin at room temperature. 
 
iTRAQ involved digestion of different protein samples to peptides. Peptides in each sample 
of cells from the same topography were tagged with a specific isotope. The tagging will 
identify from which sample each peptide was derived. Thence the ratio of levels of a tagged 
peptide from a pair of original paired samples was calculated as r. iTRAQ analysis was 
repeated twice. Two results were pooled and the proteins were selected as significantly 
changed on either (+ve)pST or (-ve)pST compared to (f)pST based on the cut off  r values 
of ≥1.2 as up-regulation and ≤ 0.8 as down-regulation. Further, peptide variation was the 
variation between the ratios of peptides from a particular protein, as a percentage. Here, 
proteins that had mean peptide variation of > 17 % were excluded. (more description of the 
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2.14 VEGF ELISA Assay 
 
Cells were cultured for 60 hours and the medium was collected in an Eppendorf tube for 
VEGF level analysis. The medium was aspirated from culture substrate very carefully so 
that no cell debris was collected which can interfere with the ELISA assay reading. Also, 
the collected medium was spun down at 12,000 rpm for 7 min, and the supernatant was 
transferred to a new tube and immediately stored at -20 ºC until VEGF ELISA.  
 
VEGF ELISA was performed using DuoSet Human VEGF ELISA Kit according to the 
manufacturer’s instructions. Briefly, the immune-plate was first coated with capture 
antibody (anti-VEGF) and was blocked to reduce non-specific binding.  Then, cell culture 
media of each sample was added into a corresponding well, and any secreted VEGF was 
captured by the capture antibody. The secondary antibody (anti-VEGF) coupled to biotin 
then recognized the bound VEGF. The biotin was then bound by streptavidin HRP.  Then 
tetramethylbenzidine was added as substrate for HRP and the absorbance of the colour 
product was read at 570nm.  
 
These secreted VEGF concentrations were normalized with cell number (8.5.1.1) or the total 
protein measured by Bio-Rad DC protein assay kit (8.5.1.2 and 9.5.9.1). The normalisation 
is to counteract the effect of variation in cell number among samples and to look at the 
VEGF secretion per cells. The common way of normalisation is by cell number. However, 
in sections 8.5.1.2 and 9.5.9.1, the VEGF secretion level was normalised by total protein. 
This was because from the same sample, the cells were lysed for western blot and the 
medium was collected for VEGF analysis. The cell lysates collected were unable to be used 
for cell counting, but the total protein of the cell lysates was measured for both VEGF and 
western blot normalisations. Further, as discussed in section 2.9 and the data in Table 3, a 
direct relation between cell number and total cell protein was  observed. 
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2.15 Nitric Oxide Assay 
 
Nitric oxide secretion was measured using a Cayman nitric oxide calorimetry assay kit, 
following the instructions from the manufacturer. This assay measured the total level of 
nitrate and nitrite, which are the final products of secreted nitric oxide. The total level was 
obtained against a standard curve of nitrate.  
 
First, 80 µL of the sample or standard was added into a well of a 96-well plate, then 10 µL 
of Enzyme Cofactor Mixture was added into each sample and standard wells. This was 
followed by adding of 10 µL of Nitrate Reductase Mixture into samples and standards. 
Nitrate reductase functions to convert nitrate to nitrite. The plate was covered with 
aluminium foil and incubated at room temperature for two hours. After the incubation time, 
50 µL of Griess Reagent R1 was added and immediately followed by adding of 50 µL of 
Griess Reagent R2. The mixtures were incubated for 10 minutes at room temperature 
(covering was optional at this step). The absorbance of the assay was read at 550nm. 
 
2.16 Cell Treatments 
2.16.1 Cell EGCG and CoCl2 Treatments 
 
Cells were cultured on respective culture substrates for 36 hours, and then the cell culture 
medium was replaced with medium without FBS for another 24 hours to synchronize the 
cells before treatments. Cells were then treated with 10µM EGCG and 100µM CoCl2 for 24 
hours. The treatment doses were determined from previous work in our lab. 10μM of EGCG 
was used in this project. Previously work in our lab showed that 5μM of EGCG caused 
significant effect on cell cluster but not on cell monolayer (Hogg et al. 2015). Here, the dose 
of EGCG was doubled since Ishikawa cells were grown as cell monolayer on the Bioimprint 
and 10μM has been reported in literature to have caused effects on cells (Wu et al., 2012). 
Similarly, 100μM dose of CoCl2 was chosen based on the previous work in our lab (Dann, 
2008). 
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Then the medium was collected for VEGF analysis and the cells were lysed for total protein 
and western blot analysis. 
 
2.16.2 Aldosterone Treatment 
 
We used aldosterone to soften and reduce stiffness of Ishikawa endometrial cancer cells 
(visualised as depolymerisation of cortical actin). First immunofluorescent staining was 
used to choose the aldosterone optimal concentration since the direct measurement of cell 
stiffness is currently unavailable. For this, we added 1nM, 10 nM and 100 nM of 
aldosterone to Ishikawa endometrial cells and examined the actin structure after 7mins by 
phalloidin staining of the actin filaments. A detection of fragmented cortical actin filaments 
indicated aldosterone depolymerisation of cell cortical actin. The final concentration chosen 
was 10 nM. 
 
Cell culture for NO measurement was done with DMEM-F12 without phenol red as the 
presence of phenol red may interfere with the assay absorbance reading. Cell cultures at 60 
hours were subjected to treatments. After an appropriate time, the cell culture medium was 
collected for nitrite level measurement. After collection into well-labelled Eppendorf tubes, 
the culture medium was immediately stored at -20 ºC. The cells were lysed and were 
quantified for the total protein. The cell lysate was stored at -20 ºC. Nitrite level was 
measured with Cayman nitrate/nitrite calorimetric assay. The brief method was described in 
section 2.15. The nitrite level was normalised with total protein. 
 
2.16.3 Cisplatin and Paclitaxel Treatments 
 
Ishikawa endometrial culture at 36 hours was subjected to cisplatin (20µM) or paclitaxel 
(0.1µM) for 24 hours. The treatment doses were determined from previous work in our lab 
(Hogg et al., 2015; Chitcholtan et al., 2012). Then the cell culture medium was collected for 
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VEGF level analysis, and the cells were lysed for western blot analysis. Since both of these 
clinical drugs were dissolved in DMSO, an equal amount of DMSO was added to another 
set of cell culture as the control for this study. 
 
2.17 Statistical Analysis 
 
The quantitative measuremets in this thesis are presented as the mean of data, plotted as bar 
chart, and SEM indicated by the error bar. The mean and the SEM were calculated from 
measurements from x independent experiments (x = the number of experiment repeat) with 
y replicates (the number of culture well in each experiment repeat) for each culture 
substrates.  
 
The measurements in this thesis were continuous variables and were normally distributed. 
Further, the design of the experiments enabled paired t-test, which controlled for run-to-run 
variation. Hence, the student paired t-test was used to check if there is any statistical 
difference between compared groups in this thesis. Statistic test comparisons were carried 
out between 1) combinations of different culture materials 2) (f)pMA and (-ve)pMA 3) 
(f)pST to each (-ve) and (+ve)pST and 4) between the non-treated sample to treated sample 
on each culture topography. 
 
A difference was described as ‘significant’ when p < 0.05 whereas a ‘trend’ was claimed 
when the p > 0.05 but a pattern of increasing or decreasing was observed between the 
compared samples. 
 
The next chapter will describe in detail the making of pMA and pST Bioimprints, and the 
use of each in cell culture.   
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A Bioimprint is a platform of replication of biological cell impression made by a technique 
based on soft lithography. It was first developed by applying a liquid PDMS polymer 
composite on cultured cells and allowing it to cure to capture the cell topography. The 
imprint  captured the cell nano-and micron-features such as cell membrane vacuoles, but the 
high temperature and the long curing time resulted in dehydration effects on cells (Muys et 
al., 2006). Thereafter instead of PDMS, a photo-curable siloxane copolymer was used to 
make the Bioimprint, though the curing time has been greatly reduced (5 minutes) compared 
to PDMS moulding, the captured cell impression was still the ‘average impression’ of that 
few minutes instead of a snapshot of cells (Muys et al., 2006). Then, another UV curable 
polymer, ethylene glycol dimethacrylate (EGDMA)/ methacrylic acid copolymer, was used 
to make the Bioimprint of cells. An advantage of using this EGDMA polymer was the even 
shorter curing time of this co-polymer, hence reducing artefacts and offering high 
replication resolution (Murray, 2012; Samsuri et al., 2010). However EGDMA polymer is 
not fully biocompatible as a cell culture substrate, and subsequently a Bioimprint was made 
on treated pST microscope slides combining soft lithography and hot embossing methods 
(Goral et al., 2011). The utilization of pST to make the Bioimprint has two advantages; first, 
it is a common cell culture substrate hence the results would be relatively easy to compare to 
other studies. Second, the use of pST enables the making of different presentations of the 
Bioimprint, namely the positive and the negative Bioimprints (Figure 9). 
 
Two polymers were used in this project, pMA and pST. The protocol for making pMA 
Bioimprint was based on the optimised methods developed by Murray (Murray et al., 2014) 
with some minor modifications. In this study, the Bioimprint was made of Ishikawa 
endometrial cancer cells, except for a few proof-of-concept experiments in which the 
Bioimprint was made of C2C12 murine myoblast cells and HMEC-1 cells. To examine the 
role of surface topography on cancer cell behaviours and responses, Ishikawa cells were 
cultured on the Bioimprint of Ishikawa cells to explore how cells respond to physical 
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features that resemble themselves. Biological responses and changes were analysed and will 
be discussed in following chapters.  
 
3.2 Protocol of Making Bioimprint 
3.2.1 PDMS Circular Chambers 
3.2.1.1 PDMS Circular Chambers for Cell Culture for Making of 
Bioimprint 
 
For both pMA and pST Bioimprints, the imprint was taken from cells cultured on glass 
microscope slides in chambers made of PDMS (Figure 7). First of all, PDMS chambers 
were made using the following protocol; 10 parts of Sylgard 184 Silicone Elastomer base 
with 1 part of Sylgard 184 Silicone Elastomer curing agent were well-mixed and poured on 
to a single well Omni tray to mould it as a flat sheet in a dust-free environment. This was 
followed by 20 minutes desiccation to remove any entrapped air bubbles introduced during 
mixing. This mixture was cured on a hot plate at 80 °C for 2 hours. The cured PDMS sheet 
was then cut into rectangular blocks. Each block had an area similar or smaller to a 
microscope glass slide. Then a cork borer with a diameter of 15 mm was used to make 3 
chambers within one PDMS block and these blocks of PDMS were attached firmly to a 
microscope slide.  
 
For the PDMS wells, the wells were made circular instead of any regular shape to distribute 
curing stress more evenly across the surface of the pMA, when used for Bioimprint process 
(protocol described in 3.2.2.1), though the stress was still found to be most intense at the 
middle of the circle which resulted in a concave pMA Bioimprint. In order to distribute the 
stress more evenly, the well diameter had been changed from 14mm (Murray et al., 2014) to 
15 mm; this minor modification reduced the concavity of the Bioimprint platform. 15 mm 
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The microscope glass slides with PDMS chambers were autoclaved prior to cell culture. 
After these PDMS chambers were sterilized, the glass slides with the PDMS chambers were 
ready for cell culture for the making of pMA Bioimprint (protocol described in section 





Figure 7  PDMS block with circular chambers on glass microscope slide. 
Figure showing a PDMS block sticking on a glass microscope slide. Three 15mm 
diameter circular chambers were made on the PDMS block with a cork borer. 
 
To culture the cells, first, the PDMS chamber was half filled with the cell culture medium, 
and then cells in suspension were added to the wells, followed by fully filling the well with 
cell culture medium. This was to maximize an equal dispersion of cells across the circular 
surface. The number of cells added depended on the experiment requirement for the density 
of the Bioimprint. After 48 hours, the cells were all fixed (protocol described in section 
2.4.1), and were used for pMA Bioimprint or PDMS Bioimprint. 48 hours was chosen as 
this is the time point where Ishikawa endometrial cancer cells were well-spread as a 
monolayer. These Bioimprints were done on fixed cells which reduced the dehydration and 
‘average’ impression capture issues as discussed in section 3.1. 
 
3.2.1.2 PDMS Circular Chambers for Cell Culture on Glass and Tissue 
Culture Grade Polystyrene 
 
For cell culture on glass and tissue culture grade pST (both as the controls for cell culture on 
pMA substrate), PDMS circular chambers prepared with methods described above were 
used to make culture chambers on glass microscope slides and tissue culture grade pST 
(Nunc® OmniTray). The PDMS rectangular block with circular chambers was attached 
PDMS sheet 
Circular chamber 
Glass microscope slide 
15mm 
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firmly onto the respective surfaces and the chamber was sterilized with absolute alcohol, 
followed by washing with sterile PBS pH7.4 before cell culture. 
 
3.2.2 Polymethylacrylate (pMA) Culture Substrates 
3.2.2.1 The Making of Polymethacrylate (pMA) Flat and Bioimprint Culture 
Substrates 
 
Polymethacrylate (pMA) polymer was prepared from a 6:3:1 mixture of ethylene glycol 
dimethacrylate (EGDMA): methacrylic acid: IRGAcure 2022. A fresh mixture was made 
each time to minimize reaction occurrence once the solutions mixed. The mixture was then 
vortexed for at least 30 seconds to ensure mixing. Approximately 300 µL of the mixture was 
then loaded slowly into each PDMS sheet chamber and cured with 40% intense UV light for 
240 seconds. Next the pMA disks were left to dry in the chamber. The PDMS blocks were 
peeled off and the pMA disks were collected. The surface of the pMA disk in contact with 
the glass microscope slide captured the impression of the cells (Figure 8 left). This surface 
contained a negative/pit-like Bioimprint and is named (-ve)pMA. On the other hand, the 
control flat polymethacrylate (f)pMA) was made by curing the same mixture on cell-free 
glass slides (Figure 8 right).  
 
Figure 8 The making of pMA UV curable polymer. 
A mixture of 6:3:1 of ethylene glycol dimethacrylate:methacrylic acid:IRGAcure2022 was 
loaded into a PDMS chamber with (a) fixed cells or (b) without cells. The mixture was then 
cured with UV light and the resulted cured polymers were (a) (-ve)pMA with captured cell 
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To ensure that there was no biological residue on the pMA disk, the disks of pMA 
Bioimprint and flat disks were cleaned by sonication in 10% SDS followed by shaking with 
5x trypsin for at least 40 minutes. All disks were then washed with double distilled water 
with agitation in a 24 well plate. After discarding the washing water solution, fresh double 
distilled water was added into each well and the disks were soaked in water overnight to 
dissolve any unreacted polymer. The clean biopolymer disks were next sterilized by dipping 
in absolute alcohol followed by rinsing with PBS to remove left over absolute alcohol. The 
disks were then soaked in cell culture medium DMEM-F12 without FBS for at least 
overnight to buffer the pMA disks to further remove any unreacted methacrylic acid.  
 
3.2.2.2 Cell Culture on Polymethacrylate (pMA) Flat and Bioimprint 
Culture Substrates 
 
In order to use pMA disks as a cell culture substrate they must be placed in a chamber that 
can accommodate the cell culture medium. The pMA disks were first put in a PDMS sheet 
chamber cut with the same diameter cork borer. Yet this often resulted in culture medium 
leakage due to distortion of the bond between the PDMS sheet and the glass slide while 
attempting to fit the pMA disk into the well. In addition to that, the volume of the medium 
that could be put into the PDMS well was limited.  
 
After changing the pMA disks from 14mm to 15mm, the disks were fitted into 24 well 
plates that had a well diameter of 15.6mm. However there was still a 0.6 mm gap between 
the disk and the well, which meant that cells may have had a chance of accidently 
depositing onto the well plate bottom and growing on the pST surface. The use of 24 well 
plates to accommodate pMA disks was still a preferred method compared to fitting the pMA 
disks into PDMS chambers. First, it avoided the risk of culture medium leaking, and second, 
it allowed more culture medium to be filled in the wells. In fact, microscopic examination 





69 | P a g e  
 
3.2.3 Polystyrene (pST) Bioimprints 
 
For pST Bioimprints, the imprint was made of two forms. One was ‘positive’. In this case, 
the features were of humps above the horizontal plane. This Bioimprint is named (+ve)pST. 
The second was ‘negative’ and the features were hollows below the horizontal and is named        
(-ve)pST (Figure 9).  
 
 
Figure 9 Schematic outline of the making of (f)pST, (-ve)pST and (+ve)pST.  
Endometrial cancer cells were cultured and fixed on a glass slide (1). Liquid PDMS was 
poured on top of the cells and cured (2). The cured PDMS was peeled off as the negative 
PDMS Bioimprint (3). Liquid PDMS was poured on the negative PDMS Bioimprint obtained 
at (3) and cured, and then peeled off as the positive PDMS Bioimprint (4). A flat PDMS (5), 
the positive PDMS Bioimprint (6) and the negative PDMS (7) were pressed against a 
polystyrene slide. A flat polystyrene (8), negative polystyrene Bioimprint (9) and positive 
polystyrene Bioimprint (10) was obtained with application of heat and pressure on the 




























(5) (6) (7) 
(8) (9) (10) 
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3.2.3.1 Positive pST Bioimprint 
 
pST Bioimprints were made from PDMS master moulds of the cell impression. First, cells 
were cultured and fixed in a PDMS circular chamber made as described in section 3.2.1 
followed by washing with PBS and distilled water. Then a pre-cured PDMS (34 ºC for 2 
mins) was poured on top, followed by 2 hours curing at 80°C. This PDMS with negative 
cell impressions was peeled off the glass slide and cleaned with 10% SDS and 5% trypsin 
(the cleaning steps as described in section 3.2.2.1 for pMA substrates), and was ready as the 
mould for positive pST Bioimprint.  
 
3.2.3.2 Negative pST Bioimprint 
 
To make positive PDMS moulds for the negative pST Bioimprint, (-ve)pST, a second layer 
of PDMS needed to be cured on top of the negative PDMS Bioimprint made as described in 
section 3.2.3.1. Two methods were used to prevent the formation of crosslinking between 
the two layers of PDMS during the double casting. The first method used HPMC to treat the 
negative PDMS Bioimprint before curing the second layer of PDMS. The negative 
Bioimprint was treated in 0.1% HPMC for 10 minutes on a shaker followed by washing 
thoroughly with distilled water on a shaker for at least one hour. A positive PDMS 
Bioimprint was then made by pouring another layer of PDMS onto this HPMC-treated 




The second method is named thermal aging (Ziółkowska et al., 2011). This method was 
used to replace the HPMC treatment method because this method did not require any 
chemical treatment, hence preventing the risk of chemical residue contamination of the first 
PDMS negative Bioimprint. In this method, the positive PDMS Bioimprint was made by 
pouring another layer of PDMS onto the first PDMS Bioimprint and curing at 80 °C for 48 
hours. This long curing time enabled crosslinking of low molecular species in the master 
PDMS Bioimprint, hence preventing it from forming bonds with the casting PDMS layer.  
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To make a pST Bioimprint, a pST microscope slide was pressed against a PDMS mould, 
and both were sandwiched with glass microscope slides. Then, this sandwich was clamped 
with 6 3/4” wide binder clips to give the pressure needed for transferring the pattern, and the 
imprint was transferred onto the pST slides at 180°C for 15 min. 
 
 
Scanning electron microscope imaging (Figure 10) was done to examine the structure and 
resolution of the negative and positive Bioimprints. As can be seen from the images, the cell 
fine structure such as the filopodia (the thin membrane rod-like extensions) could be 
replicated faithfully down to the nanometer scale onto the pST with this method.  
 
3.2.3.3 Flat pST 
 
The control for pST Bioimprints was flat pST ((f)pST). (f)pST was made from flat PDMS 




Figure 10 Representative scanning electron microscope images of the Bioimprints. 
(A) A (-ve)pST imprint and (B) a (+ve)pST imprint. The images illustrate the retained 
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3.2.3.4 Cell Culture on pST Microscope Slide Bioimprints 
 
As described in section 3.2.1, the cell culture for making the PDMS Bioimprint was done in 
circular PDMS chambers, and hence, the PDMS Bioimprint that peeled off the glass slide 
had defined circular Bioimprint areas. This circular Bioimprint area was cut out from the 
non-imprinted area using a 15mm cork borer, and was pressed against a pST microscope 
slide during the hot embossing transfer of the Bioimprint from PDMS to pST. Because the 
pressure was applied only between the circular PDMS Bioimprint and the pST microscope 
slide, this created a circular pit on pST microscope slide only at the imprinted area, which 
served as a chamber for retaining cell culture medium.  
 
To use either the negative or positive pST Bioimprints for cell culture, the pST Bioimprint 
was first sterilized with absolute ethanol, then rinsed with sterilized PBS pH7.4 followed by 
rinsing with sterilized cell culture medium without FBS. The pST Bioimprint was then 
ready for cell culture. Similar to cell culture on all other substrates, the Bioimprint chamber 
was first half-filled with cell culture medium, and then the cells were seeded into the 




The Bioimprint was first developed to replicate cell surface and membrane features to 
facilitate examination under high-resolution AFM. It was then realised that the cell-like 
topography of the Bioimprint may potentially be a useful substrate/platform for cell culture 
as it provides a physical environment with cell-like physiological features that are absent in 
conventional flat culture surfaces.  
 
In this work, the Bioimprints made on pMA and pST were used, for the first time, as the 
culture substrate for endometrial cancer cells, and the responses of endometrial cancer cells 
to surface topography were studied. 
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There are a few technical limitations in Bioimprint making. Some improvements have been 
made, and will be discussed below together with suggestions that can further refine the 
platform. First, to ensure that the Bioimprint surface was clean enough for cell culture, after 
the replication process, a few cleaning steps were performed to make sure that there was no 
cell debris left on the Bioimprint. However, the assumption that these cleaning steps were 
enough to remove all biological materials has not been validated yet. Future experiments 
that use various staining methods for extracellular matrix or cells will be needed.  
 
On the other hand, it was technically difficult to produce a fully confluent Bioimprint. This 
is because cancer cells would start to grow as a clump once they neared confluence, and if 
the Bioimprint was taken at that stage the imprint would lose the topography of individual 
cells. Hence, the densest Bioimprint would be only 80-90% confluent, which meant that the 
cells would still be encountering flat topography on the Bioimprint platforms. This may 
explain the large error bar in some experiments and the need for many repetitions for 
statistical robustness in most of the experiments (these experiments are presented in chapter 
4 to 9 in this thesis). 
 
In addition, each Bioimprint was sourced from a different cell culture; hence each 
Bioimprint was different from each other in their exact cell-like topography. Although, for 
the pST microscope slide Bioimprint, the PDMS Bioimprint master mould can be repeatedly 
used for a few times, the prolonged use of it was not recommended due to possible polymer 
defects resulting from repeated peeling. Hence, a methodology to turn the topography 
information into a computer program that enables the making of the Bioimprint from 
defined and constant topography information is proposed.  
 
For pMA substrate, concavity of the pMA disk made it hard to be examined under the 
optical microscope. A few steps have been taken to minimise this problem, such as 
increasing the disk diameter from 14mm to 15mm, and the disk was made as thin as 
possible. Also, any unreacted methacrylic acid residue would lower the pH of the cell 
culture medium which is unfavourable for cells, and this was minimised by many washing 
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steps and overnight soaking in sterile double distilled water and cell culture medium without 
FBS.  
 
On the other hand, for pST Bioimprints, the making of pST Bioimprints required the 
replication of cell topography onto PDMS polymer. The need for a long curing process in 
the PDMS Bioimprint making may cause a major issue because adding the polymer liquid 
on the cell layer may change the cell structure over the curing time. This concern was 
minimized by fixing the cells prior to making the Bioimprint. Furthermore, the making of a 
positive PDMS Bioimprint involved casting a second layer of PDMS on the negative PDMS 
Bioimprint. This required a number of peeling steps; hence often a good replication of cell 
features was not uniform across the Bioimprint disks due to lost information upon peeling. 
This was avoided only by careful peeling at this stage, and chosing only the good 




Bioimprint, which is made by utilising soft lithography and hot embossing techniques, is an 
advanced 2D culture substrate with cell-like topography that enables biologists to study the 
influence of cell-like surface topography on cell growth, attachment and biological changes 
in response to physical environment. This could lead to the development of cell culture 
platforms to guide cell growth and spread. The more physiologically relevant topography of 
the Bioimprint compared to other regular patterns makes it a valuable tool for cell culture.  
 
In the next few chapters, the responses of Ishikawa endometrial cancer cells to the 
Bioimprint were reported. First, the morphology and spreading behaviour of Ishikawa cell 
on pMA and pST Bioimprints were studied and were compared the response to cells on flat 
substrates. These results are presented in the next chapter. 
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Chapter 4  Influences of Substrate Material 





Chapter three describes in detail the protocols of the making of both pMA and pST 
Bioimprints. Ishikawa endometrial cancer cells were cultured on the Bioimprints and then 
the cell morphology and spreading were examined on the Bioimprints. The results are 
presented in this chapter.  
 
Cell spreading is a process where cells attach and expand their surface area across a surface. 
A well spread cell is a cell that extends across a large surface area and apprears flatten on 
the culture substrate whereas a non-adhered cell is a cell that attaches loosely on the surface 
appears circular. Cell spreading also reflects the cell adhesion on a surface because in order 
to spread on a surface, a cell will attach on the surface through adhesion molecules and then 
re-arrange the cell cytoskeleton to support and expand the cell body across the surface. Cell 
spreading is influenced by substrate material and surface topography. 
 
Different surface properties such as wettability (hydrophilicity or hydrophobicity) (Horbett 
et al., 1988) and surface charge (Curtis et al., 1983), influence cell adhesion and spreading. 
Cell interaction with surfaces occurs indirectly, it involves cell binding to the adsorbed 
proteins on the substrate surfaces. The type, amount, rate and secondary conformation of 
protein adsorption on surfaces are in turn influenced by surface wettability and charges 
(Arima & Iwata, 2007; Clarke et al., 2005; Lampin et al., 1997). For example, it has been 
shown that proteins from culture medium serum, especially fibronectin, deposited onto 
surfaces assisted cells to adhere and spread, and fibronectin has been shown to be adsorbed 
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better on hydrophilic surfaces than on hydrophobic surfaces (Lampin et al., 1997). In a 
longer term culture, secreted proteins from cells such as fibronectin, laminin, collagen or 
other ECM fibrous proteins will replace the adsorbed proteins. These adsorption and 
desorption processes occur constantly and are optimum on a surface with moderate 
wettability (Grinnell & Feld, 1982; Lampin et al., 1997). The optimal wettability depends on 
the surface material and are also different among different cell types. It has been shown that 
endothelial cells adhered and grew better on methacrylate surface with a contact angle 40ᵒ 
degrees (van Wachem et al., 1987). On the other hand, fibroblasts grew best on polymer 
surface with a contact angle 70ᵒ degress (Tamada & Ikada, 1994) and L cells grew best on 
polymer surface with a  contact angle 60-70ᵒ (Ikada et al., 1994) (Summarized in Figure 26, 
adapted from Saltzman & Kyriakides, 2007).  
 
Wettability is not the only factor that determines protein adsorption. Surface charge that is 
largely determined by surface functional groups also affects the deposition of proteins onto 
surfaces (Arima & Iwata, 2007; Evans-Nguyen et al., 2005; Thevenot et al., 2008). For 
example, surface charge affected the cleavage of fibrinogen to fibrin (Evans-Nguyen et al., 
2005), FA assembling and integrin α5β1 activation (Keselowsky et al., 2004).  Moreover, 
surface charge determines cell morphology directly through electrostatic repulsion or 
attraction forces. A cell membrane is negatively charged; when cells were encountering a 
negatively charged surface, the extent of electrostatic repulsion was reported to be 
proportional to the radius of cell curvature (Parent, 1992). At a small radius (< 8Å), 
attractive van der Waals forces will be dominant instead of repulsive forces. For instance, on 
a negatively charged surface, macrophages formed small radii of pseudopodia to minimize 
the repulsion force (Parent, 1992). Different cell types, which have a different distribution of 
negative charge on the cell membrane, will have different spreading behaviour on 
differently charged surfaces to minimize repulsive forces.  
 
In short, the complex combination effects of substrate surface wettability and charge 
determines cell adhesion and spreading behaviours, partly through adsorption of proteins 
onto surfaces; moreover, the outcomes are dependent on the cell type. Due to the complexity 
of the combined effects of various surface characteristics, and cell adhesion and spreading 
can be further affected by topography and mechanical factors, in which the combined effect 
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is different among different cell lines,  there is no defined rule to predict cell spreading on a 
particular surface.  
 
In this study, the three different materials used for cell culturing were glass, pST and pMA. 
All these three materials have contact angles, which are measurements of surface 
wettability, which permit cell adhesion  Glass and pST are commonly used for cell culture 
as they allow good cell adhesion; they were included in this project to be compared to the 
less common cell culture substrate, pMA. 
 
Not only substrate material but surface topography is also an important factor in influencing 
cell adhesion and spreading. A lot of work has been done in this regard with different cell 
lines: mesechyma cell, fibroblast, osteoblast, epithelial cell (Dalby et al., 2007; Karuri et al., 
2004; Kidambi et al., 2007; Webb et al., 1995; Wood, 1988; Yim et al., 2010; Zinger et al., 
2004) and so on. Some of these studies cultured cells on regular patterns such as pillars, pits, 
grooves or ridges; some in more biological mimetic 3D scaffolds made of collagen, elastin 
or synthetic polymers like polyamides, polylactides and so on. An even more biomimetic 
substrate topography was the use of bioimprinted tendon tissue microenvironment in 
guiding differentiation of mesenchymal cells (Tong et al., 2012).  
 
The surface topography influence on cancer cells is nevertheless less explored, and only a 
few studies have examined the effect of topography on cancer cell lines, mainly in cell 
adhesion, growth and migration. All these studies showed that cancer cells respond to 
surface topography and change their behaviours (refer to the detailed discussion in    
Chapter 1, section 1.6).  
 
In addition to comparing the influence of different cell culture materials, the effect of 
topography on endometrial cancer cells’ behaviours was investigated by making the 
Bioimprint on pMA (Figure 8) (comparing to the flat pMA) and on pST (Figure 9) 
(comparing to the flat pST). Additionally, Bioimprints on pST were made as negative versus 
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positive topographies (Figure 9) to further investigate the effect of topography on cell 
behaviours.  
 
Cell adhesion and spreading regulate cell survival and cell growth (Chen et al., 1997; 
Folkman & Moscona, 1978). Optimum adhesion ensures survival and growth of cells. Cell 
shape regulation of cell survival and growth may be partly through regulating intracellular 
biochemical reaction rates. This is because shape changing resulted in cell volume 
alteration, which then influenced local concentration of substrate and product, and 
ultimately affected intracellular reaction direction (Lizana et al., 2008). It has also been 
recently reported that NFκB localization in cells was modulated by cell morphology (Sero et 
al., 2015). Seeing that cell morphology can determine cell behaviours, the morphology of 
Ishikawa endometrial cancer cells was first checked, qualitatively and quantitatively, on 
different substrates. 
 
To check the cell spreading, the cell morphology at 6, 24, 48 and 60 hours was examined 
with a light microscope. Then, the cell spreading area and cell circularity (the measurement 
of the cell roundness) were quantified.  Furthermore, the spreading of actin filaments and 
Cytokeratin-18 of cells cultured on different substrates at 60 hours were also studied. Actin 
filaments were studied because they are sensitive to mechanical signals, and polymerise 
upon sensing exogenous forces to elevate intracellular tensional force, allowing cells to 
adhere and pull on an adherent surface. Cytokeratin-18 on the other hand, gives cells 
structural support and defines cell shape. Cytokeratin-18 restructuring can result in 
activation of certain intracellular biomolecules such as Rho GTPase protein, Myosin II, 
FAK etc (Chrzanowska-Wodnicka & Burridge, 1996; Cichowski, Brugge, & Brass, 1996; 
Han et al., 1997; Zheng et al.,1996) which are all biomechanically sensitive biomolecules 
that trigger downstream signalling pathways. 
 
In addition, a previous study showed that cells preferentially attached on imprinted pMA 
surfaces (Murray et al., 2014); in this study, this idea was further tested on pST Bioimprints; 
by making a ‘low-confluent-Bioimprint’, cells were deposited onto a substrate with both the 
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flat and Bioimprint. Cell preferential attachment was then measured by comparing the 




1. Ishikawa endometrial cancer cells have different spreading area, cell morphology 
and cell cytoskeleton arrangement on glass, tissue culture grade pST and pMA 
substrates; and between (f)pMA and (-ve)pMA as well as among (f)pST, (-ve)pST 
and (+ve)pST. 
2. Ishikawa endometrial cancer cells have different preferential attachment between flat 





The purposes of the experiments in this chapter were to examine whether Ishikawa 
endometrial cells were responsive to culture substrates made of different materials or to 
substrates of same material but different surface topographies, by changing their forms and 
structures, and deposition preferences between flat and imprinted surface. Here, we aimed 
to: 
1. Examine cell morphology at 6, 24, 48 and 60 hours on different culture substrates.  
2. Examine cell actin filaments and Cytokeratin-18 spreading at 60 hours on different 
culture substrates. 
3. Measure cell Cytokeratin-18 spreading and cell circularity on different culture 
substrates. 
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4.4 Experimental Approach 
 
To examine cell morphology, Ishikawa cells were examined under an inverted microscope 
and were photographed at 6, 24, 48 and 60 hours. For cell cytoskeleton spreading, Texas 
Red-X phalloidin and immunofluorescent staining were used to examine actin and 
Cytokeratin-18, respectively. Also, cell Cytokeratin-18 spreading area and cell circularity 
were measured using ImageJ.  For cell deposition, the cell spreading area on flat surface was 
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4.5 Results 
4.5.1 Ishikawa Endometrial Cancer Cell Morphology 
4.5.1.1 Ishikawa Endometrial Cancer Cell Morphology on Glass and Tissue 
Culture Grade Polystyrene, Polymethacrylate Flat and Bioimprint 
Culture Substrates 
 
To investigate cell adhesion and spreading, Ishikawa endometrial cancer cell images were 
taken after 6, 24, 48 and 60 hours so that the rate of cell adhesion and spreading on different 
surfaces could be compared. Cells growing on glass and tissue culture grade pST both had 
similar adhesion behaviour and morphology (Figure 11 and 12). Cells were first rounded 
and aggregated in small clusters in the medium after 6 hours of seeding; nonetheless, there 
were a few cells (red arrow) which had started showing attachment on the surface. From 24 
hours onward, cells were all well spread on the surface and were grown to confluency 






























Figure 11 Representative images of Ishikawa endometrial cancer cells on glass culture substrate 
at 6, 24, 48 and 60 hours.  
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Figure 12 Representative images of Ishikawa endometrial cancer cells on tissue culture grade 
pST at 6, 24, 48 and 60 hours.  
Red arrows indicate two examples of cells that showed early spreading on tissue 







6 hours 24 hours 
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In addition to glass and tissue culture grade pST, pMA was also used as our cell culture 
substrate. Ishikawa on (f) and (-ve)pMA both had similar adhesion behaviour and 
morphology to each other but distinct from Ishikawa on flat glass and tissue culture grade 
pST surfaces; cells looked rounded and clustered rather than flattened and spread at all times 
when images were taken (Figure 13 and 14). Further, at 6 and 24 hours, the cells were 
captured at a focal plane different from the culture substrate surface, indicating that the cells 
were still in the cell suspension. The culture substrate surface was identified by the visible 












Figure 13 Representative images of Ishikawa endometrial cancer cells on (f)pMA at 6, 24, 48 
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Figure 14 Representative images of Ishikawa endometrial cancer cells on (-ve)pMA at 6, 24, 48 
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4.5.1.2 Ishikawa Endometrial Cancer Cell Morphology on Flat, Negative 
and Positive Bioimprint Polystyrene Slides 
 
Next, Ishikawa endometrial cancer cells were cultured on pST flat and Bioimprint slides. 
Again, cell morphology at 6, 24, 48 and 60 hours was examined to check the cell spreading. 
Similar to cells on tissue culture grade pST (Figure 12), cells on pST slides, both flat and 
Bioimprints, started to show flattened adherent morphology after 6 hours of seeding and 
grew to confluency at 48 hours (Figure 15, 16 and 17). At 6 hours, most of the Ishikawa 
cells were still in cell suspension and not attached on surface, hence the cells were seen as 
circular cells. The background Bioimprint was not seen at this focal plane that captured the 
cells. However, at 24, 48 and 60 hours, the cells were not distinguishable from the 
Bioimprints because the focal plane that looked at the attached cells was the same as the 
focal plane that focused the background Bioimprint. But at this early stage, it was speculated 
that cells that contained vacuoles (which were seen as white spots) were the real cells 
(indicated in figures with red arrows). This indistinction indicated that the cells were well-
spread on pST microscope slide surfaces. For the remaining experiments, cell staining was 


























Figure 15 Representative images of Ishikawa endometrial cancer cells on (f)pST at 6, 24, 48 
and 60 hours.  
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Figure 16 Representative images of Ishikawa endometrial cancer cells on (-ve)pST at 6, 24, 48 
and 60 hours.  
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Figure 17 Representative images of Ishikawa endometrial cancer cells on (+ve)pST at 6, 24, 48 
and 60 hours.  
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4.5.2 Ishikawa Endometrial Cancer Cell Cytoskeleton 
4.5.2.1 Ishikawa Endometrial Cancer Cell Cytoskeleton on Glass and 
Tissue Culture Grade Polystyrene, Polymethacrylate Flat and 
Bioimprint Culture Substrates 
 
In addition to observing cell morphology with an inverted microscope, the cell actin 
filaments and Cytokeratin-18 were also stained to observe their alignment on different 
substrates. Cell cytoskeleton functions to support the cells on the surface hence a linear-type 
cytoskeleton structure indicates “well-spread” behaviour. Actin filaments were chosen to be 
stained since they are known to be responsive to the mechanical signal from the 
surroundings; also, Cytokeratin-18 was stained because it supports cell structure and defines 
cell size.  
 
Ishikawa endometrial cancer cells cultured on glass and tissue culture grade pST had similar 
actin filaments and Cytokeratin-18 arrangement. They had well-spread cytoskeleton across 
both surfaces (Figure 18).  
 
Cell actin filaments and Cytokeratin-18 staining on pMA substrates showed rounded 
spreading (Figure 18); when compared to cells on glass and tissue culture grade pST (Figure 
18). Further, cells on (-ve)pMA biomprint had slightly more spread out cell actin and 
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Figure 18 Representative images of Ishikawa endometrial cancer cell actin filaments and Cytokeratin-18 staining on glass, pST, (f)pMA and (-ve)pMA.  
Ishikawa cell actin filament was stained red with Texas Red-X phalloidin, cell Cytokeratin-18 was stained green with Alexa Fluor 488-tagged 
Cytokeratin-18 antibody. and the cell nucleus was stained blue on (a)& (e) glass, (b)& (f) tissue culture grade pST, (c)& (g) (f)pMA and (d) &         
(h) (-ve)pMA. Yellow arrows show examples of cells that had well-spread (d) actin filament and (h) cell Cytokeratin-18 on (-ve)pMA. 
 
(a) Glass: Actin (b) pST: Actin 
(g) (f)pMA:  Cytokeratin-18 (h) (-ve)pMA: Cytokeratin-18 
 
(e)Glass: Cytokeratin-18 (f) pST: Cytokeratin-18 
 
(-ve) pMA: Actin (c) (f)pMA: Actin (d) (-ve)pMA: Actin 
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4.5.2.2 Ishikawa Endometrial Cancer Cell Cytoskeleton on Flat, Negative 
and Positive Bioimprint Polystyrene Slides 
 
In agreement with the observed well-spread behaviour of cells on pST Bioimprints in 
section 4.5.1.2, an examination of fluorescently stained cell cytoskeleton again showed that 
cells on pST surfaces: (f), (-ve) and (+ve)pST Bioimprints all had well-spread morphology 




Figure 19 Representative images of Ishikawa endometrial cancer cell actin filaments and 
Cytokeratin-18 staining on (f), (-ve) and (+ve)pST.  
Ishikawa cell actin filament was stained red with Texas Red-X phalloidin, cell 
Cytokeratin-18 was stained green with Alexa Fluor 488-tagged Cytokeratin-18 antibody. 












(f) pST:  
Cytokeratin-18 
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4.5.3 Ishikawa Endometrial Cancer Cell Spreading Area and Circularity  
4.5.3.1 Ishikawa Endometrial Cancer Cell Spreading Area and Circularity 
on Glass, Tissue Culture Grade Polystyrene, Polymethacrylate Flat 
and Bioimprint Culture Substrates 
 
After the preliminary observation that cells had different morphologies between substrates 
made of conventional cell culture substrates versus pMA; and between (f)pMA versus        
(-ve)pMA; no observable difference was seen between (f)pST versus either (+ve) or (-
ve)pST. Next, to quantify cell morphology, the cell cytoskeleton spreading area was 
measured to determine the effects of material and topography on cell structure. 
 
Cells showed larger cytoskeleton spreading area on glass and tissue culture grade pST 
surfaces, which paralleled the observation that cells had well-spread morphology on these 
two surfaces. Whereas for cells on pMA surfaces, in which cells appeared to be circular on 
both the flat and the Bioimprint surfaces, cells had smaller spreading area compared to cells 
on glass and tissue culture grade pST. Nonetheless, cells on (-ve)pMA had larger spreading 
area compared to cells on (f)pMA (Figure 20). 
 
Furthermore, cell circularity measurement showed that cells on pMA substrates were 
significantly more circular than cells on glass and tissue culture grade pST, and comparison 
between (f)pMA and (-ve)pMA showed that cells were less circular on (-ve)pMA; 
interestingly, circularity of cells on tissue culture grade pST versus (-ve)pMA was not 









Figure 20 Ishikawa endometrial 
cancer cell spreading area on glass, 
tissue culture grade pST, (f)pMA and 
(-ve)pMA.  
Ishikawa cells were cultured for 60 
hours, followed by cell fixing and 
Cytokeratin-18 staining. The cell 
images were then taken from four 
corners of a culture chamber. Then at 
least 20 cells were chosen from each 
corner for cell surface area 
measurement. Data are presented as 
cell surface area mean ± SEM of at 





Figure 21 Ishikawa endometrial 
cancer cell circularity on glass, 
tissue culture grade pST, (f)pMA 
and (-ve)pMA.  
Ishikawa cells were cultured for 60 
hours, followed by cell fixing and 
Cytokeratin-18 staining. The cell 
images were taken from four 
corners of a culture chamber. Then 
at least 20 cells were chosen from 
each corner for cell circularity 
measurement. Data are presented 
as cell circularity mean ± SEM of at 








95 | P a g e  
 
4.5.3.2 Ishikawa Endometrial Cancer Cell Spreading Area and Circularity 
on Flat, Negative and Positive Bioimprint Polystyrene Slides 
 
For pST microscope slides, even though there was no observable difference in cell 
morphology, quantification of cell cytoskeleton spreading showed that cells on (f)pST had a 
larger surface area compared to cells on (-ve) and (+ve)pST (Figure 22). 
 
Furthermore, cells on (-ve)pST were less circular than cells on (f)pST and (+ve)pST, and no 
statistical difference between cells on (f)pST and (+ve)pST was observed (Figure 23). 
  
 




Figure 22 Ishikawa endometrial 
cancer cell spreading area on 
(f)pST, (-ve)pST and (+ve)pST 
imprint. Ishikawa cells were 
cultured for 60 hours, followed 
by cell fixing and Cytokeratin-18 
staining. Cell images were taken 
from four corners of a culture 
chamber. Then at least 20 cells 
were chosen from each corner 
for cell surface area 
measurement. Data are 
presented as cell surface area 
mean ± SEM of at least 80 




Figure 23 Ishikawa endometrial 
cancer cell circularity on (f)pST,       
(-ve)pST and (+ve)pST imprint.  
Ishikawa cells were cultured for 
60 hours, followed by cell fixing 
and Cytokeratin-18 staining. Cell 
images were taken from four 
corners of a culture chamber. 
Then at least 20 cells were 
chosen from each corner for cell 
circularity measurement. Data 
are presented as cell circularity 
mean ± SEM of at least 80 
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4.5.4 Specificity of Ishikawa Endometrial Cancer Cell Alignment on Surface 
Topography 
4.5.4.1 Ishikawa Endometrial Cancer Cells on Ishikawa Polystyrene 
Microscope Slide Bioimprints 
 
Previously works in our lab observed that there was preferential attachment on imprinted 
areas on (-ve)pMA compared to flat areas (Murray et al., 2014). Here cell deposition on pST 
flat or Bioimprint areas was quantitatively measured with the methods described in Chapter 
2 Section 2.7. The measured cell area was then compared to the proposed cell area.  
 
Ishikawa cells were observed to have selectively grown on a substrate negatively imprinted 
with Ishikawa cells. No selective binding was observed on the substrate that was positively 













Figure 24 Ratio of the measured Ishikawa cell area to the proposed cell area on respective 
surfaces.  
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4.5.4.2 Ishikawa Endometrial Cancer Cells on C2C12 Murine Myoblast 
Polystyrene Microscope Slide Bioimprints 
 
me procedure was performed using an imprint of C2C12 mouse myoblast cells as substrate 
for the endometrial cancer cells to investigate the possibility that the preference was a result 
of a non-specific effect of surface patterning.  In contrast to Ishikawa cells cultured on 
Ishikawa cell imprints, Ishikawa cells cultured on a substrate negatively imprinted with 
C2C12 cells showed no preferential attachment on imprinted area.  Further, there was again 














Figure 25 Ratio of the measured Ishikawa cell area to the proposed cell area on respective 
surfaces.  







































4.6.1 Ishikawa Endometrial Cancer Cell on Glass, Tissue Culture Grade 
Polystyrene and Polymethacrylate Flat and Bioimprint Culture Substrates 
 
Ishikawa endometrial cancer cells adhered on glass and tissue culture grade pST flat 
surfaces in a very short time and adhered very well to these surfaces. This is not surprising 
since glass and tissue culture grade pST are both substrates that support cell adhesion which 
makes them commonly used for cell culture. Glass was the very first material used for cell 
culture in the early 20th century; and is now mainly used for experiments involving 
microscopy imaging. In the mid-20th century, the culture substrate shifted from glass to the 
more convenient disposable pST. pST itself is not a favourable substrate for cell adhesion 
because of its charge-neutral and hydrophobic surface, hence it needs surface treatments 
such as corona discharge and plasma treatment. Surface treatments on pST surface 
incorporate oxygen ions onto surfaces to make it hydrophilic and negatively charged. In this 
project, two sources of treated pST were used for studies that involved comparison between 
tissue culture grade flat pST and pMA (the source was the Nunc Omni polystyrene tray), 
and for comparison between (f)pST and pST Bioimprints (the source was the Ted Pella 
polystyrene microscope slide); these pST substrates may have been differently surface-
treated, or have differences in their compositions. However, there were no differences in the 
effects that were observed. 
 
The reasons behind the difference in cell adhesion on glass, tissue culture grade pST and 
pMA substrates are related to the surface properties including wettability and surface 
charges of these substrates. The glass has a negatively charged surface due to dissociation of 
terminal silanol groups in aqueous conditions, while the treated tissue culture grade pST has 
a negatively charged surface in solution due to the presence of oxygenated functional groups 
on surfaces. These negatively charged surfaces may have facilitated protein deposition from 
either the serum or cell secretions, that in turns assists cell adhesion. Instead, pMA has a 
charge-neutral surface that may promote poor protein deposition and so resulting in lower 
cell adhesion compared to glass and tissue culture grade pST surfaces.  
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Moreover, each of these materials has different contact angles. Glass, tissue culture grade 
pST and pMA each has been reported to exhibit angles of wettability of 26-45, 35-68 and 
65-80 degrees, respectively (Saltzman & Kyriakides, 2007), which are the contact angle 
ranges that allow cell adhesion (Figure 26). In our laboratory, contact angles for glass and 
tissue culture grade pST were observed to be 23.935˚ and 58.295˚, respectively (Murray et 
al., 2014).  
 






Figure 26 Cell adhesion at different contact angle. Fibroblasts (open squares); L cells (open 
circles) and endothelial cells (open triangles and filled circles).  
Adapted from Saltzman, W. M., & Kyriakides, T. R. (2007). Chapter Twenty-Cell 
interactions with polymers. In R. L. L. Vacanti (Ed.), Principles of Tissue Engineering 
(Third Edition) (pp. 279-296). Burlington: Academic Press. 
 
 
It has been found that moderate wettability gave cells the optimum cell adhesiveness 
(Saltzman & Kyriakides, 2007). Hence, glass and treated pST are both ideal cell culture 
substrates since their surfaces are negatively charged and the surface contact angles are 
close to the optimum culture wettability range. On the other hand, pMA is a biocompatible 
substrate, yet it is not a very favourable cell culture substrate because of the slightly high 
surface contact angle and its neutral surface.  
 
The influence of substrate material characteristics on cells was shown in our observations 
that Ishikawa cells appeared circular and smaller on both (f) and (-ve)pMA than on glass 
and tissue culture grade pST, using inverted light microscopic examination, cell 
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cytoskeleton staining and cell circularity measurement. Nonetheless, by comparing between 
(f)pMA and (-ve)pMA, Ishikawa cells were bigger in size and less circular if the Bioimprint 
was present. This implies that even on a non-favourable substrate, the presence of cell-like 
surface topography helps cells to spread better.  
 
4.6.2 Ishikawa Endometrial Cancer Cell on Flat, Negative and Positive 
Bioimprint Polystyrene Slides  
 
On the other hand, on pST, which is a substrate optimized for cell adhesion, the Bioimprint, 
especially the positive Bioimprint may restrict cells to spread, which can be seen from 
smaller cell size and higher circularity on (+ve)pST compared to (f)pMA.  
 
For pST microscope slides, Ishikawa cells also showed preferential attachment on (-ve)pST 
but not on (+ve)pST; which was supported by the previous observation that cells showed 
preferential attachment on (-ve)pMA (Murray et al., 2014). This difference between            
(-ve)pST and (+ve)pST may be because of gravitational effect of pulling cells down into the 
pit, or gravitational effect on the deposition of proteins. To test this hypothesis, Ishikawa 
cells were cultured on a different type of Bioimprint: C2C12 murine myoblast Bioimprint. 
Here C2C12 murine myoblast cells were chosen because this cell line has different 
morphology from that of Ishikawa cells. Hence, C2C12 murine myoblast Bioimprint was a 
culture platform that similarly had pit-and hump-like topography, but the topography shape 
was different from the seeding Ishikawa cells.  
 
Ishikawa cells did not show similar preferential attachment on C2C12 (-ve)pST Bioimprint. 
Hence, the presence of negative Bioimprint is not the reason for the observed preferential 








The results in this chapter favour our hypothesis that the spreading behaviour of Ishikawa 
endometrial cancer cells can be influenced by physical microenvironment. Ishikawa cells 
had well-spread morphology, larger spreading area and were less circular on glass and tissue 
culture grade pST, compared to pMA substrates. In addition to substrate materials, the 
presence of cell-like topography, both on pMA and pST substrates, has changed the cell 
spreading and morphology. On pMA substrates, the Bioimprint improved cell spreading as 
shown by larger cell spreading area and less circularity on (-ve)pMA than on (f)pMA 
whereas on pST microscope slide substrates, (-ve) and (+ve) Bioimprints both may have 
limited cell spreading.  
 
Moreover, Ishikawa endometrial cancer cells had preferential attachment on (-ve)pST than 
on (f)pST, which paralleled with previous observations that cells had preferential attachment 
on (-ve)pMA. Most importantly, this preferential attachment was not seen on (+ve)pST nor 
on (-ve)pST Bioimprints made from a different cell type.  
 
These observations imply that surface topography, which was able to be studied 
independently from the substrate material, is influential on the area of cell spreading, 
morphology and preferential adhesion. Since cells were seen to respond to different 
substrate materials and topographies in terms of cell spreading and morphology, the 
adherence and growth of Ishikawa endometrial cancer cells on substrates of different 
materials with or without the Bioimprint were investigated. In the next chapter, the cell 
structure was characterised further by looking at the expression and behaviours of adhesion 
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Chapter 5 Influences of Substrate Material 
and Topography on Ishikawa Endometrial 





Ishikawa endometrial cancer cells morphology and spreading were observed to be different 
in response to different physical microenvironments in the previous chapter. Here in this 
chapter, the results that further characterize the cell adhesion and cytoskeleton behaviours in 
response to culture substrate material and topography are presented. 
 
Ishikawa cells were observed to have different morphologies which indicated that they 
spread differently on distinct substrates of different materials and topographies. This 
brought the project to the next question of whether or not the expression of cell adhesion 
molecules was also affected. For this, the expression of the cell adhesion receptor, β1 
integrin, and the activation of a downstream kinase FAK were quantified. Further, because 
the cell adhesion molecules were known to influence cell cytoskeleton arrangement and 
density that ultimately changed the cell spreading, the expression levels of actin and 




Integrins (Figure 27) are transmembrane hetero-dimer receptors consisting of an α subunit 
and a β subunit. There are 18 α subunits and 8 β subunits that give rise to 24 possible 
combinations of integrin receptors. Integrins were first described in 1986 and marked a 
 
104 | P a g e  
 
major breakthrough in the field of biomechanical study (Tamkun et al., 1986). The 
extracellular part of the integrin binds to ECM components, such as to fibronectin through 
Arg-Gly-Asp (RGD) tripeptide sequences. Whereas the intracellular part of the integrin is 
attached to adaptor proteins including talin, vinculin and FAK, forming a focal adhesion 
(FA), which in turn is connected to actin cytoskeleton. In short, integrin is the bridge 
between ECM and intracellular cytoskeleton and proteins. The function of integrin is to 
work as a sensor to physical environment changes. The physical environment changes can 
be either endogenously or exogenously initiated. Integrin senses the changes and then 
conveys the force signal bi-directionally. Integrin can be activated extracellularly, which 
then changes the cell signalling intracellularly. Alternatively, integrin can also be activated 
intracellularly, which alters the integrin’s affinity to ligands extracellularly. For example, 
integrin has been shown to be activated by ligand mimetic peptide or Mn2+ extracellularly, 
and altered its conformation from the inactive form to the active structure (Takagi et al., 
2002). On the other hand, integrin can also be activated by talin in the intracellular 
compartment, and then changed from the inactivate clasped structure to the activate 
unclasped conformation  (Vinogradova et al., 2002).  
 
The activated integrins cluster together with a number of adaptor proteins intracellularly and 
form FA (Galbraith et al., 2002; Paszek et al., 2005). In this activated form, integrin changes 
the composition and movement of the intracellular adaptor proteins and/or changes the 
network lattice of the intracellular cytoskeleton, which ultimately changes the cell 
behaviours. The next section discusses the role of FA in mechanical signalling. 
 
Figure 27 Diagram of hetero-dimer integrin.  
Figure showing an integrin molecule consisting of an α and 
a β subunit. Me 2+: methyl 2+, S-S: disulfide bond. Adapted 
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5.1.2 Focal Adhesion (FA) 
 
Integrin clustering is followed by a formation of cell-matrix adhesion complex or focal 
complex (FX) that matures and turns into FA by recruiting more adaptor proteins. FA 
formation is controlled by mechanical signals. The assembly of proteins and integrins to FA 
is controlled by the direction of the cell tensional force (Ballestrem et al., 2001; Besser & 
Safran, 2006). Moreover, FA sites are not static; FAs are able to assemble and disassemble 
accordingly in response to signals from the surroundings (Schwarza et al., 2006). 
 
At the mature FA sites, FAK is one of the main kinases that modulate downstream 
signalling. Activation of FAK occurs through phosphorylation at tyrosine 397 and this is 
followed by clustering of more integrins and adaptor proteins to the FA site (Kornberg et al., 
1992; Kornberg et al., 1991; Shi & Boettiger, 2003). The activated FAK also activates Src, 
Ras-related C3 botulinum toxin substrate 1 (Rac-1), Cell division control protein 42 (Cdc 
42), Rho GTPases and so on. These activated biomolecules will then change the behaviours 
of cell cytoskeleton or signalling biomolecules. For example, the activated Rho GTPases 
restructured actin cytoskeleton and increased the tensional force of the actin filaments 
(Nobes & Hall, 1995). Hence, FA has a strong relationship with the cell stress fibres and the 
tensional force the cell exerts on the ECM. Due to its effects on the cellular stress fibres, 
mechanical signal control of FA behaviours is partly through changing the features of the 
cell stress fibres, including the arrangement, density, localization or the cell stress fibres’ 
association with other biomolecules.  
 
5.1.3 Cell Cytoskeleton 
 
Biological cells are described as a tensegrity model which is an energy model in which cells 
maintain their shape by tensile force. This model is based on the architecture of cells in 
which the cells maintain their structural stability through cytoskeleton. Cytoskeleton, which 
literally means the skeleton of a cell, is a force-bearing structure that supports the cell, 
defines cell shape and controls cell movement through remodelling itself. Components of 
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cytoskeleton include microtubules, intermediate filaments (IF) and actin filaments, each of 
them having different roles in force transmission. Compression stress experienced by cells is 
tolerated by microtubules whereas tensional stress is borne by the actin microfilaments and 
the intermediate filaments (Dennerll et al., 1988; Stamenović & Coughlin, 1999; 
Stamenović et al., 1996; Wang et al., 1993; Wang et al., 2001). These three cytoskeleton 
types are connected to each other forming a network through cross-linking proteins.  
 
Actin filaments or filamentous-actin (F-actin) are made of globular actin (G-actin) and have 
a polar structure with two ends termed the plus and minus ends. The plus end grows towards 
the cell membranes and the minus end connects with microtubules. The structure of actin 
filaments can vary from highly oriented filament bundles or randomly arranged filaments. 
Different arrangements of actin filaments possess distinct functions. The function of each 
was shown clearly in a study done using endothelial cells: the organized structure anchored 
cells on substrate or was associated with cell-cell contacts whereas randomly arranged actins 
were involved in cell motility or cellular microstructure movement such as movement of 
projections during phagocytosis (Gipson & Anderson, 1979). Cells respond to extracellular 
forces through re-distributing and remodelling their actin filaments, which then alters the 
intracellular tensile force, resulting in shape or cell stiffness changing. For example, actin 
stress fibres can behave like viscoelastic cables and polymerize upon sensing exogenous 
forces to elevate intracellular tensional force, allowing cells to adhere and pull on ECM 
protein fibres (Bellows et al., 1982; Chrzanowska-Wodnicka & Burridge, 1996; Ehrlich et 
al., 1991; Forscher & Smith, 1988; Grinnell et al., 1998; Miyata et al., 1999; Paterson et al., 
1990). The ability of actin filaments to carry out these functions is because actin filaments 
are associated with myosin motors that actively convert chemical energy adenosine 
triphosphate (ATP) to mechanical energy, generating a tensional force to support cells. 
 
 
Another cell cytoskeleton protein that was of interest was Cytokeratin-18 which is an IF. IFs 
form an extensive network inside cells and link the cell membrane or organelles to the 
nuclear membrane or nucleoplasm. Due to their extensive network within cells, they are 
involved in directing intracellular organelle positioning and organization. Further, 
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Cytokeratin-18 has been reported to be involved in maintaining cell structure and plays a 
role in adhesion and spreading (Bordeleau et al., 2010; Bordeleau et al., 2012). 
  
In this project, the culturing of Ishikawa cells on substrates of different materials and 
different topographies exposed the cells to different physical signals. To study the cell 
responses to these substrates the expression and distribution of β1 integrin were first 
investigated as β1 integrin is the main β subunit and forms dimers with at least 12 α 
subunits. Then, the expression of FAK and phosphorylated-FAK (pFAK) were studied. 
Furthermore, the expression levels of actin and Cytokeratin-18 were measured to see the 
changes of these molecules in response to the Bioimprint.  
 
5.1.4 Nitric Oxide Secretion 
 
Nitric oxide (NO) is one of the compounds secreted in response to mechanical stimulation 
through modulation of the F-actin and G-actin ratio in the cell. NO is one of the few gaseous 
biological signalling messengers and is synthesized by NO synthases (NOS). There are three 
types of NOS: neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS). 
NO synthesized by nNOS acts as a neurotransmitter, NO synthesized by eNOS is involved 
in vasodilation, smooth muscle cell proliferation, inhibition of platelet aggregation and 
apoptosis, whereas NO made by iNOS is required in macrophage-related immunity. NO has 
also been linked to cancer occurrence, in which it can promote or inhibit cancer. NO 
generated by macrophages has been reported to be apoptotic to cells and reduced metastasis 
of cancer cells (Li et al., 1991; Xie et al., 1995). Nonetheless, NO has also been shown to 
promote tumorigenesis (Mordan et al., 1993) and angiogenesis through increasing VEGF 
secretion (Ambs et al., 1998). 
 
It has been observed that vascular endothelium cell stiffness determined the NO secretion 
level, where softer cells secreted more NO compared to stiff cells (Fels et al., 2010). Further 
study showed that the stiffness of endothelial cells was modulated by cortical-F actin in 
 
108 | P a g e  
 
which depolymerisation of cortical F-actin to G-actin softened the cells and released NO 
(Fels et al., 2012).  
 
Aldosterone, which is a mineralocorticoid hormone, was shown to be able to transiently 
soften endothelial cells, thereby increasing NO secretion (Fels et al., 2010). At a longer 
incubation time, aldosterone, on the other hand, has different influence on cell NO secretion, 
in which the effect depended on the NO synthase that was involved. For example, 
aldosterone has been reported to decrease NO secretion through inhibiting iNOS activity in 
rat neonatal cardiomyocytes (Chun et al., 2003), yet in another report, aldosterone enhanced 
NO secretion through eNOS activation (Mutoh et al., 2008).  
 
Here, in addition to looking at NO secretion of Ishikawa endometrial cancer cells between 
(f), (-ve) and (+ve)pST, aldosterone was used to change the cell stiffness through altering 
the Ishikawa cell actin filaments, both after transient incubation (7 minutes treatment) and 
longer time incubation (24 hours), and we hypothesized that cells on different culture 
substrates would have different responses to aldosterone treatment due to difference in their 















In this chapter, our hypotheses are: 
1. Cell adhesion is mediated through β1 integrin.  
2. The expression levels of adhesion molecule β1 integrin, downstream signalling 
kinase FAK and pFAK and cell cytoskeleton actin filaments and Cytokeratin-18 are 
different on glass, tissue culture grade pST and pMA substrates; and between 
(f)pMA and (-ve)pMA as well as among (f)pST, (-ve)pST and (+ve)pST. 
3. FAK activation, as measured by pFAK/FAK ratio, is linked to β1 integrin and these 
two biomolecules exist in the same cell compartment in cells. 
4. Cell nitric oxide secretion, that is mediated through actin structure, with or without 
aldosterone, will be different on (f)pST, (-ve)pST and (+ve)pST. 
 
5.3 Aims  
 
In this chapter, we aim to  
1. Quantify the expression levels of adhesion molecule β1 integrin and downstream 
signalling kinase FAK and pFAK. 
2. Quantify abundance levels of pFAK and calculate the ratio of pFAK/FAK as an 
indication of FAK activation. 
3. Observe the interaction of β1 integrin and pFAK by immunofluorescent double 
staining.  
4. Quantify the expression levels of cell cytoskeleton actin filaments and Cytokeratin-
18. 
5. Examine the effect of β1 integrin blockage on cell initial adhesion. 
6. Examine cell actin filaments structure with or without aldosterone treatment. 
7. Quantify cell nitric oxide secretion with or without aldosterone treatment. 
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5.4 Experimental Approach 
 
Western blot was used to semi-quantify β1 integrin, FAK, pFAK, actin and Cytokeratin-18 
protein levels. For β1 integrin blockage, L-arginylglycyl-L-α-aspartyl-L-serine (RGDS), 
which is a β1 integrin recognition peptide sequence, was used to bind to β1 integrin of 
suspended cells hence preventing them from binding to culture surfaces. The number of 
cells that bind to surfaces was calculated after 3 hours of RGDS treatment. 
 
For co-localisation of β1 integrin and pFAK, immunofluorescent double staining was 
performed. Immunofluorescence was also used to examine the cell actin structure in a study 
using aldosterone. Last, cell nitric oxide secretion levels were measured using a commercial 
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5.5 Results 
5.5.1 Ishikawa Endometrial Cancer Cell β1 integrin Expression  
5.5.1.1 Cell β1 Integrin Expression on Glass, Tissue Culture Polystyrene 
and Polymethacrylate Polymer Flat and Bioimprint Culture 
Substrates 
 
First cell β1 integrin expression was examined as it is involved in cell adhesion on surfaces. 
It was found that cells on conventional culture substrates expressed more β1 integrin than 
cells on pMA substrates. Additionally, compared to (f)pMA, cells on (-ve)pMA had higher 
expression of β1-Integrin. Further, although cells on tissue culture grade pST showed a 
trend of expressing higher β1-Integrin than cells on the glass platform, the difference was 












Figure 28 Ishikawa endometrial cancer cell β1 integrin expression on glass, tissue culture 
grade pST, (f)pMA and (-ve)pMA. 
 (A) (From left to right: glass, tissue culture grade pST,(f)pMA and (-ve)pMA) a 
representative example of β1 integrin western blot protein band.  
(B) Bar chart showing densitometry of β1 integrin of cells cultured on respective 
surfaces.  
Western blot data are presented as densitometry mean ± SEM of 5 independent 
experiments in triplicate. **, p<0.01; *, p<0.05. 
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5.5.1.2 Cell β1 Integrin Expression on Flat, Negative and Positive 
Bioimprint Polystyrene Slides 
 
Similarly, for cells on pST microscope slides, cells on (-ve)pST and (+ve)pST also had 












Figure 29 Ishikawa endometrial cancer cell β1 integrin expression on (f), (-ve) and (+ve)pST. 
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of β1 
integrin (Upper row) and GAPDH (bottom row) western blot protein bands.  
(B) Densitometry ratio of β1 integrin/GAPDH of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST. 
Data are presented as β1 integrin densitometry normalized with GAPDH densitometry 
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5.5.2 Ishikawa Endometrial Cancer Cell FAK Expression and Activation 
(pFAK/FAK Ratio) and pFAK Distribution 
5.5.2.1 Cell FAK Expression and Activation (pFAK/FAK Ratio) on Glass, 
Tissue Culture Polystyrene and Polymethacrylate Polymer Flat and 
Bioimprint Culture Substrates 
 
Western blot analysis revealed that cells cultured on conventional culture substrates 
especially on tissue culture grade pST expressed high levels of FAK. Then again, (-ve)pMA 
imprint exhibited higher FAK expression than cells on the (f)pMA (Figure 30).  
 
 
FAK activation, as indicated by the ratio of phosphorylated-FAK (pFAK) to total FAK 
levels, in constrast was lower on tissue culture grade pST compared to glass. Also, there was 

























Figure 30 Ishikawa 
endometrial cancer cell 
expression levels of FAK 
and pFAK on glass, tissue 
culture grade pST, (f)pMA 
and (-ve)pMA. 
(A) (From left to right: glass, 
tissue culture grade 
pST,(f)pMA and (-ve)pMA) 
representative examples of 
FAK (upper row) and pFAK 
(bottom row) western blot 
protein bands. 
(B) Bar chart showing 
densitometry of FAK and 
pFAK of cells cultured on 
respective surfaces. Data 
are presented as 
densitometry mean ± SEM 
of 6 independent 
experiments in triplicate. 
**,   p<0.01; *, p<0.05. 
(blue *: FAK; red *: pFAK). 
 
 
Figure 31 Ishikawa endometrial 
cancer cell FAK activation on 
glass, tissue culture grade pST, 
(f)pMA and (-ve)pMA. 
Data are presented as 
densitometry ratio mean of 
pFAK/FAK ± SEM of 6 
independent experiments in 
triplicate.                                     
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5.5.2.2 Cell FAK Expression and Activation (pFAK/FAK Ratio) on Flat, 
Negative and Positive Bioimprint Polystyrene Slides 
 
For cells on pST microscope slides, cells on (-ve)pST imprint had no difference in FAK 
expression and activation (pFAK/FAK ratio) detected compared to cells on f(pST). Further, 
an increase in FAK expression was observed in cells cultured on (+ve)pST imprint 
compared to cells on (f) and (-ve)pST (Figure 32). Further, there was a lower ratio of 
pFAK/FAK on (+ve)pST compared to (f)pST (Figure 33). 
 
Figure 32 Ishikawa endometrial 
cancer cell FAK and pFAK expression 
on (f), (-ve) and (+ve)pST. 
(A) (From left to right: (f)pST, (-ve)pST, 
(+ve)pST) representative examples of 
FAK(upper row), pFAK(middle row) 
and GAPDH(bottom row) western blot 
protein bands. 
(B) Densitometry ratio of FAK/GAPDH 
(black bar) and pFAK/GAPDH (white 
bar). 
Data are presented as FAK and pFAK 
densitometry normalized with GAPDH 
densitometry mean ± SEM of 6 
independent experiments in 




Figure 33 Ishikawa endometrial cancer 
cell pFAK/FAK on (f), (-ve) and (+ve)pST. 
Data are presented as densitometry ratio 
mean of pFAK/FAK ± SEM of 6 
independent experiments in 
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pFAK and β1 integrin were both shown to be in the cell cytoplasm in the same cell, 
suggesting possible interaction on all culture substrates that were tested (Figure 36 and 37). 
However, the pFAK level was not related proportionally to β1 integrin. Moreover, pFAK 
levels fluctuated among samples especially on the (-ve)pST. Some studies have shown that 
pFAK is an unstable molecule and the phosphorylation and dephosphorylation processes 
occur within a short period (Baillat et al., 2008). Hence, FAK and pFAK levels were 
examined again at 3 hours for cells on pST microscope slide substrates.  
 
FAK still showed a trend toward increased expression on (-ve) and (+ve)pST compared to 
the (f)pST, though this was not significant. Similarly pFAK did not show any significant 
change (Figure 34). At 3 hours, FAK activation, as determined by the ratio of pFAK/FAK, 















Figure 34 Ishikawa endometrial cancer cell FAK and pFAK expression on (f), (-ve) and (+ve)pST 
at 3 hours. 
Figure showing densitometry ratio of FAK/GAPDH (black bar) and pFAK/GAPDH (white 
bar). Data are presented as FAK and pFAK densitometry normalized with GAPDH 
densitometry mean ± SEM of 4 independent experiments in quadruplicate.   
  
 















Figure 35 Ishikawa endometrial cancer cell pFAK/FAK on (f), (-ve) and (+ve)pST at 3 hours. 
Data are presented as densitometry ratio mean of pFAK/FAK ± SEM of 4 independent 
experiments in quadruplicate. 
 
 
5.5.3 Ishikawa Endometrial Cancer Cell β1 integrin Co-exists with pFAK in cell 
cytoplasm 
5.5.3.1    β1 Integrin co-exists with pFAK in same cell cytoplasm on Glass, 
Tissue Culture Polystyrene and Polymethacrylate Polymer Flat and 
Bioimprint Culture Substrates 
 
Upon aggregation with β1integrin, FAK will be auto-phosphorylated at Y397 into pFAK. 
Auto-phosphorylation at Y397 triggers phosphorylation at other sites of FAK, and this 
creates binding sites for FA proteins such as vinculin, talin, and kinases of the Src family, 
hence activating signalling pathways.   
 
Our immunofluorescent staining results demonstrated that pFAK and β1 integrin were both 












   
 
 
Figure 36 Representative images of double-staining of β1 integrin and pFAK in cells cultured 
on (A) glass (B) tissue culture grade pST (C) (f)pMA (D) (-ve)pMA. 
Figures showing immunofluorescent staining of β1 integrin (green, left), pFAK (red, 
middle) and superimposed images  of the β1 integrin and pFAK(right). Examples of β1 
integrin and pFAK co-existence in a same cell compartment are indicated by white 














5.5.3.2 Cell β1 integrin co-exists with pFAK in the cell cytoplasm on Flat, 
negative and positive bioimprint polystyrene slides 
 
Similarly, co-existance of β1 integrin and pFAK in the cell cytoplasm was observed in cells 
on (f), (-ve) and (+ve)pST, as indicated by arrows in the figure below (Figure 37). 
 
Figure 37 Representative images of double-staining of β1integrin and pFAK in cells cultured on 
(A)(f)pST (B)(-ve)pST (C) (+ve)pST.  
Immunofluorescent staining of β1 integrin (green, left), pFAK (red, middle) and 
superimpose of the β1 integrin and pFAK images(right).  Examples of co-existance in a 
same cell compartmentare indicated by white arrows. Cell nuclei were co-stained with 
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5.5.4 Ishikawa Endometrial Cancer Cell Actin Expression  
5.5.4.1 Cell Actin Expression on Glass, Tissue Culture Polystyrene and 
Polymethacrylate Polymer Flat and Bioimprint Culture Substrates 
 
Actin is recruited to FA in response to biomechanical stimulation and modifies its structure 
to subsequently transmit information for relevant gene activation. Ishikawa cells on             
(-ve)pMA had more elongated actin filaments than cells on (f)pMA (Figure 18).  
 
By quantifying expression levels of actin, actin expression was observed to be lower on 
tissue culture grade pST than glass, and expression on tissue culture grade pST was similar 













Figure 38 Ishikawa endometrial cancer cell actin expression on glass, tissue culture grade pST 
and (f)pMA and (-ve)pMA. 
(A) (From left to right: glass, tissue culture grade pST,(f)pMA and (-ve)pMA) a 
representative example of actin western blot protein band. 
(B) Bar chart showing densitometry of actin of cells cultured on respective surfaces.  
Data are presented as densitometry mean ± SEM of 7 independent experiments in 
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5.5.4.2 Cell Actin Expression on Flat, Negative and Positive Bioimprint 
Polystyrene Slides 
 
In contrast, cells on pST had no observable difference in actin arrangement between cells on 
(-ve)pST and (+ve)pST surfaces from those on (f)pST (Figure 19) and actin expression was 












Figure 39 Ishikawa endometrial cancer cell actin expression on (f), (-ve) and (+ve)pST.  
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of actin 
(upper row) and GAPDH (bottom row) western blot protein bands.  
(B) Densitometry ratio of actin/GAPDH of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint. 
Data are presented as actin densitometry normalised with GAPDH densitometry mean 
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5.5.5 Ishikawa Endometrial Cancer Cell Cytokeratin-18 Expression  
5.5.5.1 Cell Cytokeratin-18 Expression on Glass, Tissue Culture 
Polystyrene and Polyethacrylate Polymer 
 
Cells grown on (-ve)pMA imprint had elongated Cytokeratin-18 alignment compared to 
cells on (f)pMA, which was different from the responses of cells on glass and tissue culture 
grade pST (Figure 18), and western blotting showed that there was higher expression of 
Cytokeratin-18 in cells on (-ve)pMA imprint than (f)pMA and higher expression of cell 
Cytokeratin-18 on tissue culture grade pST than on glass (Figure 40).  
 
Notably, Cytokeratin-18 expression had a similar pattern to that of the cell spreading area on 
conventional culture substrates and pMA substrates (Figure 40).  
 







Figure 40 Ishikawa endometrial cancer cell Cytokeratin-18 expression on glass, tissue culture 
grade pST and (f)pMA versus (-ve)pMA. 
(A) (From left to right: glass, tissue culture grade pST,(f)pMA and (-ve)pMA) a 
representative example of Cytokeratin-18 western blot protein band. 
(B) Bar chart showing densitometry of Cytokeratin-18 of cells cultured on respective 
surfaces. Data are presented as densitometry mean ± SEM of 7 independent 
experiments in triplicate. **, p<0.01; *, p<0.05. 
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5.5.5.2 Cell Cytokeratin-18 Expression on Flat, Negative and Positive 
Bioimprint Polystyrene Slides 
 
On the contrary, immunofluorescence showed that there was no clear difference observed 
between Cytokeratin-18 arrangement in cells on the pST surfaces (Figure 19), yet the 
expression in cells on both (-ve)pST and (+ve)pST imprint was higher than on (f)pST 
substrates (Figure 41).  
 
The trend of Cytokeratin-18 expression was opposite to the trend of the cell spreading area 
(Figure 22 and 41) among cells on pST microscope slide substrates. This indicated that there 
may be a change in Cytokeratin-18 density, yet without affecting the Cytokeratin-18 













Figure 41 Ishikawa endometrial cancer cell Cytokeratin-18 expression on (f), (-ve) and 
(+ve)pST.  
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of 
Cytokeratin-18 (upper row) and GAPDH (bottom row) western blot protein bands. 
(B) Densitometry ratio of Cytokeratin-18/GAPDH of cells cultured on (f)pST, (-
ve)pST and (+ve)pST. 
Data are presented as Cytokeratin-18 densitometry normalized with GAPDH 
densitometry mean ±SEM of 12 independent experiments in quadruplicate.             
*, p<0.05.  
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5.5.6 Ishikawa Endometrial Cancer Cell β1 Integrin Blocking 
 
RGDS is a tetra-peptide found in fibronectin and fibrinogen that interacts with β1 integrin in 
cell adhesion. β1 integrin expression was shown to be affected by the topography of the 
substrate (Figure 28 and 29), which suggested that β1 integrin was involved in cell 
responses to the physical environment. Therefore, to confirm the role of β1 integrin in cell 
adhesion on pST the effect of RGDS binding to β1 integrin, which blocks the β1 integrin 
from binding to the pST surface, was investigated. The initial binding of cells (determined 
with cell counting method described in section 2.2.3) to pST substrate was indeed blocked 
by RGDS (Figure 42). Control peptide arginyl-glycyl-glutamyl-serine (RGES), in which 
Asp3 is replaced by Glu3, had no effect on adhesion which is consistent with the hypothesis 
















Figure 42 Effects of β1 blockage on cell initial adhesion.  
Cells were grown on respective substrates with No Treatment, RGDS, RGES, or RGDS + 
RGES for 3 hours. Data are presented as mean ± SEM of measurements of 3 
independent experiments in quadruplicate. **, p<0.01; *,p<0.05. 
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5.5.7 Ishikawa Endometrial Cancer Cell Nitric Oxide Secretion 
5.5.7.1 Aldosterone Effects on Cell Cortical Actin at Different 
Concentrations  
 
The aldosterone concentration was first chosen using immunofluorescent staining based on 
the hypothesis that aldosterone would disrupt cell cortical actin structure. Cortical actins 
refer to the actin filaments adjacent or underneath the cell membrane. A disruption of 
cortical actin can be seen as discontinuity of the filamentous actin structure (Figure 43, spots 
of disrupted cortical actin indicated by yellow arrows). 
 
Ishikawa cells were treated with 1nM, 10nM and 100nM aldosterone for 7 mins and then the 
cells’ cortical actin filaments were examined with Texas Red-X phalloidin. The cells’ 
cortical actin filaments were seen to have depolymerised at 10nM and 100nM aldosterone 
(Figure 43). The final aldosterone concentration chosen for the experiment here was 10nM. 























Figure 43 Representative images of Ishikawa endometrial cancer cell actin filaments staining.  
Ishikawa cell actin filaments were stained with Texas Red-X phalloidin (red), and the 
cell nuclei were stained with Hoechst 33342 stained (blue) on (f)pST. Cells were 
treated for 7mins with (A) No treatment and (B) 1 nM (C) 10 nM (D) 100 nM 
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5.5.7.2 Cell Cortical Actin Filaments on Flat, Negative and Positive 
Bioimprint Polystyrene Slide with or without Aldosterone Treatment 
 
By examining the structure of cortical actin filaments with or without aldosterone treatment, 
some distortion of the cortical actin structures was observed in cells with 7 mins aldosterone 
treatment (Figure 44(D)-(F), yellow arrows) but not in cells with no aldosterone treatment 
(Figure 44(A)-(C)). There was less distortion in cells on (+ve)pST compared to cells on (f) 
and (-ve)pST. 
 
At 24 hours, all cells with and without treatment showed dense actin filaments (Figure 































Figure 44 Representative images of Ishikawa endometrial cancer cell actin filaments staining. 
Ishikawa cell actin filaments were stained with Texas Red-X phalloidin (red), and cell 
nuclei were stained with Hoechst 33342 (blue). Cells on (A),(G):(f) pST (B),(H):(-ve)pST  
and (C),(I): (+ve)pST were the control cells without aldosterone treatment. Cells on 
(D),(J):(f) pST (E),(K):(-ve)pST  and (F),(L): (+ve)pST were the cells with 10 nM 
aldosterone treatment. The time indicates when the cells were fixed and stained. 
Examples of fragmented cortical actin filaments are indicated by yellow arrows. 
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5.5.7.3 Cell Nitric Oxide Secretion on Flat, Negative and Positive 
Bioimprint Polystyrene Slide with or without Aldosterone Treatment 
 
At 7 mins and without any treatment, Ishikawa endometrial cancer cells showed similar NO 
secretion on all substrates. Whereas at 24 hours without the addition of aldosterone, cells on 
(-ve)pST had significantly higher NO level compared to cells on (f) and (+ve)pST (Figure 
45). This was similar to the observation that there may be an increase in actin filaments 
expression on (-ve)pST compared to (f) and (+ve)pST (Figure 39). More repetitions are 
needed for statistical robustness in quantifying the actin expression. Further experiments are 
also needed to more specifically quantify the cell stiffness. The higher actin filaments may 
be an indication of higher cell stiffness thus resulting in higher NO secretion.  
 
Aldosterone did not have an effect in increasing NO release in the short term treatment. 
Aldosterone treatment for 24 hours decreased NO secretion significantly in cells on             
(-ve)pST as compared to the cells without treatment. No significant effect was observed for 
cells on (f) and (+ve)pST with aldosterone treatment at 24 hours (Figure 45).  
 
Figure 45 Ishikawa endometrial 
cancer cell NO secretion at 7mins 
and 24 hours with or without 
aldosterone on (f), (-ve) and 
(+ve)pST. 
NO level measurement was 
normalised with total protein. Data 
are presented as NO µg/µg total 
protein mean ± SEM of 
measurements of 4 independent 
experiments in quadruplicate. *, 
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5.6 Discussion 
5.6.1 Cell Culture on Glass, Tissue Culture Grade Polystyrene and 
Polymethacrylate Flat and Bioimprint Culture Substrates 
 
In this chapter, the influence of culture substrate material and topography on cell expression 
of β1 integrin, activation of FAK and expression of actin and Cytokeratin-18 were studied. 
Cells on glass and tissue culture grade pST have been observed to have well-spread 
morphology and the cells on pMA substrate had a circular morphology, and that in the 
presence of the Bioimprint, cells were more spread out compared to (f)pMA (Figure 11, 12, 
13, 14 and 18). The expression of β1 integrin and FAK were in parallel to the observed cell 
spreading behaviour. Initially, Ishikawa cells on glass and tissue culture grade pST were 
shown to have higher expression of β1 integrin and FAK when compared to cells on pMA 
substrate. Hence, the well-spread behaviour on glass and tissue culture grade pST is most 
probably due to an increase in expression of β1 integrin and FAK. This may be because the 
surface wettability allows efficient adsorption of serum protein especially fibronectin onto 
surfaces (Lampin et al., 1997), which encourages cell adhesion and spreading through 
activating β1 integrin and increasing FAK expression. 
 
The cells on glass showed no significant difference in β1 integrin expression compared to 
the cells on the tissue culture grade pST. This may be because glass and tissue culture grade 
pST are both surfaces that support cell adhesion and growth. There is still a non-significant 
difference in β1 integrin expression between cells on glass and tissue culture grade pST, 
which may be due to the different wettabilities, surface functional groups and charges 
between the two surfaces, where the serum protein may have adsorped better on the tissue 
culture grade surface and encouraged cell adhesion and increased β1 integrin expression.  
 
When compared between (f) and (-ve)pMA, β1 integrin expression was higher in cells on (-
ve)pMA than (f)pMA. Similarly, FAK expression level was higher in cells on (-ve)pMA 
compared to (f)pMA. The presence of the Bioimprint increased cell expression of β1 
integrin and FAK, an effect similar to cell spreading area, this indicates surface topography 
also plays a role in affecting cell spreading through β1 integrin and FAK. 
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In parallel to the observation that cells on glass and tissue culture grade pST spread better 
than cells on pMA substrates, actin and Cytokeratin-18 both showed a trend of higher 
expression in cells on glass and tissue culture grade pST compared to cells on pMA 
substrates. Moreover, comparison between cells on (f) and (-ve)pMA substrates showed a 
higher expression on the (-ve)pMA than on (f)pMA. This suggests not only substrate 
material (glass versus tissue culture grade pST) but topography (between (f)pMA and (-
ve)pMA) can affect cell cytoskeleton expression which in turn modifies the cell spreading. 
 
5.6.2 Cell Culture on Flat, Negative and Positive Bioimprint Polystyrene Slides  
 
The topography effect can be further seen between pST microscope slide substrates, i.e. 
(f)pST, (-ve)pST and (+ve)pST. The expression levels of β1 integrin and Cytokeratin-18 
were again higher on pST Bioimprints than on (f)pST, moreover, the expression level of 
FAK was higher on (+ve)pST compared to cells on (f)pST. These observations further 
indicating that surface topography could alter cell expression levels of β1 integrin, FAK and 
Cytokeratin-18. 
 
Unlike the comparison between (f) and (-ve)pMA, in which there was an increase in actin 
expression on (-ve)pMA compared to (f)pMA; on pST substrates, there was no significant 
difference in actin expression between (f)pST and both (-ve) and (+ve)pST. However, the 
cell actin architecture (changing between a filamentous actin structure to a globular actin 
structure) was altered as shown from the NO measurement. This suggests that the culture 
substrate topography itself is not the only factor in the microenvironment that affects cell 
behaviours, but the culture substrate materials are also important in affecting cells.  
 
Even though immunofluorescent examination of β1 integrin and pFAK showed that these 
two molecules were located in the cell cytoplasm of the same cell (Figure 36 and 37), which 
provides them potential to interact, an examination of the ratio of pFAK/FAK showed that 
there was a non-parallel change in β1 integrin and FAK activation (as indicated by the 
pFAK/FAK ratio). A physical topographical effect on lowering FAK activation was 
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observed between (f) and (-ve)pMA and between (f), (-ve) and (+ve)pST microscope slide 
substrates. One possible reason may be due to the temporal dynamic of cellular 
phosphorylation, in which phosphorylation and dephosphorylation occur over time. For this, 
we examined the activation of FAK at 3 hours on pST microscope slide substrates, which 
showed no difference between substrates of different materials. Hence, β1 integrin may have 
an inhibition effect on FAK activation, which requires further investigation.  
 
Notably, pFAK and actin expression levels fluctuated in cells on (-ve)pST (Figure 46). 
There was a possibility that the wide mean distribution was due to the presence of outliers, 
although the same lysates had more compact ranges for other compounds, and in the same 
culture set the (f) and (+ve)pST substrates did not have excessive variation, hence the wide 
distribution warrants further investigation.  
 
Figure 46 Boxplots of (A) pFAK and (B) Actin expression levels.  
Boxplots of pFAK (A) and actin (B) densitometry measurement of expression level.  
Box=25th and 75th percentiles; median= dark line in the box; bar=minimum and 
maximum values; n=6 for pFAK and 5 for actin. 
 
 
Aldosterone treatment at 7min did not increase NO secretion of cells. This was different 
from Fels’ report in which aldosterone was reported to increase NO secretion (Fels et al., 
2010). A possible reason could be due to the different cell types used which involve 
different nitric oxide synthase and hence difference responses to aldosterone treatment. Fels’ 
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study was on endothelial cells that mainly used eNOS for NO secretion (Kirsch et al., 2013). 
However, in cancer cells, iNOS may be more influential than eNOS (Crowell et al., 2003; 
Lechner et al., 2005). The involvement of different NOS also explained the observation of 
decreased NO secretion at 24 hours of aldosterone treatment. For example, a study on 
smooth muscle cells showed that aldosterone decreased iNOS activity at 24 hours treatment 
(Godfrey et al., 2011), and another report showed that aldosterone decreased NO secretion 
by reducing iNOS activity (Chun et al., 2003). Hence, different cell types would have 
different responses to aldosterone modulation of NO secretion due to the involvement of the 
different NOS.  
 
Here, a decrease in NO secretion at 24 hours with aldosterone treatment was observed; it is 
speculated that iNOS may be involved in Ishikawa endometrial cancer cell NO secretion. 
More studies to examine the expression levels of different nitric oxide synthases will 
certainly be required. Nonetheless, aldosterone only showed an effect in decreasing NO 
level on (-ve)pST but not on (f) and (+ve)pST. This indicates that surface topography may 
have changed the cells’ actin activity, which affects the cell response to aldosterone.  
 
Without any treatment, cells on (-ve)pST had higher NO secretion compared to cells on (f) 
and (+ve)pST at 24 hours. Previous western blot measurements of actin expression level 
showed no significant difference among the three substrates. However, an examination of 
the raw data showed that actin expression on (-ve)pST had a wide distribution in which 3 
out of 6 samples of cells on (-ve)pST showed high actin expression level. Hence, the actin 
expression may fluctuate for cells on (-ve)pST (Figure 39 and 46B). Besides, when the cell 
size was compared between cells on different substrates, the cells on (-ve)pST were smaller 
than cells on (f)pST (Figure 22), hence, some cells on (-ve)pST may have more actin packed 
into a smaller cell area, which may result in stiffer cells and thus higher NO secretion.  
 
Further studies that examine the expression of different types of NOS as mentioned above, 
and also studies to measure the stiffness of cells would be needed to interpret the results 
presented here. Nonetheless, these preliminary observations showed that cells growing on 
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different physical topographies altered their NO secretion pattern, which may be partly due 




The results showed that the integrin receptor expression was affected by the physical 
topography. Cells on (-ve)pMA imprint and both (-ve) and (+ve)pST imprint exhibited a 
higher expression of integrin than cells on flat surfaces. Further, we showed that the 
interaction between Ishikawa cells and different culture surfaces during adhesion was 
through an RGD moiety. As a result, cell interaction with substrate surfaces is at least partly 
through fibronectin that may be deposited from culture serum and secreted by the cells 
themselves. Further, physical topography also affected cell FAK expression and 
phosphorylation, which may be partly through β1 integrin.  
 
Ishikawa cells on all imprints (pMA and pST) showed a higher expression of Cytokeratin-
18 expression than the cells on respective flat surfaces. In contrast, actin did not. This may 
indicate that the cell-like topography influence on cells is more prominently modulated by 
Cytokeratin-18 than actin. Alternatively or additionally, changes in actin may be involved in 
the changes in actin dynamics, i.e. alteration of ratio of F-actin to G-actin, which can be 





The results in this chapter favour our hypothesis that the adhesion molecules and 
cytoskeleton of Ishikawa endometrial cancer cell can be modulated by physical 
microenvironment. Comparisons between (-ve)pMA to (f)pMA and among (-ve)pST or 
(+ve)pST to (f)pST confirmed that cell-like topography, independent from culture substrate 
material, increased cell expression of β1 integrin (an adhesion receptor), FAK (a 
downstream kinase) and Cytokeratin-18. On the other hand, comparison between glass, 
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tissue culture grade pST and pMA substrates suggests that cells also responded to culture 
substrate material, and examination of cell responses to pMA Bioimprint and pST 
Bioimprints showed that cell’s responses to physical topography were influenced by 
substrate material. In short, physical topography and culture substrate material, may work 




Next Ishikawa endometrial cancer cell growth was examined by quantifying cell number 
and semi-quantifying cell growth biomolecule expression level. The results are presented in 
the next chapter.  
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Chapter 6 Influences of Substrate Material 
and Topography on Ishikawa Endometrial 
Cancer Cell Adhesion, Growth and Activation 




As discussed in chapters 4 and 5, Ishikawa endometrial cancer cells changed their spreading 
and adhesion behaviours in response to their physical environment. Investigations of 
Ishikawa cell growth on substrates of different materials and topographies were then carried 
out since cell growth can be influenced by cell spreading. The results are presented in this 
chapter.  
 
Regulation of cell growth through modulating cell shape and size has been reported as long 
ago as 1978. Folkman and Moscona reported that cell shape regulated cell DNA synthesis, 
where DNA synthesis was reduced as cells became rounded, and DNA synthesis was only 
initiated when the cells reached a certain size (Folkman & Moscona, 1978). Another study 
in cell cycle regulation by cell shape demonstrated that cells that were prevented from 
spreading failed to progress from the G1 to S phase, and this was due to the failure of cyclin 
D1 levels to increase, resulting in the downregulation of p27Kip1, and phosphorylation of the 
retinoblastoma protein (Huang et al., 1998).  
 
This cell shape regulation of growth is reported to be through actin filaments. A recent 
report of cell shape regulation of a growth-related transcription factor, NFκB was through 
modulation of actin filaments (Sero et al., 2015). Another example was shown in a study 
reported by Ingber et al. who used cytochalasin D to inhibit actin polymerization; they 
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observed that there was a dose-dependent inhibition of cell spreading, nuclear extension as 
well as DNA synthesis (Glushankova & Vasil'ev Iu, 1986; Ingber et al., 1995).  
 
Previously a change in cell morphology and cell size of Ishikawa cells growing on 
substrates of different materials (glass, tissue culture grade pST and pMA) and between flat 
and the Bioimprint substrates (Figure 11, 12, 13, 14, 20 and 21) was observed. It was also 
observed that there was an alteration in cell actin distribution and expression between cells 
growing on glass, tissue culture grade pST and pMA substrates (Figure 18 and 38). 
Although no significant alteration in actin expression and arrangement between cells on (f), 
(-ve) and (+ve)pST (Figure 19 and 39) was seen, a difference in cell NO secretion on these 
substrates (Figure 45) indicated that there may be a difference in cell actin dynamics 
(change of F-actin to G-actin ratio) on (-ve)pST compared to (f)pST and (+ve)pST. 
Therefore, the growth of cells on those substrates further was investigated.  
 
The cell number was first counted, and then the cell cyclins D2, B1 and B2 and a 
proliferation marker proliferating cell nuclear antigen (PCNA) expression levels were 
quantified. Cyclin D2 is involved in cell cycle G1/S transition by coupling with CDK4 or 
CDK6, whereas cyclin B interacts with Cdc 42 and is required for the late phase of mitosis. 
Hence measuring the expression levels of cyclins D and B, as well as PCNA may indicate 
the growth of cells growing on different substrates. 
 
Further, the activation of signalling molecules on two proliferation pathways was observed: 
mitogen-activated protein kinase/extracellular signal-regulated kinases (MAPK/ERK) and 
Phosphoinositide 3-kinase/protein kinase B (PI3K/AKT). Studies have shown that these two 
pathways are activated by mechanical signals. For example, integrin clusters have been 
shown to activate MAPK/ERK-and Rho-dependent pathways (Paszek et al., 2005). Growth 
related epidermal growth factor (EGF)-dependent MAPK/ERK activation was found to be 
higher in a stiff tissue environment, and MAPK/ERK activity was sustained only when FAs 
formed (Paszek et al., 2005), which indicates that MAPK/ERK pathway is one of the 
modulators of mechanical signals. Moreover, it has been shown that cyclic mechanical 
strain induced the PI3K/AKT pathway through actin cytoskeleton-related signalling 
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(Horiuchi, Akimoto, Hong, & Ushida, 2012). ECM stiffness was also found to stimulate the 
assembly of the vinculin-talin-actin complex at FA which then activated the PI3K pathway 
(Rubashkin et al., 2014). Furthermore, nicotine-promoted NSCLC cell proliferation as 
discussed above (Chapter 1 section 1.4) occurred through the MAPK/ERK and PI3K/mTOR 




1. Ishikawa endometrial cancer cells cultured on glass, tissue culture grade pST and 
pMA substrates, and cells between (f)pMA and (-ve)pMA have different early 
adhesion, growth, and expression of cyclin D2 and signalling molecules of the 
MAPK/ERK pathway. 
2. Ishikawa endometrial cancer cells cultured on (f)pST, (-ve)pST and (+ve)pST have 
different early adhesion, growth, and expression of cyclin B and D2, PCNA and 





Among culture substrates that are made of different materials, i.e. glass, tissue culture grade 
pST and pMA; and between (f)pMA versus (-ve)pMA as well as (f)pST, (-ve)pST and 
(+ve)pST, we aim to: 
1. Quantify cell adhesion and cell growth by measuring the number of adherent and 
non-adherent live and dead cells on different surfaces at 6 and 60 hours. 
2. Quantify cell cycle D2 expression levels. 
3. Investigate activation of the MAPK/ERK pathway.  
Further, for Ishikawa cells cultured on (f)pST, (-ve)pST and (+ve)pST, we aim to 
1. Quantify cell cycle B and PCNA expression levels. 
2. Examine activation of the PI3K/AKT pathway.  
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6.4 Experimental Approach 
 
To measure cell numbers at 6 and 60 hours, two different methods were used for 
quantification; trypan blue exclusion cell count was used for cells cultured on glass, tissue 
culture grade pST and pMA substrates whereas coomassie blue staining was used for cells 
seeded on pST flat and the Bioimprint substrates; the rationale for using the two different 
methods was discussed in Chapter 2 section 2.5. 
 
Western blot was used to quantify the expression levels of the cell cycle regulator, PCNA, 
ERK, phosphorylated ERK (pERK), AKT and phosphorylated-AKT (pAKT). The relative 
activation of each pathway was measured by calculating the ratio of pERK/ERK and 
pAKT/AKT, respectively.  
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6.5 Results 
6.5.1 Ishikawa Endometrial Cancer Cell Adhesion and Growth 
6.5.1.1 Ishikawa Endometrial Cancer Cell Adhesion and Growth on Glass, 
Tissue Culture Grade Polystyrene and Polymethacrylate Flat and 
Bioimprint Culture Substrates 
 
By quantifying the cell numbers at 6 hours and 60 hours, it was found that there were less 
cells adhered on pMA substrates at 6 hours (Figure 47) compared to cells on glass and pST 
substrates. The cell adhesion was measured at 6 hours, so it is not related to cell growth. To 
look at cell growth, cell number was measured at 60 hours. The  cells on pMA had lower 
growth at 60 hours than cells on glass and tissue culture grade pST (Figure 48). 
Nonetheless, cells on (-ve)pMA imprint had higher growth rate than cells on (f)pMA 

















Figure 47 Percentage of adherent Ishikawa cells on glass, tissue culture grade pST, flat and    
(-ve)pMA  at 6 and 60 hours.  
Data are presented as mean ± SEM of 3 independent experiments in triplicate.       
*, p<0.05; **, p<0.01 (black *: 6 hours; red *: 60 hours). 
 




















Figure 48 Number of Ishikawa cells on glass, tissue culture grade pST, flat and (-ve)pMA  at 60 
hours.  
Data are presented as mean ± SEM of 3 independent experiments in triplicate.          
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6.5.1.2 Ishikawa Endometrial Cancer Cell Adhesion and Growth on Flat, 
Negative and Positive Bioimprint Polystyrene Slides 
 
For cells cultured on the (f), (-ve) and (+ve)pST, cells on (-ve) and (+ve)pST showed lower 
growth at 60 hours than cells on the (f)pST (Figure 49).  
 
The cell number measurements were performed on adherent cells at 6 and 60 hours. There 
was no difference in the non-adherent cells among pST substrates at 6 hours (percentages of 















Figure 49 Ishikawa cell numbers on (f)pST, (-ve)pST and (+ve)pST  at 6 and 60 hours.  
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6.5.1.3 Time Point of Analyses 
 
The time point of analysis in this project was chosen as 60 hours unless otherwise stated. 
There were insufficient cells on pMA subsrates at 48 hours whereas there was too low cell 
survival on pMA substrates at 72 hours. Hence, 60 hours was chosen because this was the 
optimum time point where sufficient viable cell number was available for all end point 
analysis on all culture substrates.  
 
6.5.1.4 Ishikawa Endometrial Cancer Cell Growth on Flat, Negative and 
Positive Human Dermal Microvascular Endothelial Cell Bioimprint 
Polystyrene Slides  
 
To investigate the possibility that the differential cell growth was a result of a non-specific 
effect of surface patterning, here another non-cancerous human dermal microvascular 
endothelial cell line: HMEC-1, was used to make the Bioimprint. Ishikawa endometrial 
cancer cells were then cultured on HMEC-1 (-ve) and (+ve)pST Bioimprints, and their cell 
growth at 60 hours was examined. The HMEC-1 cell line was chosen here because it has 
originated from a human source. In contrast to Ishikawa cells cultured on Ishikawa cell 
imprints, Ishikawa cells cultured on HMEC-1 (-ve) and (+ve)pST showed no difference in 
cell numbers at 60 hours, indicating there was no difference in growth behaviour on 
different pST substrates (Figure 50).   
 
 













Figure 50 Ishikawa cell numbers on (f)pST, (-ve)pST and (+ve)pST of human dermal 
microvascular endothelial cell 60 hours.  





6.5.2 Ishikawa Endometrial Cancer Cell Cycle Biomolecules and Proliferation 
Marker Expression 
 
Since substrate material and surface topography affected cell growth, cyclin D2 expression 
was then quantified, and for cells on pST microscope slide substrates, cyclin B1, B2 and 
PCNA were measured. 
 
Results showed that cells on (f)pMA had a trend for lower expression of cyclin D2 
compared to cells on glass, tissue culture grade pST and (-ve)pMA, which paralleled the 
result of cell growth at 60 hours (Figure 48) though there was no statistical difference. 
Further studies may be required to increase the sample size for statistical verification.  
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6.5.2.1 Cell Cyclin D2 Expression on Glass, Tissue Culture Polystyrene and 











Figure 51 Ishikawa endometrial cancer cell cyclin D2 expression on glass, tissue culture grade 
pST, (f)pMA and (-ve)pMA. 
(A) (From left to right: glass, tissue culture grade pST,(f)pMA and (-ve)pMA) a 
representative example of cyclin D2 western blot protein band.  
(B) Densitometry of cyclin D2 of cells cultured on glass, tissue culture grade pST, 
(f)pMA and (-ve)pMA.  
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6.5.2.2 Cell PCNA, Cyclin D2, B1 and B2 Expression on Flat, Negative and 
Positive Bioimprint Polystyrene Slides 
 
For cells cultured on pST microscope slide substrates, cells on (-ve)pST had lower 
expression of PCNA compared to (+ve)pST and (f)pST (Figure 52), with no statistical 
difference between (+ve)pST and (f)pST, which may be the reason for the observed lower 
cell growth on (-ve)pST compared to cell growth on (f)pST (Figure 49). Further, cells on 
(+ve)pST showed significantly lower expression of cyclin B2 (Figure 53 B) compared to 
cells on (f) and (-ve)pST, which again agreed with the result of cell growth at 60 hours 
(Figure 49). Cells on (+ve)pST showed a trend toward lower cyclin D2 compared to cells on 
(f) and (-ve)pST but the difference was not statiscally significant (Figure 53 C). There was 










Figure 52 Ishikawa endometrial cancer cell PCNA expression on (f), (-ve) and (+ve)pST.   
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST imprints) representatives examples of 
PCNA (upper row) and housekeeping protein GAPDH (bottom row) western blot 
protein bands. 
(B) Densitometry ratio of PCNA/GAPDH of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint. 
Data are presented as PCNA densitometry normalized with GAPDH densitometry 








Figure 53 Ishikawa endometrial cancer 
cell (A) cyclin B1, (B) B2 and (C) D2 
expression on (f), (-ve) and (+ve)pST. 
  
[Top] (From left to right: (f)pST, (-
ve)pST, (+ve)pST). (Upper rows) 
Examples of (A) cyclin B1, (B) B2 and (C) 
D2 and (bottom rows) housekeeping 
protein GAPDH of western blot protein 
bands. 
[Bottom] Densitometry ratio of cyclin 
(A) B1/GAPDH, (B) cyclin B2/GAPDH and 
(C) cyclin D1/GAPDH of cells cultured  
on (f)pST, (-ve)pST and (+ve)pST 
imprint. 
Data are presented as densitometry 
normalized with GAPDH densitometry 
mean ±SEM of 4 independent 
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6.5.3 Ishikawa Endometrial Cancer Cell ERK Signalling 
6.5.3.1 Cell ERK/pERK Ratio on Glass, Tissue Culture Polystyrene and 
Polymethacrylate Polymer Flat and Bioimprint Culture Substrates 
 
Next, to further study the control of cell behaviours, the expression of ERK and 
phosphorylated ERK kinases were investigated to examine if the pathway was involved in 
cell responses to culture substrate material and topography. No significant difference 
between cells growing on different materials (between glass, tissue culture grade pST and 
pMA substrates) as well as between (f)pMA and (-ve)pMA were detected. Although there 
may be a lower expression ratio of pERK/ERK on (f)pMA compared to cells on glass, tissue 











Figure 54 Ishikawa endometrial cancer cell pERK/ERK on glass, tissue culture grade pST, 
(f)pMA and (-ve)pMA. 
(A) (From left to right: glass, tissue culture grade pST,(f)pMA and (-ve)pMA) 
representative examples of ERK (upper row) and pERK (bottom row) western blot 
protein bands.  
(B) Densitometry ratio of ERK and pERK of cells cultured on glass, tissue culture grade 
pST, (f)pMA and (-ve)pMA.  
Data are presented as densitometry ratio mean ±SEM of 3 independent experiments 
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6.5.3.2 Cell pERK/ERK ratio on Flat, Negative and Positive Bioimprint 
Polystyrene Slides 
 
Similar to the cells on glass, tissue culture grade pST and pMA substrates, there was no 











Figure 55 Ishikawa endometrial cancer cell ERK/pERK on (f), (-ve) and (+ve)pST. 
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of ERK 
(upper row) and pERK (bottom row) western blot protein bands.  
(B) Densitometry ratio of ERK and pERK of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint. 
Data are presented as densitometry ratio mean ±SEM of 12 independent experiments 
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6.5.4 Ishikawa Endometrial Cancer Cell PI3K/AKT Signalling 
6.5.4.1 Cell AKT/pAKT Ratio on Flat, Negative and Positive Bioimprint 
Polystyrene Slides 
 
For pST microscope slide substrates, the PI3K/AKT pathway was also studied, another 
pathway involved in cell growth regulation that is also mechano-sensitive. Yet again, no 











Figure 56 Ishikawa endometrial cancer cell AKT/pAKT on (f), (-ve) and (+ve)pST.  
(A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of AKT 
(upper row) and pAKT (bottom row) western blot protein bands. 
(B) Densitometry ratio of AKT and pAKT of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint. 
Data are presented as densitometry ratio mean ±SEM of 9 independent experiments 












Table 4 Summary of Results from Section 6.5.1.1, 6.5.2.1, 6.5.3.1. A table showing the 
comparative level of the measured parameters between Ishikawa endometrial 
cancer cells on glass, tissue culture grade pST, (f)pMA and (-ve)pMA. The numbers 
relate to the comparative measurements (cell number and western blot 
desitometry); 1=lowest value and 4=highest value. The “-“ symbol indicates no 
statistically significant difference between the compared groups. 




Cell adherence at 6 hrs 2 2 1 1 
Cell adherence at 60 hrs 2 3 1 1 
Cell Number 3 4 1 2 
Cyclin D2 - - - - 
pERK/ERK - - - - 
 
Table 5 Summary of Results from Section 6.5.1.2, 6.5.2.2, 6.5.3.2, 6.5.4.1. A table showing 
the comparative level of the measured parameters between Ishikawa endometrial 
cancer cells on (f)pST, (-ve)pST and (+ve)pST. The numbers relate to the 
comparative measurements (cell number and western blot densitometry); 
1=lowest value and 4=highest value. The “-“ symbol indicates no statistically 
significant difference between the compared groups. 
 (f)pST (-ve)pST (+ve)pST 
Cell Number at 6 hrs - - - 
Cell Number at 60 hrs 2 1 1 
PCNA 2 1 2 
Cyclin B1 - - - 
Cyclin B2 2 2 1 
Cyclin D2 - - - 
pERK/ERK - - - 
pAKT/AKT - - - 
 
The growth effect of incubating cells on glass, tissue culture grade pST and pMA substrates 
was investigated. Glass and pST are both conventional cell culture substrates; pMA, 
however, is not a common cell culture substrate although it is biocompatible. There was 
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only a small difference in initial adherence from that on conventional pST culture surfaces 
(approximately 89% on (f)pMA compared to approximately 97% on (f)pST; p<0.05). When 
cells were incubated for a longer period (60hours), the cells on pMA substrate showed lower 
growth than cells on glass and tissue culture grade pST; this may be partly due to the 
hydrophobic and charge-neutral surface of pMA; that had affected cell membrane 
interactions with the substrate surface which reduced the cell shape and size (Figure 20 and 
21). This size reduction then may have influenced the cell DNA synthesis rate, as suggested 
by Folkman’s study (Folkman & Moscona, 1978), or have altered the cell NFκB signalling 
(Sero et al., 2015). The observation that cells cultured on pMA surfaces had lower 
populations is consistent with the sparing use of polymethacrylate in in vitro culture studies 
and corresponding wide use of glass and tissue culture grade pST that are well-characterized 
for cell growth and maintenance. 
 
Next, when the effect of the cell-like topography was investigated; the topographical 
influence depended on the substrate material. On the pMA substrate, in which the material is 
not the optimized cell culture material, the presence of the Bioimprint helped in cell 
adhesion and enhanced cell growth. On the contrary, on pST, a material that supports 
maximized cell growth, the presence of the Bioimprint acted instead to restrict cell spread, 
hence reducing the cell growth as compared to the flat surface.  
 
 
The effect of pMA Bioimprint on enhanced cell growth may likely be through increasing 
cell adhesion and spreading by increasing β1 integrin and cell Cytokeratin-18 expression, 
and probably through cyclin D2. On the other hand, on pST Bioimrprint, the decreased cell 
growth may also be mediated by β1 integrin and cell Cytokeratin-18 modulated mechanisms 
that involved PCNA on (-ve)pST and cyclin B2 on (+ve)pST.  
 
 
Further, by using the Bioimprint made of different cell lines, it has been clearly shown that 
different physical topographies carried different physical signals. Here the results 
demonstrated that Ishikawa endometrial cancer cells only reduced growth on their own 
Bioimprint. Even a cell Bioimprint using other cells of human origin did not result in a 
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change in Ishikawa cell growth. This suggests that the shape of the topography is important 
in directing cell behaviours. 
 
Moreover, influences of the substrate material and physical topography on cell growth were 
not related to either the activation of the MAPK/ERK or PI3K/AKT pathways. In fact, 
iTRAQ analysis suggested that other pathways may be involved in our context, for instance, 
the c-JUN pathway or NFκB or signal transducer and activator of transcription 3 (STAT3) 
related signalling pathways (discussed in Chapter 7 section 7.5.3). Futhermore, Ishikawa 
endometrial cancer cells are cells with a phosphatase and tensin homolog (PTEN) mutation. 
PTEN is a tumour suppressor protein that suppresses cancer cell growth by negatively 
regulating the PI3K/AKT pathway (Stambolic et al., 1998). Hence, the PTEN mutation in 
Ishikawa cells may have limited the cells’ response to surface topography through 
modulation of PI3K/AKT pathway. 
 
Further studies have yet to be done to look at the proliferation of cells growing on pMA 
substrates, and instead of measuring the proliferation biomarker expression level, the rate of 
DNA synthesis may be a better indicator of cell growth in all cases since the cell size effect 




The results in this chapter favour our hypothesis. The observations discussed in this chapter 
have demonstrated that the Ishikawa endometrial cancer cell growth can be affected by 
different substrate materials and surface topography. On a less favourable surface, cell 
number was reduced compared to cells on a surface that supports cell growth. Notably, on 
the less favourable surfaces, the cell-like topography acted to assist cell growth whereas on 
a surface that supported cell growth, the topography instead restricted the cells’ ability to 
spread and grow.  
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Furthermore, different substrate materials and topographies regulate cell growth by different 
mechanisms. Comparison between cells growing on the glass, tissue culture grade pST and 
pMA substrates showed that the MAPK/ERK signalling molecules were not involved in the 
observed distinct growth characteristics. However, β1 integrin, cell Cytokeratin-18, and 
probably cyclin D2 were likely to be involved in cell proliferation regulation.  
 
Cell growth on (f), (-ve) and (+ve)pST may involve other pathways that were also cell 
spreading-related. It is also clearly shown that the presentation of topography (both positive 
and negative) is also important in determining the expression of cell growth-related 
biomolecules. The ‘hump’ like topography affected the cell cyclin B2, which reduced cell 
number, whereas the ‘pit’ like topography influenced the cell PCNA expression with 
reduced cell number.  
 
Also, on all culture substrate materials and topographies the MAPK/ERK and PI3K/AKT 
pathways were not involved in cell growth regulation. Other proliferation pathways 
suggested above are worthy of further exploration.  
 
Here in this chapter Ishikawa endometrial cancer cells were shown to have different growth 
behaviours in response to culture substrate of different materials and topographies. In the 
next chapter, the results obtained from iTRAQ are presented. iTRAQ is a technique that 
profiles the protein expression in Ishikawa cells to further characterize the cell behaviours 
that are changed in response to surface topography.   
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Chapter 7  Proteomic Analysis of Ishikawa 
Endometrial Cancer Cell on Flat, Negative and 




In the last few chapters Ishikawa endometrial cancer cells were observed to have responded 
to physical microenvironments by changing their morphology, spreading, adhesion and 
growth. Here the iTRAQ technique was utilised to further characterize the protein 
expression in Ishikawa endometrial cancer cells. 
 
Proteomics is the large-scale qualitative and quantitative analysis of proteins, or, in other 
words, profiling the entire set of proteins present in the specimens analysed. In addition to 
2-dimensional electrophoresis (2-DE), iTRAQ is another method in proteomics study. In 
particular, iTRAQ enables comparative analysis of several samples. Also, the chemical-
based labelling of samples allows iTRAQ to be done on any biological specimens such as 
cell or tissue lysates.  
 
iTRAQ involves digestion of different protein samples to peptides. Peptides in each sample 
of cells from the same topography are tagged with a specific isotope to the N-terminus and 
the side chain amines. All samples are then pooled and fractioned by nano-liquid 
chromatography and the fragments are next identified and quantified by tandem mass 
spectrometry. The tandem mass spectrometry fragments are searched through a 
fragmentation database. The tagging will identify from which sample each peptide was 
derived. Thence the ratio of levels of a tagged peptide from a pair of original paired samples 
can be calculated (i.e. (+ve)pST / (f)pST or  (-ve)pST / (f)pST or (+ve)pST / (-ve)pST).  
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iTRAQ is a discovery-based methodology to determine the pattern of protein expression of 
the tested specimens. iTRAQ was used here to compare protein expression in cells that were 
cultured on (f), (-ve)pST or (+ve)pST, and thence to study the proteins that were affected by 
physical topography. This allowed formulation of possible hypotheses regarding the 




In this chapter, we utilize iTRAQ technique aiming to profile the proteins presence in 
Ishikawa endometrial cancer cells cultured on (f)pST, (-ve)pST and (+ve)pST. 
 
7.3 Experimental Approach 
 
iTRAQ was performed by The Centre for Protein Research of The University of Otago in 
Dunedin, New Zealand. The cell culture and cell lysate preparation were done in Laboratory 
of Cell and Protein Regulation in Christchurch, New Zealand and sent to Dunedin. Details 
of samples preparation were described in Section 2.13. Each iTRAQ sample was pooled 
from 16 wells of cultures on a substrate type and iTRAQ analysis was done twice 
independently. 
 
Proteins that were potentially sensitive to topography were selected by including only 
proteins that had an expression ratio, x, that were x < 0.8 or 1.2 < x. However, proteins that 
showed opposite direction of difference in the two iTRAQ analysis runs were excluded. 
Further, the values of the ratios obtained in the analysis varied between peptides from a 
protein and these, as percentages, formed the basis of a variability confidence level. Proteins 
that had mean variability confidence levels of > 17 % were excluded. Proteins that complied 
with both of these criteria were identified as those being most likely to be potentially 
sensitive to physical topography. 
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Proteins are presented in Table 6. Each protein is listed under a functional group the protein 
belongs to; the functions of the protein are obtained from a literature search. In the 
discussion section, a more detailed discussion of those proteins’ functions is presented 
(Table 7 to Table 12). Under each functional group, the proteins are ranked from high to 
lower ratio of the compared samples. 
 
7.4 Results 
7.4.1 Identification of Changed Proteins  
 
The expression of a total of thirty-four proteins was identified to be sensitive to the 
topography of the substrates. With nineteen up-regulated and six down-regulated in cells on 
(+ve)pST compared to (f)pST; four up-regulated and five down-regulated in cells on (-
ve)pST compared to (f)pST, and fifteen up-regulated and one down-regulated in cells on 
(+ve)pST compared to (-ve)pST (Table 6). The functions of these proteins were searched 
through literature. 
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Table 6 List of proteins that were up-regulated or down-regulated in comparisons between (+ve) / (f)pST, (-ve) / (f)pST and (+ve) / (-ve)pST.  
The number in parentheses: upper row: ratio, x=̅ mean of ratio from two individual iTRAQ tests; bottom row: % of the variability, ȳ =mean of 
% of the variability from two individual iTRAQ tests. Highlighted cells indicate proteins’ x ̅of > 1.2 or < 0.8 and ȳ of < 17.0%.  









(16.1,7.0; ȳ =̅11.5) 
(1.2,1.3; x̅=1.2) 
(29.4,2.2; ȳ =15.8) 
(1.0,1.6; x̅=1.3) 
(18.9,7.5; y=13.2) 
SRA stem-loop-interacting RNA-binding 
protein, mitochondrial isoform 3 precursor 
(1.2,1.6; x̅=1.4) 
(8.1,18.3; ȳ =13.2) 
(1.0,1.0; x̅=1.0) 
(8.9,15.9; ȳ =12.4) 
(1.2,1.5; x̅=1.4) 
(7.2,13.0; ȳ =10.1) 
ATP-dependent RNA helicase DDX18 
(1.1,1.4; x̅=1.3) 
(8.6,13.5; ȳ =11.1) 
(1.1,1.2; x̅=1.1) 
(12.8,18.6; ȳ =15.7) 
(1.0,1.2; x̅=1.1) 
(5.4,4.4; ȳ =4.9) 
non-histone chromosomal protein HMG-14 
(1.3,0.6; x̅=0.9) 
(30.5,98.3; ȳ =64.4) 
(1.4,1.2; x̅=1.3) 
(10.2,3.8; ȳ =7.0) 
(0.9,0.5; x̅=0.7) 
(18.9,103.3; ȳ =61.1) 
SWI/SNF complex subunit SMARCC1 
(0.9,0.8; x̅=0.9) 
(22.2,36.9; ȳ =29.6) 
(0.8,0.8; x̅=0.8) 
(9.9,9.3; ȳ =9.6) 
(1.0,1.0; x̅=1.0) 
(24.6,47.1; ȳ =71.7) 
Extracellular Matrix 
Proteins, Cell Structural 
and Cell Migration 
 
UBX domain-containing protein 4 
(1.0,4.1; x̅=2.5) 
(13.5,13.4; ȳ =13.5) 
(1.1,1.5; x̅=1.3) 
(25.0,26.4; ȳ =25.7) 
(0.9,2.5; x̅=1.7) 
(12.6; ȳ =12.6) 
spondin-1 precursor 
(1.0,1.4; x̅=1.2) 
(5.2,12.6; ȳ =8.9) 
(1.1,0.9; x̅=1.0) 
(12.9,11.2; ȳ =12.0) 
(0.9,1.5; x̅=1.2) 
(7.9,21.4; ȳ =14.7) 
thyroid receptor-interacting protein 6 (TRIP6) 
(1.0,1.3; x̅=1.2) 
(14.9,16.0; ȳ =15.4) 
(0.9,1.0; x̅=1.0) 
(24.5,7.0; ȳ =15.8) 
(1.2,1.3; x̅=1.2) 




nodal modulator 2 isoform 2 precursor 
(1.0,1.8; x̅=1.4) 
(4.3,24.3; ȳ =14.3) 
(1.0,1.2; x̅=1.1) 
(16.6,18.7; ȳ =17.6) 
(1.0,1.5; x̅=1.3) 
(15.4,22.3; ȳ =18.9) 
COP9 signalosome complex subunit 5 (CSN5) 
(1.0,1.3; x̅=1.2) 
(15.4,15.2; ȳ =15.3) 
(1.0,0.9; x̅=0.9) 
(8.6,13.0; ȳ =10.8) 
(1.1,1.4; x̅=1.3) 
(14.9,2.3; ȳ =8.6) 
signal transducer and activator of transcription 3 
(STAT3) isoform 3  
(0.9,1.2; x̅=1.0) 
(1.7,3.5; ȳ =2.6) 
(0.8,0.8; x̅=0.8) 
(1.1,7.6; ȳ =4.3) 
(1.1,1.3; x̅=1.2.) 
(0.3,6.8; ȳ =3.6) 
Energy Modulation 
complement component 1 Q subcomponent-
binding protein, mitochondrial precursor 
(1.0,2.0; x̅=1.5) 
(16.1,15.0; ȳ =15.5) 
(1.1,1.0; x̅=1.1) 
(16.2,16.9; ȳ =16.5) 
(1.0,2.0; x̅=1.5) 
(16.7,0.2; ȳ =8.5) 
 adenylate kinase 2, mitochondrial isoform c 
(1.3,1.1; x̅=1.2) 
(10.8,,11.4; ȳ =11.1) 
(1.1,0.9; x̅=1.0) 
(13.8,14.1; ȳ =14.0) 
(1.2,1.2; x̅=1.2) 
(12.8,25.0; ȳ =18.9) 
 uridine 5'-monophosphate synthase 
(0.9,1.5; x̅=1.2) 
(14.2,17.7; ȳ =16.0) 
(0.9,1.0; x̅=0.9) 
(12.1,18.6; ȳ =15.3) 
(1.0,1.4; x̅=1.2) 
(25.1,4.7; ȳ =14.9) 
 
inorganic pyrophosphatase 2, mitochondrial 
isoform 1 precursor (PPi) 
(1.0,0.7; x̅=0.8) 
(8.7,25.4; ȳ =17.1) 
(1.0,0.9; x̅=0.9) 
(13.0,14.2; ȳ =13.6) 
(1.0,0.7; x̅=0.9) 
(10.4,20.5; ȳ =15.5) 
 1,4-alpha-glucan-branching enzyme 
(0.8,0.7; x̅=0.7) 
(11.5,8.7; ȳ =10.1) 
(0.7,1.1; x̅=0.9) 
(28.1,6.8; ȳ =17.4) 
(1.2,0.7; x̅=1.0) 
(27.5,25.1; ȳ =26.3) 
Cell Viability apoptosis regulator BAX isoform sigma 
(0.8,0.8; x̅=0.8) 
(16.9,2.5; y ̅=9.7) 
(1.2,0.9; x̅=1.1) 
(17.7,14.7; y ̅=16.2) 
(0.7,0.8; x̅=0.8) 
(35.1,17.3; y ̅=26.2) 
puromycin-sensitive aminopeptidase 
(0.9,1.6; x̅=1.3) 
(7.0,14.6; ȳ =10.8) 
(0.9,0.8; x̅=0.9) 
(7.0,22.4; ȳ =14.7) 
(0.9,1.7; x̅=1.3) 
(13.4,17.8; ȳ =10.6) 
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Innate Immune Response 
(also in Cell Growth 
Regulation) 
macrophage migration inhibitory factor (MIF) 
(1.0,0.9; x̅=1.0) 
(28.0,8.5; ȳ =18.2) 
(0.8,0.8; x̅=0.8) 
(12.9,11.2; ȳ =12.0) 
(1.2,1.1; x̅=1.2) 









endoplasmic reticulum resident protein 29 
isoform 1 precursor 
(1.1,1.6; x̅=1.3) 
(6.0,24.3; ȳ =15.1) 
(1.0,1.1; x̅=1.0) 
(6.9,5.0; ȳ =6.0) 
(1.0,1.4; x̅=1.2) 
(5.3,24.4; ȳ =14.9) 
selenide, water dikinase 1 isoform 2 
(1.2,1.6; x̅=1.4) 
(15.4,24.9; ȳ =20.1) 
(1.1,1.1; x̅=1.1) 
(3.4,14.5; ȳ =8.9) 
(1.1,1.4; x̅=1.3) 
(8.9,18.0; ȳ =13.5) 
long-chain fatty acid transport protein 4 
(1.0,1.4; x̅=1.2) 
(14.3,1.9; ȳ =8.1) 
(0.9,1.1; x̅=1.0) 
(8.0,1.2; ȳ =4.6) 
(1.1,1.1; x̅=1.1) 
(5.5,1.0; ȳ =3.3) 
26S protease regulatory subunit 4 
(1.1,1.4; x̅=1.2) 
(5.2,18.6; ȳ =11.9) 
(1.0,1.1; x̅=1.1) 
(6.7,10.3; ȳ =8.5) 
(1.0,1.1; x̅=1.1) 
(7.2,15.0; ȳ =11.1) 
E3 ubiquitin-protein ligase CHIP 
(1.0,1.2; x̅=1.1) 
(19.2,2.8; ȳ =11.0) 
(0.9,0.9; x̅=0.9) 
(10.8,6.5; ȳ =8.7) 
(1.1,1.3; x̅=1.2) 
(12.5,5.1; ȳ =8.8) 
phosphoacetylglucosamine mutase isoform 2 
(0.8,0.8; x̅=0.8) 
(13.3,43.4; ȳ =28.3) 
(0.8,0.8; x̅=0.8) 
(21.3,9.3; ȳ =15.3) 
(1.2,0.9; x̅=1.1) 
(11.2,48.7; ȳ =30) 
eukaryotic translation initiation factor 3 subunit 
M 
(0.8,0.6; x̅=0.7) 
(20.6,11.7; ȳ =16.2) 
(1.0,1.1; x̅=1.0) 
(2.0,20.0; ȳ =11.0) 
(0.9,0.5; x̅=0.7) 
(20.9,19.7; ȳ =20.3) 
Ribosomal Protein, RNA 
Processing 
 
U2 small nuclear ribonucleoprotein A' 
(1.0,1.7; x̅=1.3) 
(7.6,10.7; ȳ =9.1) 
(1.1,1.1; x̅=1.1) 
(6.5,8.4; ȳ =7.4) 
(1.0,1.4; x̅=1.2) 
(8.5,10.3; ȳ =9.4) 
60S ribosomal protein L35 
(1.1,3.4; x̅=2.2) 
(12.4,40.9; ȳ =26.7) 
(1.3,1.3; x̅=1.3) 
(4.9,15.0; ȳ =10.0) 
(0.8,2.5; x̅=1.7) 
(8.2,29.1; ȳ =18.7) 
pre-mRNA 3'-end-processing factor FIP1 
isoform 3 
(1.0,1.5; x̅=1.2) 
(18.6,14.0; ȳ =16.3) 
(0.9,,0.8; x̅=0.9) 
(17.0,4.5; ȳ =10.8) 
(1.1,1.7; x̅=1.4) 
(36.3,15.0; ȳ =25.7) 
Lipid Transport and 
Metabolism 
enoyl-CoA delta isomerase 1, mitochondrial 
isoform 2 precursor 
(0.9,,1.9; x̅=1.4) 
(8.2,18.3; ȳ =13.3) 
(0.9,1.1; x̅=1.0) 
(18.2,24.2; ȳ =21.3) 
(1.0,1.7; x̅=1.4) 
(22.0,16.9; ȳ =19.5) 
oxysterol-binding protein 1 
(1.2,3.1; x̅=2.1) 
(20.2,50.1; ȳ =35.2) 
(1.1,1.3; x̅=1.2) 
(12.4,16.2; ȳ =14.3) 
(1.0,2.2; x̅=1.6) 
(13.3,38.6; ȳ =26) 
Calcium-Mediated 
Processes 
copine-1 isoform c 
(0.9,1.6; x̅=1.2) 
(18.3,2.7; ȳ =10.5) 
(0.9,1.0; x̅=1.0) 
(13.4,13.5; ȳ =13.4) 
(0.9,1.5; x̅=1.2) 
(10.8,5.7; ȳ =8.3) 
Vesicles And Organelles 
Movement 
cytoplasmic dynein 1 light intermediate chain 2 
(1.1,0.8; x̅=0.9) 
(22.7,19.3; ȳ =21.0) 
(1.0,0.6; x̅=0.8) 
(13.7,11.7; ȳ =12.7) 
(1.0,1.3; x=1.2) 
(8.6,28.3; ȳ =18.5) 
Golgi apparatus 
Functions 
ADP-ribosylation factor-like protein 1 
(1.0,0.7; x̅=0.8) 
(26.7,7.5; y =̅17.1) 
(1.1,1.0; x̅=1.0) 
(9.1,4.6; y ̅=6.8) 
(0.8,0.6; x̅=0.7) 
(27.0,7.1; y ̅=17.1) 
Accelerate Apoptosis apoptosis regulator BAX isoform sigma 
(0.8,0.8; x̅=0.8) 
(16.9,2.5; y ̅=9.7) 
(1.2,0.9; x̅=1.1) 
(17.7,14.7; y ̅=16.2) 
(0.7,0.8; x̅=0.8) 
(35.1,17.3; y ̅=26.2) 
Bone Mineral Phase alpha-2-HS-glycoprotein preproprotein 
(0.9,0.4; x̅=0.7) 
(16.1,15.0; y ̅=15.6) 
(1.0,0.6; x̅=0.8) 
(19.0,29.0; y ̅=24.0) 
(1.0,0.7; x̅=0.9) 
(6.5,23.0; y ̅=14.8) 




The proteins are grouped into different functional groups and are discussed below. The order 
of proteins in each functional group is the same as the order in Table 6. 
7.5.1 DNA Condensation 
 





Histone H1.0 -A linker histone (LH) that connects DNA between nucleosome 
chains. 
-Organizes and condenses the nucleosome chains into high order 
chromatin structure.  
-Compact chromatin has limited DNA transcription and replication. 
It has been shown that dissociation of H1 histone from chromatin 





-Binds to SRA RNA and acts as a nuclear receptor corepressor that 











-Maintains actively transcriptable genes in an accessible chromatin 
structure 
-Stimulates transcriptional process through stimulating RNA 
polymerase II elongation 
SWI/SNF complex 
subunit SMARCC1 
- Regulates transcriptional activation and repression of genes through 
remodeling chromatin.  
- Involved in neural development and dendrite growth. 
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There were five proteins belong to the functional group of DNA structure and gene 
transcription regulation. Three were up-regulated on (+ve)pST compared to cells on (f)pST 
while two were also up-regulated compared to cells on the (-ve)pST. There were two proteins 
up-regulated on (-ve)pST compared to cells on (f)pST whereas only one protein was down-
regulated on (-ve)pST compared to (f)pST.  
 
Histone H1.0 was the only protein that was up-regulated on both (+ve) and (-ve)pST 
compared to (f)pST. A higher expression of histone H1.0 on (+ve)pST and (-ve)pST 
compared to cells on (f)pST may imply a more compact chromatin structure in cells on pST 
Bioimprints, and therefore explain the lower growth of cells on these substrates.  
 
Moreover, SRA stem-loop-interacting RNA-binding protein, a protein that functions as a 
nuclear receptor corepressor that represses gene transcription, showed an increased 
expression on (+ve)pST compared to cells on (f)pST, this may also explain the lowered cell 
growth on (+ve)pST than on flat substrate.  
 
Further, we observed that the non-histone chromosomal protein HMG-14 had a higher 
expression on (-ve)pST compared to cells on (f)pST and (+ve)pST. This protein functions to 
maintain actively transcriptable genes in an accessible chromatin structure and it stimulates 
transcriptional process through stimulating the rate of RNA polymerase II elongation (Ding et 
al.,1994). A higher expression of this protein on (-ve)pST compared to cells on (f)pST and 
(+ve)pST may explain a less reduction effect on cell proliferation by the negative cell-like 
topography compared to the positive topography. Though there was a less reduction effect on 
cell proliferation on the (-ve)pST than (+ve)pST, the cells still showed lower growth 
compared to (f)pST, probably due to a down-regulation of SWI/SNF complex subunit 
SMARCC1. 
 
There have been studies that reported that mechanical signals can change a cell chromosome 
structure and alter the cell transcription. For example, the assembly of DNA and histone 
octamer into an individual nucleosome (Mihardja et al., 2006) and assembly and disassembly 
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of nucleosomes into chromatins (Leuba et al., 2003) were shown to be reversible and 
inducible by mechanical force. Furthermore, distortions of nucleus and chromatin structures 
were observed with an application of force (Bloom et al., 1996; Le Beyec et al., 2007; 
Maniotis et al., 1997). Also, it was observed that following cytoskeletal restructuring, 
fibroblast nuclei and nucleus lamina were shrunk. This change of cell nucleus morphology 
limited accessibility of transcription factors to certain chromosomal segments, hence gene 
expression was reduced and eventually the fibroblast adhesion patterns and shapes were 
altered (Dalby et al., 2007). All these force-dependent modifications of DNA structures 
suggest that the accessibility of DNA for transcription and replication can be manipulated 
mechanically, and cell-like topography may have changed gene expression through histone 
condensation of chromatin.  
 
7.5.2 Extracellular Matrix Proteins, Cell Structural and Cell Migration 
 
Table 8 The proteins under the functional group of extracellular matrix proteins, cell 







-Associated with Rho-GTPase and restructured cell actin filaments 






-Cell secreted ECM protein that regulates cell adhesion and cell 
spreading.  
-Attached cells to basement membrane through interacting with 
integrin (Woo et al., 2008). 
-Inhibits angiogenesis by inhibiting spreading and FAK 
phosphorylation of endothelial cells. 
-It has been shown to mature existing neo-vessel by stimulating the 
growth of vascular smooth muscle cells (Terai et al., 2001).  
Thyroid receptor-
interacting protein 6 
(TRIP6) 
-Localized to focal adhesion (FA) and transmits signals from the 
cell surface to the nucleus, then disintegrates adherens junctions, 
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reorganizes actin cytoskeleton and promotes cell migration and 
invasion. 
 
Three proteins identified were involved in cell-ECM protein secretion and cell adhesion 
regulation. All these proteins were up-regulated in cells on (+ve)pST compared to cells on 
(f)pST. The observation of different expression of proteins associated with ECM and cell 
adhesion is consistent with the hypothesis that cells may respond to physical features by 
modulating the cell neighbourhood to alter cell spreading and growth. 
 
UBX domain-containing protein was expressed higher on both Bioimprint compared to the 
flat platform. It has been shown that this protein was associated with Rho-GTPase and 
restructured cell actin filaments (Katoh et al., 2002). Rho-GTPase is a well-known protein 
family involved in mechanical signals sensing and responding. Hence endometrial cancer 
cells may respond to the surface topography through modulating UBX domain-containing 
protein regulation of Rho-GTPase and actin filaments.  
 
On the other hand, spondin-1 (or F-spondin and vascular smooth muscle growth factor) is a 
cell secreted ECM protein that regulates cell adhesion and cell spreading. It has been shown 
on human umbilical vein endothelial cells (HUVECS) that it reduced cells spreading on 
extracellular matrix through functional blocking of with integrin (Woo et al., 2008; Terai et 
al., 2001) and inhibiting FAK phosphorylation (Terai et al., 2001). We observed smaller cell 
size (Figure 22), and up-regulation of β1 integrin (Figure 29) but down-regulation of 
pFAK/FAK (Figure 33) in cells on (+ve)pST compare to flat culture substrate, it is speculated 
spondin-1 may have increased adherence of cells on substrate surface through integrin, and 
then limited cell spreading by lowering FAK phosphorylation.  
 
On the other hand, TRIP6 that is localised to FA showed an up-regulation in cells on 
(+ve)pST compared to cells on (f)pST and (-ve)pST; this is consistent with previously 
observed higher FAK expression in cells on (+ve)pST than cells on (-ve)pST (Figure 34), 
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which suggests a potential role of TRIP6 in responding to physical topography through 
association with FAK. 
 
7.5.3 Signalling Pathways 
 





Nodal modulator 2 
isoform 2 precursor  
-Antagonizes Nodal signalling.  
COP9 signalosome 
complex subunit 5 
(CSN 5) 
-Involved in phosphorylation of tumor protein p53 (TP53/p53), c-
JUN, NFκB, inositol-tetrakisphosphate 1-kinase (ITPK1) and 
Interferon regulatory factor 8 (IRF8) pathways. 
-Overexpressed in cells in response to UV irradiation (Wei et al., 
2008). 
-Regulates DNA-damage repair. 
-It has been correlated to resistance to chemotherapy and 
radiotherapy (Pan et al., 2013). 
-Has an important role in cell growth, as seen in studies that showed 
that down-regulation of CSN reduced cell growth through 
decreasing cell cycle regulator S-phase-associated protein (Skp-2) 
levels (Denti, Fernandez-Sanchez, Rogge, & Bianchi, 2006) and 
insufficient down-regulation of p27 in cell cycle (Tomoda et al., 
2004). 
signal transducer 
and activator of 
transcription 3 
isoform 3 (STAT3) 
-A transcription factor and a regulator of cell growth and apoptosis.  
-Activated by receptor-associated kinase or cytokines such as 
interferons, epidermal growth factor (EGF), Interleukin -5 and -6. 
-Binds to small GTPase and Rac-1 (two of the well-known 
mechano-responsive biomolecules). 
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Thyroid receptor-
interacting protein 6 
(TRIP6) 
-Transcriptional co-activator for NF-kappa-B and c-JUN pathways.  
 
Four proteins that were involved in signalling pathways were identified to be possibly 
changed on Bioimprints compared to flat substrate. Three had higher expression on (+ve)pST 
than on (f)pST and/or (-ve)pST whereas one of these signalling molecules was down-
regulated in cells on (-ve)pST compared to cells on flat substrate. 
 
Nodal modulator 2 isoform 2 precursor showed an increased expression on the (+ve)pST than 
on (f)pST, this protein involves in Nodal signalling that plays a part in pattern formation and 
differentiation during embryo development. The role of Nodal signalling in embryonic 
pattern formation and differentiation suggests that this signalling may also involve in 
mechanical signalling because embryonic development involves mechanical changes. The 
endometrial cancer cells may possibly alter this signalling in response to the physical 
topography which requires further investigation. 
 
COP9 signalosome complex subunit 5 (CSN 5) regulates DNA-damage repair has an 
important role in cell growth, as seen in studies that showed that down-regulation of CSN 
reduced cell growth through decreasing cell cycle regulator S-phase-associated protein (Skp-
2) levels (Denti et al., 2006) and insufficient down-regulation of p27 in cell cycle (Tomoda et 
al., 2004). Though an increased expression of CSN 5 may seem contradict to the reduced 
growth of cells on (+ve)pST compared to cells on flat substrate (Figure 49), CSN5 may play 
a role in cells survival response to the (+ve)pST.  
 
On the other hand, signal transducer and activator of transcription 3 isoform 3 (STAT3) 
showed reduced expression on (-ve)pST than cells on (f)pST. STAT3 is a transcription factor 
and a regulator of cell growth and apoptosis that binds to small GTPase and Rac-1. A 
decreased expression of those signalling proteins may explain the reduced growth of 
endometrial cancer cells on the negative Bioimprint. 
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Further, TRIP6 that involves in cell migration is also involved in the cell NF-kappa-B and c-
JUN pathways regulation. iTRAQ analysis suggests an involment of these two signalling 
pathways in Ishikawa cells response to the topography through TRIP6. 
 
iTRAQ analysis may explain the reason for no significant difference being observed for 
MAPK/ERK and PI3K/AKT pathways between cells on different substrates (Sections 6.5.3.2 
and 6.5.4). As shown by the proteins identified by iTRAQ analysis, the pathways that were 
most likely affected by the Bioimprint on Ishikawa endometrial cancer cells were the Nodal 
signalling, JAK/STAT3, NFκB and CSN 5. JAK/STAT3 and NFκB also have been linked to 
mechanical signalling previously (Kumar & Boriek, 2003; Leychenko et al., 2011; 
MacKenna et al., 1998; Pan et al., 1999).  
 
An identification of alteration of these signalling molecules suggests that the physical 
topography may alter cell signalling molecules that regulate cell growth and cell survival.  
 
7.5.4 Energy Modulation 
 






component 1 Q 
subcomponent-
binding protein 
-Involved in oxidative phosphorylation (OxPhos) pathway by 
binding to p32 which was part of OxPhos regulation (Muta et al., 
1997). 
-Interacted with β1 integrin in endothelial cells and mediated cell 
adhesion and spreading (Feng et al., 2002). 
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Adenylate kinase 2 -Participates in cellular energy homeostasis by catalysing the 
reversible transfer of the phosphate group between ATP and 




-Catalyses the formation of uridine monophosphate which is the 




isoform 1 precursor 
(PPi) 
-Part of ATP biosynthesis: 
butyrate + ATP + CoA ⇌  butyryl-CoA +PPi +AMP 
-Involved in maintaining the balance of thermodynamic process of 
ATP biosynthesis and usage (Harold, 1962) by driving the above 
equilibrium equation from right to left. 
-Restored ATP biosynthesis (Mansurova et al., 1975). 
1,4-alpha-glucan-
branching enzyme 
-Synthesizes glycogen, which is a form of energy storage in cells. 
 
 
iTRAQ analysis suggests that the cells responded to (+ve)pST by adjusting the cell energy 
homeostasis because five proteins that were up- or down-regulated were related to cell energy 
generation. Three proteins in this functional category were up-regulated in cells on (+ve)pST 
compared to the cells on (f)pST, and two of them showed higher expression compared to 
cells on (-ve)pST. On the other hand, there were two proteins down-regulated on (+ve) 
compared to cells on (f)pST, the down-regulation of these proteins were associated with 
generation of more energy. This suggests that cells on the (+ve)pST may require more energy 
for cell growth and function.  
 
Complement component 1 Q subcomponent-binding protein, a protein that is involved in 
oxidative phosphorylation (OxPhos) pathway (Muta et al., 1997) has been shown to interact 
with β1 integrin in endothelial cells and mediated cell adhesion and spreading (Feng et al., 
2002). An elevated β1 integrin expression in cells on (+ve)pST was observed previously 
(Figure 29), so it is reasonable to propose that complement component 1 Q subcomponent-
binding protein may be altered by surface topography in association with β1 integrin to 
increase cell energy production. 
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There were two down-regulated proteins in cells on (+ve)pST and (-ve)pST compared to 
(f)pST: 1,4-alpha-glucan-branching enzyme and inorganic pyrophosphatase 2 (PPi). 1,4-
alpha-glucan-branching enzyme involves in the process of synthesizing glycogen, which is a 
form of energy storage in cells. The detection of a down-regulation of 1,4-alpha-glucan-
branching enzyme proposes that the cells reduce the energy storage to produce more energy 
for spreading and adhesion on Bioimprints. Further, an identification of PPi, which is a 
molecule part of ATP biosynthesis and is involved in maintaining the balance of 
thermodynamic process of ATP biosynthesis and usage (Harold, 1962), suggests that the cells 
on (+ve)pST may have consumed PPi for ATP generation. 
 
The alteration of these proteins in cells on (+ve) compared to (f)pST suggests the requirement 
of more energy to grow on (+ve)pST. This may explain our previous observation of no 
preferential adhesion on (+ve)pST (Figure 24). We propose that cells have preference to 
adhere and grow on surfaces that require less energy. Essentially cellular energy conversion 
is apparently one of the cellular responses to the positive topography, where Ishikawa cells 
may require more kinetic energy from ATP phosphate bond chemical energy to spread on 
(+ve)pST. Moreover, even when the cells are in a static state, cell actin filaments that are 
associated with myosin motors will still actively convert chemical energy (ATP) to 
mechanical energy to pre-stress the actin filaments and generate tensional force to support 
cells (Lodish et al., 2000). Hence, an increase in cellular energy requirement suggests that 
Ishikawa cells may be generating more tensional force to support them to adhere on the 
Bioimprints. 
 
The modification of energy-related peptides is not predicted, but the hypothesis that 
topography and the associated physical signals are important components of cell regulation 
readily links to schemes that incorporate differential energy usage. 
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7.5.5 Cell growth and viability 
 
Table 11 The proteins under the functional group of cell growth and viability. 
 
Apoptosis regulator 
BAX isoform sigma  









- Pro-inflammatory cytokine, regulates the innate immune response 
to bacterial pathogens 
 
Apoptosis regulator BAX isoform sigma, was identified to be down-regulated on (+ve)pST 
compared to cells on (f)pST. The apoptosis regulator BAX isoform sigma is a protein that 
accelerates apoptosis process, the mechanism of how the positive topography reduces 
apoptosis is unclear, it may be that the endometrial cancer cells defended against the growth 
reduction effect of the positive topography through reducing the cell apoptosis.  
 
Two of the proteins that are part of the cell innate immune response regulation also play a 
role in regulating cell growth. Puromycin-sensitive aminopeptidase was upregulated on 
(+ve)pST compared to the cells on (-ve) and (f)pST, and MIF was downregulated in cells on 
the (-ve)pST compared to cells on (f)pST. MIF has been reported to have increased 
expression in cancer cells and it has been related to tumour growth (Nishihira, 2000). Further, 
MIF has been shown to increase the expression of αvβ3 integrin in Ishikawa endometrial 
cancer line (Bondza, 2008) and also in chondrosarcoma cells through the PI3K and NF-κB 
pathways (Lee et al., 2012). A decreased MIF expression on (-ve)pST may be responsible for 
the reduced growth (Figure 49) on this substrate. 
 
The observation of different expression of proteins associated with cell apoptosis and growth 
regulation is consistent with the hypothesis that the physical microenvironment may 
modulate cells growth and survival. 
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7.5.6 Proteins involved in intermediary functions 
 
Table 12 The proteins with intermediary functions. 
 
Golgi apparatus functions 
ADP-ribosylation 
factor-like protein 1 
- Maintains the function of of the Golgi apparatus. 
Calcium-mediated intracellular processes 
Copine-1 isoform c 
- Regulates calcium-mediated intracellular precesses such as neuronal 
progenitor cell differentiation; induces neurite outgrowth, membrane 
trafficking, TNF-alpha-induced NF-kappa-B transcriptional repression 
Lipid transport and metabolism 
Oxysterol-binding 
protein 1 
- Involved in the transportation of lipid between the Golgi complex and 
membranes of the endoplasmic reticulum, regulates sterol degradation, 




isoform 2 precursor 
- Involved in fatty acid beta-oxidation pathway, which is part of lipid 
metabolism 
Protein synthesis, processing, degradation and transportation 
Selenide, water 
dikinase 1 isoform 2 
 
- Synthesizes selenophosphate 
Endoplasmic 
reticulum resident 
protein 29 isoform 1 
precursor 
- Involved in the protein folding within the endoplasmic reticulum (ER) 
E3 ubiquitin-protein 
ligase CHIP  
- Involved in proteasomal degradation of misfolded chaperone 
substrates and regulate certain proteins’ polyubiquitination. 
Phosphoacetylglucos
amine mutase 
isoform 2  
- Catalyzes the conversion of GlcNAc-6-P into GlcNAc-1-P. 
26S protease 
regulatory subunit 4 
 
- ATP-dependent degradation of ubiquitinated proteins. 
Long-chain fatty acid 
transport protein 4 
- Regulates long-chain fatty acids translocation across the plasma 
membrane, formation of the epidermal barrier, inhibits light-induced 




factor 3 subunit M 
 
- Initiation of protein synthesis 
Ribosomal protein, RNA processing 
60S ribosomal 
protein L35  
- A ribosomal protein. 
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U2 small nuclear 
ribonucleoprotein A'  
- Associated with sn-RNP U2. It helps the A' protein to bind stem loop 
IV of U2 snRNA. 
Pre-mRNA 3'-end-
processing factor 
FIP1 isoform 3  
- Involved in pre-mRNA processing. 




- Regulates the bone’s mineral phase. Shows affinity for calcium and 
barium ions. 








- Involves in antigen-processing pathway for MHC class I molecules 
Intracellular vesicles and organelles movement 
Cytoplasmic dynein 
1 light intermediate 
chain 2 
- Regulates movement of vesicles and organelles along microtubules, 
binding of dynein to membranous organelles or chromosomes. 
 
In addition to cell energy homeostasis, a change in the cell physical microenvironment also 
potentially altered other cell functions. These processes were protein synthesis, processing 
and transportation and RNA processing. An alteration in these processes proposes a change in 
the cell functions including cell growth, cell spreading and cell metabolism in response to the 
physical microenvironment.  
 
The initiation of cell defence activities can also be seen from a change in the proteins that 
have the function in regulation of innate immune response. This response may function to 
enhance cell survival though further studies are required to examine the exact roles of these 
proteins. 
 
Though iTRAQ analysis is not a confirmative experiment that definitely identifies the 
responsive proteins in Ishikawa cells to surface topography, it is a method that is designed to 
enable us to search for potential responsive proteins. We reported that cells on (+ve)pST 
showed more alterations in protein expression than the cells on (-ve)pST as compared to cells 
on (f)pST). Further, the proteins identified were all in functional categories that fitted our 
hypothesis that Ishikawa cells responded to surface topography by altering cell structure, 
 
172 | P a g e  
 
signalling and ECM proteins secretion. This again suggests that Ishikawa cells are responsive 
to surface topography. On the other hand, iTRAQ analysis generates two other hypotheses in 
which Ishikawa cells may also have modified their nuclear structure in response to surface 
topography, moreover, Ishikawa cells’ energy modulation may also be affected by the surface 
topography. 
 
There is a limitation of this iTRAQ analysis because there were only two pooled samples 
used for the analysis. However, there were filters in place so moderately reliable data are 
presented in this thesis. Further, the iTRAQ results are being followed up in our lab by doing 
western blot analysis on a few targeted proteins.  
 
iTRAQ analysis screened the cell’s whole set of proteins. Certain criteria were applied to 
select the proteins that were likely being regulated by the cell’s physical microenvironment. 
And the proteins that were neither up or down were the proteins that may not be involving in 
the mechanical responses. However, further detailed analysis on potentially changed protein 





Though iTRAQ analysis is not an experiment that definitely identified the responsive proteins 
in Ishikawa cells to surface topography, it is a method that is designed to enable us to search 
for potential responsive proteins, i.e., iTRAQ is rather a hypothesis generating experiment. 
The fact that the identified proteins were all in functional categories that fitted our hypothesis 
that Ishikawa cells responded to surface topography by altering cell signalling molecules, 
structure and ECM proteins secretion again suggests that Ishikawa cells are responsive to 
surface topography. On the other hand, iTRAQ analysis generates two other hypotheses in 
which Ishikawa cells may also have modified their nuclear structure in response to surface 
topography, and also, Ishikawa cells’ energy modulation may also be affected by surface 
topography. 
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Cells on (+ve)pST showed more alteration in protein expression than cells on (-ve)pST (as 
compared to cells on (f)pST), and this together with the observation that cells may possibly 
require more energy to spread over the hump-like topography, may explain the reason of no 
preferential adhesion on (+ve)pST (Figure 24). We propose that cells have preference to 
adhere and grow on surfaces that require less energy. Further, lower growth on (+ve)pST and 
an upregulation of CSN5 suggest that cells respond to the reduced growth by activating a 
DNA repairing system, a mechanism that has been correlated to drug resistance development. 
This suggests that (+ve)pST may be an  in vitro model that has the ability to trigger cell 
responses that have been masked by the unnatural spreading on flat culture surface. Though 
fewer regulated proteins have been identified in cells on (-ve)pST, the proteins identified 
nonetheless suggested different transcription activities, ribosome homeostasis, lipid 
metabolism and most importantly, different ECM protein (hyaluronan) synthesis when 
compared to cells on (f)pST.  
 
Taken altogether, surface topography affects endometrial cancer cells protein synthesis, and 
the presentation of topography (positive versus negative topographies) determines the degree 
of influence on cells. The proteins that were suggested to have changed in response to 
physical topography are functioning in alteration of nucleus structure, cell adhesion, ECM 
protein synthesis, cell cytoskeleton-related behaviours, growth behaviours and cell energy 
generation. Moreover, a greater response in cells on (+ve)pST compared to cells on (-ve)pST 
agreed with results from other experiments. Cells on (+ve)pST changed their protein 
expression from those of cells on flat surfaces to a larger extent than cells on (-ve)pST. These 
results from iTRAQ studies provide preliminary evidence that cell biochemistry is responsive 
to the physical environment. The influence of cell-like topography on Ishikawa cell nucleus 
structure, the type and the amount of cell ECM protein secretion, cell energy pathways and 
modulation of STAT3 and CSN5 signalling pathways are worthy of further study. 
 
This chapter presents the results from iTRAQ analysis in which the data obtained agreed with 
our previous observations that Ishikawa endometrial cancer cells responded to physical 
microenvironment. In the next chapter the experiments that investigated Ishikawa cells VEGF 
secretion and the cell response to chemotheraphy drugs are presented: cisplatin and 
paclitaxel, on culture substrates of different topographies.  
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Chapter 8  Influences of Substrate Material 
and Topography on Endometrial Cancer Cell 





Following the previous chapters that discussed the influence of the cell’s physical 
microenvironment on Ishikawa cells behaviours, here in this chapter the VEGF secretion of 
these cells (which is the key mediator in cancer angiogenesis) and cellular response to 
chemotheraphy drugs are investigated.  
 
 
In this introduction, first the linkage between VEGF and cancer is discussed, especially the 
mechanical signals modulation of VEGF secretion, followed by discussion of a potential anti-
cancer agent, EGCG, and a hypoxia mimicking agent, CoCl2, in cancer VEGF secretion 
studies. Then a discussion on the two clinical chemotherapy drugs, cisplatin and paclitaxel 
follows. Finally, studies that demonstrated differential cell responses to chemical treatments 
due to mechanical influences are noted, leading us to study the effects of culture substrate 
materials and cell-like topography on Ishikawa endometrial cancer cell responses to cisplatin 
and paclitaxel.  
 
 
Cancer has been associated with the overexpression of VEGF because an abnormally 
growing tumour requires adequate blood and oxygen supplies to form new blood vessels. 
VEGF modulation may occur partly through mechanical factors. VEGF secretion has been 
reported to be regulated by cellular tension (Faure et al., 2008). Also, it has been shown that 
chondrocytes responded to mechanical signals and increased VEGF secretion (Perera et al., 
2010). In cancer cells, VEGF secretion was stimulated by fluid shear stress which then 
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promoted chondrosarcoma invasion (Wang et al., 2014). Furthermore, cancer cells growing 
in a 3D culture model had different VEGF secretion pattern than cells growing on 2D 
monolayer (Chitcholtan et al., 2012). 
 
 
There are a number of natural compounds that have been reported to have an impact on 
regulating cell VEGF secretion. One of these natural compounds is (−)-epigallocatechin-3-
gallate (EGCG), an extract from green tea. Green tea, which is derived from the plant 
Camellia sinensis, contains polyphenolic compounds such as (−)-epigallocatechin (EGC), 
(−)-epicatechin-3-gallate (ECG), and (−)-epicatechin (EC) in addition to EGCG. EGCG is the 
most potent antioxidant and anti-cancerous polyphenol due to the presence of the gallic acid 
group. EGCG has been shown to reduce angiogenesis (Gu et al., 2013; Rodriguez et al., 
2006). This is partly through EGCG inhibition of VEGF secretion that has been observed in 
vitro (Luo et al., 2014; Sartippour et al., 2002; Zhu et al., 2011) and through down-regulating 
hypoxia induced factor (HIF-1α) that has been reported in vivo (Gu et al., 2013).  
 
 
Alternatively, CoCl2 works conversely to EGCG which induced HIF-1α and increased cell 




Here, the VEGF secretion of endometrial cancer cells on different substrates was measured, 
and then the cells were treated with CoCl2 and EGCG and their stimulation and suppression 
effects on cell VEGF secretion were studied, respectively, as a positive and negative control 
on cell VEGF secretion. 
 
 
In addition to CoCl2 and EGCG, Ishikawa cells were also treated with cisplatin and 
paclitaxel. Cisplatin and paclitaxel are both clinical chemotherapy drugs. Cisplatin is an 
alkylating agent that attacks DNA by attaching an alkyl group to the guanine base of DNA. 
This crosslinks the DNA double strand and causes a halt in cell division and eventually cells 
undergo apoptosis. The cisplatin mechanism of action is not cell cycle specific, and therefore 
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differs from paclitaxel. Paclitaxel is a cytotoxic plant alkaloid with a cell-cycle specific 
mechanism of action. Paclitaxel has been shown to promote cells to enter the mitotic phase 
and then cells at the mitosis checkpoint by binding to microtubules to prevent them from 
separation during mitosis, which eventually induced cell apoptosis (Yang et al., 2009).  
 
It has been shown that cell responses to drugs are partly modulated by mechanical signals. 
This has been demonstrated where cells in 3D culture responded to drugs differently than 
cells in a 2D culture model. For example, human epithelial carcinoma cells showed higher 
sensitivity to tirapazamine (TPZ) when cultured as a 3D model compared to the 2D culture 
(Tung et al., 2011). Moreover, JIMT1 breast cancer cells growing as a 2D monolayer, 
clustered on poly-2-hydroxyethyl methacrylate (polyHEMA) and 3D structure in Matrigel 
each showed a different response to the drugs. The cells in Matrigel showed higher 
responsiveness to drugs which were similar to drug responsiveness in a xenograft model 
(Hongisto et al., 2013). However, the increased sensitivity to drugs in 3D culture is not 
always the case, for example, in the same study done by Tung as stated above, the human 
epithelial carcinoma cells were less sensitive to the anticancer drug 5-fluorouracil (5-FU) 
(Tung et al., 2011). A study performed in our lab also showed less sensitivity to doxorubicin 
in 3D culture model than in a 2D cell monolayer (Chitcholtan et al., 2012). These observed 
differences may be due to the different cell lines and the different drugs used. Nonetheless, it 
is clear that cells grown as 3D culture, which closely represents the real cell living 
microenvironment, show different responses to drugs compared to cells that are grown on an 
unnatural 2D culture substrate. 
 
Based on the reports that cancer cell VEGF secretion and cell responses to anticancer agents 
can be influenced by mechanical signals, we questioned if the culture substrate materials and 
cell-like topography would have any effect on cell VEGF secretion. Further, if Ishikawa cell 




The effects of cisplatin and paclitaxel on cells cultured on (f), (-ve) and (+ve)pST studied 
were cell VEGF secretion, and cell growth by quantifying cell number and expression of the 
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cell proliferation marker, PCNA and also the cell cycle modulators, cyclins B and D2. For 
paclitaxel treatment, cyclin B and cyclin D2 were studied as reports had shown that increased 
cyclin B stability (Giovinazzi et al., 2012) and up-regulation of cyclin D2 (Liu et al., 2012) 
had been associated with increased cell resistance to paclitaxel.  Also, cyclin B1 inhibition 
enhanced the effect of paclitaxel treatment (Androic et al., 2008; Yuan et al., 2005). Hence, a 
study on the expression level of cyclin B and D2 may indicate the efficacy of paclitaxel on 
cells growing on different substrates. The cisplatin working mechanism is not cell cycle 
specific; here the expression of cyclin B and D2 in Ishikawa cells with cisplatin treatment 




1. Ishikawa endometrial cancer cell VEGF secretion differs among cells cultured on 
glass, tissue culture grade pST and pMA substrates, and also differs between cells 
cultured on (f) and (-ve)pMA. Also, Ishikawa cells show a different extent of 
responses to CoCl2 and EGCG treatments by increasing and reducing their VEGF 
secretion, respectively.  
2. Ishikawa endometrial cancer cell VEGF secretion differs among cells cultured on 
(f)pST, (-ve)pST and (+ve)pST, and exhibit a different extent of responses to CoCl2, 
EGCG, cisplatin and paclitaxel treatments in altering their VEGF secretion.  
3. Ishikawa endometrial cancer cells grown on (f)pST, (-ve)pST or (+ve)pST will reduce 
their growth, cyclin B1, B2, D2 and PCNA expression in response to cisplatin and 
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8.3 Aims  
 
VEGF secretion was studied in cells growing on glass, tissue culture grade pST, (f)pMA and 
(-ve)pMA as well as cells growing on (f), (-ve) and (+ve)pST. Further, EGCG and CoCl2 
influences on cell VEGF secretion were investigated. 
 
Furthermore, the effects of cisplatin and paclitaxel on cells on (f), (-ve) and (+ve)pST with 
regard to cell VEGF secretion, cell growth and cell PCNA, cyclin B1,B2 and D2 were 
studied. 
 
8.4 Experimental Approach 
 
VEGF secretion level was measured using an R&D System ELISA Duo Set kit.  
Cell proliferation markers and cell cycle regulators expression levels were measured by 
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8.5 Results 
8.5.1 Cell VEGF Secretion 
8.5.1.1  Cell VEGF Secretion on Glass, Tissue Culture Polystyrene and 
Polymethacrylate Flat and Bioimprint Culture Substrates  
 
The control cells without any treatment showed that the VEGF secretion level was the highest 
in cells on (f)pMA compared to cells that were grown on glass and tissue culture grade pST, 
and the presence of (-ve)pMA Bioimprint significantly lowered the cell VEGF secretion. 
When CoCl2 was added, VEGF levels were increased on all culture substrates, but the 
elevation was not significant on (f)pMA and (-ve)pMA compared to respective no treatment 
cells; whereas when EGCG was added, VEGF secretion was lowered on glass and tissue 
culture grade pST, and significantly on glass. EGCG did not reduce the VEGF secretion of 










Figure 57 Ishikawa endometrial cancer cell VEGF secretion with or without CoCl2 and EGCG 
Treatments on glass, tissue culture grade pST, (f)pMA and (-ve)pMA. 
VEGF level measurement was normalised with cell number. Data are presented as VEGF 
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8.5.1.2    Cell VEGF Secretion on Flat, Negative and Positive Bioimprint 
Polystyrene Slides  
 
On the other hand, for cells on pST microscope slides, VEGF secretion was similar among 
non-treated (f), (-ve) and (+ve)pST cells (Figure 58 (A) and (B)).  
 
The effects of cisplatin and paclitaxel on cell VEGF secretion were next investigated, along 
with the influence of CoCl2 and EGCG on cell VEGF secretion. There was no significant 
decrease in VEGF secretion level with either cisplatin or paclitaxel treatments and there was 
no substrate topographic effect on cell VEGF secretion level with cisplatin and paclitaxel 
treatments (Figure 58 (A)). 
 
When CoCl2 was added, VEGF level showed a significant increase in cells grown on (f)pST 
compared to non-treated cells. Whereas with EGCG treatment, no significant reduction of 
VEGF secretion was observed on all substrates, though among EGCG treated cells on (f), (-
ve) and (+ve)pST, the cells on (f)pST showed significantly lower VEGF secretion compared 
to cells on (+ve)pST (Figure 58 (B)). 
Figure 58 Ishikawa endometrial cancer cell VEGF secretion with or without (A) cisplatin, 
paclitaxel and (B) CoCl2, EGCG Treatments on (f), (-ve) and (+ve)pST. 
VEGF level measurement was normalised with total protein. Data are presented as 
VEGF (pg/mg total protein) mean ±SEM of 4 independent experiments in quadruplicate. 
**,p<0.01;*, p<0.05.  
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8.5.2 Cisplatin and Paclitaxel Treatments for Cells on Flat, Negative and Positive 
Bioimprint Polystyrene Slides 
 
8.5.2.1 Cell Proliferation  
 
Ishikawa cell numbers on (f), (-ve) and (+ve)pST with the treatment of cisplatin and 
paclitaxel were quantified. Cisplatin and paclitaxel reduced cell growth on all substrates. The 
reductions of cell number were significant in cells on (f) and (+ve)pST as compared to the 
















Figure 59 Ishikawa endometrial cancer cell number with or without cisplatin and paclitaxel 
treatments on (f), (-ve) and (+ve)pST. 
Ishikawa cell numbers on (f)pST, (-ve)pST and (+ve)pST  with DMSO (control), cisplatin 
or paclitaxel treatment. Data are presented as mean ± SEM of 4 independent 
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8.5.2.2 Expression of Cell PCNA  
 
Following cell number quantification, the expression level of the cell proliferation marker, 
PCNA, and also the cell cycle regulators: cyclin B1, B2 and D2 (section 8.5.2.3) were 
measured. Cisplatin and paclitaxel had no significant effect in reducing Ishikawa cell PCNA 
expression compared to control cells. Within the group of cells with paclitaxel treatment, 
there was a significant difference in PCNA expression level between cells on (f) and 












Figure 60 Ishikawa endometrial cancer cell PCNA expression with or without cisplatin and 
paclitaxel treatments on (f), (-ve) and (+ve)pST. 
 (A) Representative examples of PCNA (upper row) and GAPDH (bottom row) western 
blot protein bands of cells grown on (f)pST, (-ve)pST and (+ve)pST imprint with DMSO 
(control), cisplatin or paclitaxel treatment.  
(B) Densitometry ratio of PCNA/GAPDH of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint with DMSO (control), cisplatin or paclitaxel treatment. 
Data are presented as PCNA densitometry normalized with GAPDH densitometry mean 
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8.5.2.3 Expression of Cell Cyclin B1, B2 and D2  
 
Cisplatin and paclitaxel treatments both reduced the expression of cyclin B1 and B2 in cells 
on all substrates although the reduction was not significant (Figure 61 A and B). 
 
Furthermore, cisplatin and paclitaxel treatments both reduced the expression of cyclin D2 in 
cells on all substrates. Paclitaxel treatment reduced cyclin D2 significantly in cells on (f)pST 
and (+ve)pST compared to respective DMSO-treated cells but not on (-ve)pST. Moreover, 
there was significantly lower cyclin D2 expression in cells with paclitaxel treatment on 
(f)pST compared to cells with paclitaxel treatment on (+ve)pST. Cisplatin reduced cyclin D2 
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Figure 61 Ishikawa endometrial cancer 
cell (A) cyclin B1, (B) B2 and (C) D2 
expression on (f), (-ve) and (+ve)pST 
with or without cisplatin and paclitaxel 
treatments. 
  
[Top] (From left to right: (f)pST, (-
ve)pST, (+ve)pST with DMSO (control), 
cisplatin or paclitaxel treatment) 
(upper rows) representative examples 
of (A) cyclin B1, (B)B2 and (C) D2 and 
(bottom rows) housekeeping protein 
GAPDH of western blot protein bands.  
[Bottom] Densitometry ratio of cyclin 
(A) B1/GAPDH, (B) cyclin B2/GAPDH 
and (C) cyclin D2/GAPDH of cells 
cultured on (f)pST, (-ve)pST and 
(+ve)pST imprints with DMSO 
(control), cisplatin or paclitaxel 
treatment. 
Data are presented as densitometry 
normalized with GAPDH densitometry 
mean ±SEM of 4 independent 
experiments in quadruplicate.           
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8.6 Discussion 
8.6.1 VEGF Secretion in Cells Growing on Glass, Tissue Culture Polystyrene and 
Polymethacrylate Flat and Bioimprint Culture Substrates  
 
For the cells that were grown on glass, tissue culture grade pST and pMA substrates, the cell 
VEGF secretion was studied. The cells secreted less VEGF on glass and tissue culture grade 
pST compared to cells on pMA substrates. VEGF secretion may be one of the cell self-
protection responses to the less-favourable substrate (pMA), as the VEGF secretion level was 
found to be tightly correlated with various cell stresses (Østergaard et al., 2009; Storkebaum 
& Carmeliet, 2004). The stress from pMA culture substrate discussed here could be due to 
the charge-neutral surface that does not encourage cell spreading or the non-optimum cell 
spreading contact angle of this material (as discussed in Chapter 4 section 4.6). The presence 
of the Bioimprint with cell-like features, however, may have reduced the stress on cells which 
then reduced VEGF secretion. This observation was consistent with our previous findings 
that more cells grew on (-ve)pMA than on (f)pMA (Figure 48).  
 
CoCl2 increased VEGF levels on all substrates. Yet EGCG was less effective on pMA 
substrates in suppressing VEGF levels compared to its effect on cells on glass and tissue 
culture grade pST. The cell stress resulting from pMA material may not be able to be 
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8.6.2 VEGF Secretion in Cells Growing on Flat, Negative and Positive Bioimprint 
Polystyrene Slides 
 
On a favourable cell culture material (pST), an addition of cell-like topography did not have 
any effect on cell VEGF secretion. Further, Ishikawa cells with cisplatin and paclitaxel 
treatments did not have a significant reduction in their VEGF secretion on all substrates. 
However, there was a trend that both CoCl2 and EGCG were most effective on cells cultured 
on (f)pST. 
 
For cells that were cultured on (f), (-ve) and (+ve)pST , CoCl2 increased VEGF secretion 
significantly in cells on (f)pST but not significantly in cells on pST Bioimprints. This may 
indicate greater responses in cells grown on (f)pST to CoCl2 than cells on (-ve) and 
(+ve)pST.  
 
Alternatively, EGCG did not have a significant effect in reducing cell VEGF secretion, but 
among the cells with EGCG treatment on (f), (-ve) and (+ve)pST, the cells on (f)pST showed 
a significantly lower VEGF level than cells on (+ve)pST, which may again indicate a greater 
response in cells grown on (f)pST to EGCG than cells on (+ve)pST.  
 
There are several possible explanations for the observed differential effects of CoCl2 and 
EGCG on cells grown on different substrates. These reasons are related to the mechanism of 
actions of CoCl2 and EGCG.  
 
The anti-cancerous activity of EGCG has been reported to be through various mechanisms. 
One of these mechanisms was by interacting with vimentin (Ermakova et al., 2005). 
Vimentin is an intermediate filament that has been reported to function to maintain cell 
shape, cell motility and in regulating FAs (Mendez et al., 2010). Since differing cell 
spreading area (Figure 22) and different cell FAK expression and pFAK/FAK ratio (Figure 
32 and 33) were observed between cells cultured on different topographical substrates, the 
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cell vimentin may be influenced by the cell-like topography. Hence, EGCG that works by 
interacting with vimentin will be influenced by the different vimentin behaviours among 
these cells.  
 
Then again, a study showed that treatment with CoCl2 had an indirect effect on the cell actin 
filaments by upregulating cofilin-1 (Østergaard et al., 2009). Cofilin-1 binds to actin and 
regulates assembly and disassembly of actin filament. In our study, we postulate the 
possibility that there is a difference in actin dynamicity (by alteration of F-actin and G-actin 
ratio), by our observation that there was a difference in NO secretion between cells on (f), 
(+ve)pST and (-ve)pST (Figure 45). Hence, CoCl2 influences on cells on (f), (-ve) and 
(+ve)pST, through cofilin-1, may be different due to dissimilarity in their actin behaviours. 
 
In short, the physical topography may have altered the cell responses to CoCl2 and EGCG 













188 | P a g e  
 
8.6.3 Cisplatin and Paclitaxel Influence on Cell Growth on Flat, Negative and 
Positive Bioimprint Polystyrene Slides 
 
Table 13 Summary of results of section 8.5.2.  
A table summarizing the extent of cell responsiveness to cisplatin and paclitaxel 
treatments on (f), (-ve) and (+ve)pST as compared to control DMSO-treated cells. The 
direction of arrows indicates down-regulation of measured endpoints. The number of 
the arrows relates to the extent of responsiveness, as compared among (f), (-ve) and 
(+ve)pST. The “-“ symbol indicates no statistically significant difference between the 
compared groups. 
 
 (f)pST (-ve)pST (+ve)pST 
Cisplatin Paclitaxel Cisplatin Paclitaxel Cisplatin Paclitaxel 
Cell Number ↓ ↓ - - ↓ ↓ 
PCNA - ↓ - - - - 
CyclinB1 - - - - - - 
CyclinB2 - - - - - - 
CyclinD2 - ↓↓ - - - ↓ 
 
When Ishikawa endometrial cancer cells were treated with cisplatin and paclitaxel, generally 
cells showed a greater response to paclitaxel compared to cisplatin. There was a trend that 
cells on (f)pST were slightly more responsive to paclitaxel compared to cells on (+ve) and (-
ve)pST, as shown by the significant difference of measured parameters between DMSO-
treated control cells and paclitaxel-treated cells on (f)pST, and between cells on (f) and 
(+ve)pST within the paclitaxel treated group.  Notably, on (-ve)pST, all the measured 
parameters showed a trend of reduction similar to cells on (+ve)pST, although there were not 
significant differences compared to the control cells.  
 
Cells on (f) and (+ve)pST with cisplatin and paclitaxel treatments showed a significant 
reduction in cell number compared to control cells. Although cells on (-ve)pST showed no 
significant reduction in cell number with either cisplatin or paclitaxel treatments, there was a 
trend to reduce cell number. By comparing among cells growing on different surface 
topographies, results with regard to cell number support a topographical effect on cell 
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responses to cisplatin and paclitaxel although further studies are needed to confirm these 
statistics.  
 
For cisplatin and paclitaxel treatments, although there was no significant reduction in PCNA 
expression level between treated cells to control cells, within the group of paclitaxel treated 
cells, cells on (f)pST showed significantly less PCNA expression compared to cells on 
(+ve)pST. This indicated a significantly greater response to paclitaxel in cells on (f)pST 
compared to cells on (+ve)pST. 
 
Further, for cells with paclitaxel treatment, there was a non-significant reduction in cell 
cyclin D2 on (-ve)pST compared to control cells. Whereas there was a significant reduction 
of cyclin D2 in cells on (f) and (+ve)pST compared to control cells. The cells on (f)pST had 
significantly lower cyclin D2 expression level compared to the cells on (+ve)pST within the 
group of paclitaxel treatment, which again indicates less sensitivity of cells on pST 
Bioimprints to paclitaxel.  
 
The observed different drug efficacies on cells on different culture substrates may be linked 
to the cell responses to physical topography, which in turn affected the drug mechanism of 
actions. 
 
The paclitaxel mechanism of action is the cell cycle and is M phase specific; paclitaxel binds 
to cell microtubules and prevents them from separation during cell division. Cells on (+ve) 
and (-ve)pST had lower  growth activity (Figure 49). Paclitaxel, which works on fast-dividing 
cancer cells, may have less dividing cells on (-ve) and (+ve)pST to target, resulting in the 
difference in paclitaxel efficacy observed between cells on (f), (-ve) and (+ve)pST.  
 
Ishikawa cells were less responsive to cisplatin compared to paclitaxel. Further; no 
topographical effect on cell responses to cisplatin treatment was observed. 
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Ishikawa endometrial cancer cells cultured on (f), (-ve) and (+ve)pST showed responses to 
chemotherapy drugs, in which they showed a reduction in their expression of PCNA and 
some of the cyclins. Moreover, results showed that on different substrate topographies, there 




The results in this chapter favour our hypothesis that culture substrate material and surface 
topography alter Ishikawa endometrial cancer cell responses to potential anti-cancer agents, 
both natural products and synthetic drugs. These results agreed with other findings that the 
physical environment can change the cell sensitivity to drug treatments. The use of the 
Bioimprint that can provide the cell with different physical microenvironment signals, 
compared to the flat culture substrate and is potentially a valuable and reliable culture 
substrate in drug studies. 
 
All the observations presented in previous chapters were obtained from Ishikawa cells 
cultured in medium with FBS. The next chapter will present the results obtained from culture 
in medium without FBS. 
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Chapter 9  Influences of Substrate 
Topography on Ishikawa Endometrial Cancer 




Ishikawa endometrial cancer cell responses to physical topography in culture medium with 
FBS were presented in chapters four to eight. Here in this chapter the observations obtained 
from cell culture in medium without FBS are presented. Thus the involvement of biological 
source of serum chemical factors in cell-surface interactions was investigated. 
 
In vitro culture medium often requires a supplement of serum that can be from different 
animals and of adult, newborn or fetal origins. Some examples of serum are the adult horse, 
goat, swine and bovine or fetal bovine serum (FBS). The most commonly used serum is of 
fetal origin because this source provides a few advantages. First, fetal serum has a low 
concentration of antibodies due to the non-fully developed immune system. Second, to 
support growth, fetal serum is rich in growth factors, and this makes it ideal for maintaining 
cells in culture.  
 
FBS consists of macromolecules, cell adhesion and spreading factors, low molecular weight 
nutrients, hormones and growth factors. FBS often enhances cell growth, survival, adhesion 
and spreading, minimizes protease activities, maintains culture pH and detoxifies the culture 
medium. However, there are some disadvantages of adding FBS into culture medium, mainly 
because of its poorly defined composition and batch-to-batch variation.  
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This project is a study of cell interaction with culture substrate topography, and we 
hypothesized that the cell adhesion factors in FBS may influence the cell responses to 
topography factors.  
 
It has been shown that cell adhesion is affected by the FBS in the culture medium. For 
example, by quantifying the attachment of cells cultured in medium with or without FBS, it 
was reported that 74% ± 3% of Chinese hamster ovary (CHO) cells attached on surfaces in 
serum-free medium whereas 98% ± 2% of cells attached on surfaces in FBS-containing 
medium. Also, even 1% of serum concentration was shown to be enough for maximum cell 
adhesion strength (Yildirim & Whish, 1997). Moreover, it has been reported that osteoblasts 
formed FAs on substrate surfaces in medium with FBS, yet without FBS, the cell-substrate 
adhesion bonds involved no FAs formation (Verdanova et al., 2012). 
 
A study showed that cell adhesion was partly controlled by competitive adsorption of 
fibronectin, vitronectin or collagen (either from cell secretion or contained in serum) with 
albumin and globulin that were present in serum (Dewez et al., 1997; Dewez et al., 1998). 
The adsorption of serum proteins on the substrate surface could delay or promote cell 
adhesion, depending on the cultured cell types and the proteins adsorbed. The rate and the 
type of proteins adsorbed on a solid surface are in turn controlled by the interphase free 
energy between the solid surface and the culture medium.  
 
It has been observed that the FBS influence on cell adhesion depends on the solid surface 
wetting property. For example, BSA was found to be more easily adsorbed onto hydrophobic 
surfaces. Hence, FBS lowered cell adhesion on a hydrophobic surface which may be due to 
the adsorption of BSA, which inhibits cell attachment, from FBS onto the culture surface 
(Carré & Lacarrière, 2010). On the other hand, fibronectin, which is from serum or secreted 
by cells, has been reported to be deposited on a hydrophilic surface more easily than on a 
hydrophobic surface (Grinnell & Feld, 1981). Hence, FBS assists cell adhesion on 
hydrophilic surfaces. In short, cell adhesion is influenced by protein adsorption on culture 
surfaces, which in turn is determined by the protein content in culture solutions, and the type 
of culture substrate and its surface free energy. 
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In this chapter, the effect of pST topography on Ishikawa endometrial cancer cells in culture 
medium without FBS was studied, whereas the examination of topography influence on 
Ishikawa cells, in the presence of FBS was presented and discussed in Chapter 4-8.  
 
9.2  Hypothesis 
We hypothesize that Ishikawa endometrial cancer cells cultured on (f)pST, (-ve)pST and 
(+ve)pST in medium without FBS would exhibit different characteristics compared to cells 
cultured in medium with FBS. 
 
9.3  Aims 
The purpose of the experiments in this chapter was to study the responses of Ishikawa 
endometrial cell to surface topographies in the absence of FBS.  
 
9.4 Experimental Approach 
 
All these experiments were done at the same time as the respective experiments of cells 
cultured in medium with FBS described above. 
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9.5 Results 
9.5.1 Ishikawa Endometrial Cancer Cell Morphology in Serum-Free Culture 
Medium  
 
Inverted microscope images are shown for cells on (f)pST at 6 and 60 hours (Figure 62), and 
for cells on (-ve) and (+ve)pST the cell morphology was studied with immunofluorescent 
staining, which will be shown in section 9.5.2 .  
 
Ishikawa endometrial cancer cells cultured in the serum-free medium had similar attachment 
rate compared to cells cultured in medium supplemented with FBS. At 6 hours, a few cells 
started to have flattened morphology (red arrow), indicating that the cells may have started to 
attach onto surfaces. At 60 hours, there was more cell debris observed compared to cells 
cultured in medium with FBS (cell culture in medium with FBS:Figure 15. Cell culture in 
medium without FBS:Figure 62, the yellow arrow indicates cell debris), indicating that cells 
may be under stress and a number of cells were unable to survive. 
 
 
Figure 62 Representative images of Ishikawa endometrial cancer cell morphology in culture 
medium without FBS.  
(A) Cells on (f)pST at 6 hours (B) Cells on (f)pST at 60 hours. Red arrow shows an 
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9.5.2 Ishikawa Endometrial Cancer Cell Cytoskeleton in Serum-Free Culture 
Medium 
 
Ishikawa endometrial cancer cells in culture medium without FBS showed smaller actin 
cytoskeleton and Cytokeratin-18 spreading (Figure 63) compared to cells cultured in medium 
with FBS (Figure 19). The cells in medium without FBS on (f)pST were more spread out 
compared to cells on (-ve) and (+ve)pST which were more clumped (yellow arrows) (Figure 
63).  
   
    
 
 
    
 
 
Figure 63 Representative images of Ishikawa endometrial cancer cell actin filaments and 
Cytokeratin-18 staining.  
Ishikawa endometrial cancer cell actin filament was stained withTexas Red-X phalloidin 
(red, upper row), the cell Cytokeratin-18 was stained with Alexa Fluor 488-tagged 
Cytokeratin-18 antibody (green, bottom row), and the cell nucleus was stained with 
Hoestch 33342 (blue) on (f)pST (left), (-ve)pST and (+ve)pST (right). Yellow arrows 




(f)pST: Actin (-ve)pST: Actin (+ve)pST: Actin 
(f)pST: Cytokeratin-18 (-ve)pST: Cytokeratin-18 (+ve)pST: Cytokeratin-18 
18 
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9.5.3 Ishikawa Endometrial Cancer Cell Spreading Area and Circularity on Flat, 
Negative and Positive Bioimprint Polystyrene Slides in Serum-Free Culture 
Medium  
 
When Ishikawa endometrial cancer cells were cultured in medium without FBS, the cell 
spreading area on (f), (-ve) and (+ve)pST followed a similar trend to the cell spreading area 
in medium with FBS (Figure 22 and 23), in which cells were smallest on (+ve)pST and had 
more spherical morphology on (+ve)pST compared to (-ve)pST (Figure 64). 
 
Figure 64 Ishikawa endometrial cancer cells (A) spreading area and (B) circularity on (f)pST, (-
ve)pST and (+ve)pST in medium without FBS. 
Ishikawa cells were cultured for 60 hours, followed by cell fixing and Cytokeratin-18 
staining. The cell images were taken from four corners of a culture chamber. Then at 
least 25 cells were chosen for cell surface area measurement. Data are presented as   
(A) cell surface area and (B) cell circularity measured from at least 100 Ishikawa cells.        
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9.5.4 Ishikawa Endometrial Cancer Cell β1 Integrin Expression on Flat, Negative 
and Positive Bioimprint Polystyrene Slides in Serum-Free Culture Medium 
 
Although Ishikawa endometrial cancer cells that were cultured in medium without FBS had 
similar cell spreading pattern on (f), (-ve) and (+ve)pST, as compared to cells cultured in 
medium with FBS, they were different in their β1 integrin expression and the subsequent 
FAK activation. When cells were cultured in medium without FBS, there was no significant 
difference in the β1 integrin expression between (f)pST and either (-ve) or (+ve)pST (Figure 
65 compared to Figure 29).  Moreover, the initial binding did not involve β1 integrin as 
RGDS did not have any effect on blocking the initial attachment of Ishikawa endometrial 
cancer cells (Figure 66 compared to Figure 42).  
Figure 65 Ishikawa endometrial cancer 
cell β1 integrin expression on (f), (-ve) 
and (+ve)pST, in medium without FBS. 
(A) (From left to right: (f)pST, (-ve)pST, 
(+ve)pST) representative examples of β1 
integrin (Upper row) and GAPDH (bottom 
row) western blot protein bands.  
(B) Densitometry ratio of β1 
integrin/GAPDH of cells cultured on 
(f)pST, (-ve)pST and (+ve)pST imprint. 
Data are presented as β1 integrin 
densitometry normalized with GAPDH 
densitometry mean ± SEM of 11 




Figure 66 Effects of β1 
blockage on cell initial 
adhesion in serum-free 
culture medium. 
Data are presented as mean 
± SEM of measurements of 3 
independent experiments in 
quadruplicate.   
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9.5.5 Ishikawa Endometrial Cancer Cell FAK Expression and Activation 
(pFAK/FAK) on Flat, Negative and Positive Bioimprint Polystyrene Slides in 
Serum-Free Culture Medium  
 
In addition to the different expression of β1 integrin, FAK activation (as indicated by the 
ratio of pFAK to total FAK levels) was also different in cells cultured in medium with FBS 
from those cultured in medium without FBS. Cells cultured in medium without FBS did not 
have higher FAK expression on the imprinted substrates (Figure 67) but have elevated FAK 
activation (as indicated by pFAK/FAK ratio) at 60 hours (Figure 68). Furthermore, FAK 
expression and activation at 3 hours were not significantly different among (f), (-ve) and 
(+ve)pST (Figure 69 and 70), though there was a trend of increased activation on (-ve) and 
(+ve)pST compared to (f)pST (Figure 70). 
 
These were different from cells in medium with FBS, in which cells on imprinted surfaces 
had higher expression of β1 integrin and FAK (Figure 29 and 32) but had lower pFAK/FAK 


























Figure 67 Ishikawa endometrial cancer cell (B) FAK and pFAK expression and (C) pFAK/FAK on 
(f)pST, (-ve)pST and (+ve)pST in serum-free culture medium. 
 (A) (From left to right: (f)pST, (-ve)pST, (+ve)pST) representative examples of FAK 
(upper row),  pFAK (middle row) and GAPDH (bottom row) western blot protein bands. 
(B) Densitometry ratio of FAK/GAPDH (black bar) and pFAK/GAPDH (grey bar). 
Data are presented as FAK and pFAK densitometry normalized with GAPDH 
densitometry mean ± SEM of 4 independent experiments in quadruplicate. *, p<0.05.  
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Figure 68 Ishikawa endometrial cancer cell pFAK/FAK on (f), (-ve) and (+ve)pST. 
Data are presented as densitometry ratio mean of pFAK/FAK ± SEM of 4 independent 







































Figure 69 Ishikawa endometrial cancer cell FAK and pFAK expression and on (f)pST, (-ve)pST 
and (+ve)pST in serum-free culture medium at 3 hours. 
Figure showing the densitometry ratio of FAK/GAPDH (black bar) and  
pFAK/GAPDH(grey bar). Data are presented as FAK and pFAK densitometry normalized 












Figure 70 Ishikawa endometrial cancer cell pFAK/FAK on (f), (-ve) and (+ve)pST at 3 hours. 
Data are presented as densitometry ratio mean of pFAK/FAK ± SEM of 4 independent 
experiments in quadruplicate. 
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9.5.6 Ishikawa Endometrial Cancer Cell Cytoskeleton Expression and Nitric 
Oxide Secretion on Flat, Negative and Positive Bioimprint Polystyrene 
Slides in Serum-Free Culture Medium 
9.5.6.1 Ishikawa Endometrial Cancer Cell Actin and Cytokeratin-18 
Expression on Flat, Negative and Positive Bioimprint Polystyrene 
Slides in Serum-Free Culture Medium 
 
Ishikawa endometrial cancer cells cultured in medium without FBS had distinct cell 
cytoskeleton responses to surface topography compared to cells cultured in medium with 
FBS. Previously it was observed that cells cultured in medium with FBS had a higher 
Cytokeratin-18 expression on both (-ve) and (+ve)pST compared to a flat substrate (Figure 
41). Cells in medium without FBS, on the other hand, had no significant difference in cell 
Cytokeratin-18 expression (Figure 72).  
 
Similar to cells cultured in medium with FBS, there was no change in actin filaments 
expression (Figure 71 compared to Figure 39), though there was a trend of decreased actin 
expression on (+ve)pST compared to (f) and (-ve)pST (Figure 71). The smaller cell spreading 
area in medium without FBS was therefore apparently not related to the cell Cytokeratin-18 














Figure 71 Ishikawa endometrial cancer 
cell actin expression on (f)pST, (-ve)pST 
and (+ve)pST in serum-free culture 
medium. 
(A) (From left to right: (f)pST, (-ve)pST, 
(+ve)pST) representative examples of 
actin western blot protein bands. 
(B) Densitometry ratio of actin/GAPDH 
of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint.  
Data are presented as actin 
densitometry normalized with GAPDH 
densitometry mean ±SEM of 5 






Figure 72 Ishikawa endometrial 
cancer cell Cytokeratin-18 expression 
on (f)pST, (-ve)pST and (+ve)pST in 
serum-free culture medium. 
(A) (From left to right: (f)pST, (-ve)pST, 
(+ve)pST) representative examples of 
Cytokeratin-18 western blot protein 
bands. 
(B) Densitometry ratio of Cytokeratin-
18/GAPDH of cells cultured on (f)pST 
versus (-ve)pST, (+ve)pST imprint.  
Data are presented as Cytokeratin-18 
densitometry normalized with GAPDH 
densitometry mean ±SEM of 9 






204 | P a g e  
 
9.5.6.2 Ishikawa Endometrial Cancer Cell Cortical Actin Filaments on Flat, 
Negative and Positive Bioimprint Polystyrene Slides in Serum-Free 
Culture Medium with or without Aldosterone Treatment 
 
By examining the cortical actin filaments structure with or without aldosterone treatment, 
some distortion of the cortical actin structures could be observed after 7 mins of aldosterone 
treatment (Figure 73, yellow arrows). However, less distortion of cortical actin filaments was 
observed in cells cultured in medium without FBS (Figure 73) compared to cells in medium 
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  7 minutes 
 
 
Figure 73 Representative images of Ishikawa endometrial cancer cell actin filaments staining. 
Ishikawa cell action filament was stained with Texas Red-X phalloidin (red), and cell 
nucleus was stained with Hoechst 33342 (blue). Cells on (A),(G):(f) pST (B),(H):(-ve)pST  
and (C),(I): (+ve)pST were the control cells without aldosterone treatment. Cells on 
(D),(J):(f) pST (E),(K):(-ve)pST  and (F),(L): (+ve)pST were the cells with 10 nM 
aldosterone treatment. The time indicates when the cells were fixed and stained. 
Examples of fragmented cortical actin filaments are indicated by yellow arrows. 
  
(A) (B) (C) 
(D) (E) (F) 
(J) (K) (L) 
(G) (H) (I) 
24 hours 
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9.5.6.3 Ishikawa Endometrial Cancer Cell Nitric Oxide Secretion on Flat, 
Negative and Positive Bioimprint Polystyrene Slides in Serum-Free 
Culture Medium 
 
NO secretion, a cell activity that is partly regulated by actin, showed different responses to 
topography by cells in the presence of FBS compared to those cultured in medium without 
FBS. Cells in the serum-free medium had less NO secretion (Figure 74) compared to cells 
cultured in medium with FBS (Figure 45). Further, there was no difference in NO secretion 
among cells on (f), (-ve) and (+ve)pST in culture medium without FBS (Figure 74). This was 
different from cells in medium with FBS in which the cells without aldosterone treatment on 
(-ve)pST at 24 hours showed higher NO secretion than cells on (f) and (+ve)pST (Figure 45). 
This may be because of the less well-spread cell morphology with more densely-packed actin 
filaments (Figure 63 and 73) and the compaction of actin filaments in cells on all 
topographies may have caused the no difference in NO secretion. 
 
 
Figure 74 Ishikawa 
endometrial cancer cell 
NO secretion in serum-
free medium with or 
without aldosterone at 
7min and 24 hours. 
NO level measurement 
was normalised with 
total protein. Data are 
presented as NO µg/µg 
total protein mean ± 
SEM of measurements 
of 3 independent 
experiments in 
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9.5.7 Ishikawa Endometrial Cancer Cell Growth and Expression of Proliferation 
Marker and Cell Cycle Molecules on Flat, Negative and Positive Bioimprint 
Polystyrene Slides in Serum-Free Culture Medium 
 
To examine Ishikawa endometrial cancer cell growth behaviour in culture medium without 
FBS, the cell number was quantified at 6 and 60 hours, and the expression of PCNA and 
cyclin B2, because there were significant changes of these parameters in the experiments with 
cells in medium with FBS (Figure 49, 52 and 53 B). Cyclin D2 expression was also studied 
because previously there was a trend of decreased cyclin D2 expression (Figure 53 C) in 
Ishikawa cells in response to physical topography. 
 
Ishikawa endometrial cancer cells growing in serum-free medium showed similar growth 
behaviours compared to cells growing in medium with FBS on all substrates. Cells similarly 
showed fewer number at 60 hours on (+ve)pST and a trend of fewer cells on (-ve)pST when 
compared to (f)pST (Figure 75 compared to Figure 49). Moreover, similar to cells grown in 
medium with FBS (Figure 53 B), cells on (+ve)pST have reduced cyclin B2 expression 
compared to  (-ve)pST (Figure 77 A). Additionally, there was no significant difference in cell 
cyclin D2 expression between cells growing on different topographies (Figure 77 B compared 
to Figure 53 C). 
 
Cells in medium without FBS, however, responded differently, compared to cells in culture 
medium with FBS with regard to cell PCNA expression. The PCNA expression in cells 
without FBS exhibited no significant difference among different substrates (Figure 76), 
unlike cells in medium with FBS in which cells on (-ve)pST had lower PCNA expression 
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9.5.7.1 Ishikawa Endometrial Cancer Cell Numbers on Flat, Negative and 




Figure 75 Ishikawa cell numbers 
on (f)pST, (-ve)pST and (+ve)pST 
in serum-free medium at 6 and 
60 hours.  
Data are presented as mean ± 
SEM of 6 independent 






9.5.7.2 Ishikawa Endometrial Cancer Cell Cyclin PCNA and B2, D2 
Expression on Flat, Negative and Positive Bioimprint Polystyrene 
Slides in Serum-Free Culture Medium 
 
Figure 76 Ishikawa endometrial cancer cell 
PCNA expression on (f)pST, (-ve)pST and 
(+ve)pST in serum-free culture medium.  
(A) (From left to right: (f)pST, (-ve)pST, 
(+ve)pST) representative examples of PCNA 
(upper row) and housekeeping protein GAPDH 
(bottom row) western blot protein bands. 
(B)Densitometry ratio of PCNA/GAPDH of cells 
grown on (f)pST, (-ve)pST and (+ve)pST imprint. 
Data are presented as PCNA densitometry 
normalized with GAPDH densitometry mean 










Figure 77 Ishikawa endometrial cancer cell 
(A) cyclin B2 and (B) D2 expression on (f), 
(-ve) and (+ve)pST in serum-free culture 
medium. 
  
[Top] (From left to right: (f)pST, (-ve)pST, 
(+ve)pST)(Upper rows) representative 
examples of (A) cyclin B2 and (B) D2 and 
(bottom rows) housekeeping protein 
GAPDH of western blot protein bands. 
[Bottom] Densitometry ratio of (A) cyclin 
B2/GAPDH and (B) cyclin D2/GAPDH of 
cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint. 
Data are presented as densitometry 
normalized with GAPDH densitometry 
mean ±SEM of 4 independent 
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9.5.8 Ishikawa Endometrial Cancer Cell Proteomic Analysis on Flat, Negative 
and Positive Bioimprint Polystyrene Slides in Serum-Free Culture Medium 
9.5.8.1 Identification of Changed Proteins  
 
Without the effect of serum in culture medium, Ishikawa endometrial cancer cells responded 
to surface topography differently from those in culture with FBS with regard to the 
modulation of their protein expression. Thirty-two proteins were identified to be sensitive in 
cells by surface topography in serum-free culture medium, twenty four of which were 
upregulated and eight were down-regulated in cells on either (+ve) or (-ve)pST compared to 
cells on (f)pST. These proteins are listed in Table 14. 
 
Cells cultured in serum-free medium had a relatively similar number of differently expressed 
proteins on (+ve)pST and (-ve)pST compared to (f)pST. This was in constrast to cells 
cultured in medium with FBS that had more proteins with different expression in cells on 
(+ve)pST than cells on (-ve)pST, compared to cells on (f)pST. Most of these proteins 
identified here were involved in cell proliferation, survival, and cell cytoskeleton. One 
difference between cells cultured in serum-free medium from those in medium with FBS was 
that none of the proteins detected, from this iTRAQ analysis, were linked to cell energy 
homeostasis. Another difference was that cells cultured in medium without FBS had more 
alteration of proteins related to cell stress responses.  
 
The proteins were selected based on the same criteria as discussed in Chapter 7 section 7.1 
and each protein was listed under a functional group the protein belongs to; the functions of 
the protein were obtained from a literature search. In the discussion section, a more detailed 
discussion of those proteins’ functions are presented (Table 16 to Table 21). Under each 
functional group, the proteins are ranked from high to lower ratio of the compared samples.
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Table 14 List of proteins that were up-regulated or down-regulated in comparisons between (+ve) / (f)pST, (-ve) / (f)pST and (+ve) / (-ve)pST.  
Cells were in culture medium without FBS. The number in parentheses: upper row: ratio, x=̅ mean of ratio from two individual iTRAQ tests; 
bottom row: % of the variability, ȳ =mean of % of the variability from two individual iTRAQ tests. Highlighted cells indicate proteins’ x ̅of > 1.2 
or < 0.8 and ȳ of < 17.0%. 
  
Cell Stress Responses 
dnaJ homolog subfamily B member 1 
(1.0,2.1; x̅=1.6) 
(14.5; ȳ =14.5) 
(1.1,2.0; x̅=1.5) 
(9.9; ȳ =9.9) 
(1.0,1.0; x̅=1.0) 
(11.7; ȳ =11.7) 
peroxiredoxin-4 precursor 
(1.1,1.7; x̅=1.4) 
(9.9,32.6; ȳ =21.3) 
(1.1,1.6; x̅=1.4) 
(0.5,31.1; ȳ =15.8) 
(1.0,1.0; x̅=1.0) 
(6.0,3.4; ȳ =4.7) 
ubiquitin-conjugating enzyme E2 N 
 
(1.2,1.4; x̅=1.3) 
(16.4,17.1; ȳ =16.8) 
(1.0,1.4; x̅=1.2) 
(10.5,15.8; ȳ =13.2) 
(1.2,1.0; x̅=1.1) 
(16.7,5.8; ȳ =11.3) 
thioredoxin-related transmembrane protein 2 
isoform 2 
(1.0,1.2; x̅=1.1) 
(14.3,29.2; ȳ =21.8) 
(1.3,1.3; x̅=1.3) 
(19.9,6.4; ȳ =13.2) 
(0.8,0.9; x̅=0.9) 
(13.1,23.0; ȳ =18.1) 
reticulon-3 isoform a 
(0.8,2.1; x̅=1.5) 
(1.0,24.2; ȳ =11.6) 
(0.9,1.3; x̅=1.1) 
(11.0,9.1; ȳ =10.1) 
(0.8,1.6; x̅=1.2) 







(4.3,28.2; y ̅=16.3) 
(1.1,1.3; x̅=1.2) 
(3.3,27.6; y ̅=15.5) 
(1.1,1.0; x̅=1.1) 
(3.5,2.2; y ̅=2.9) 
SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily A member 5 
(SMARCA5) 
(1.2,1.2; x̅=1.2) 
(11.9,16.3; ȳ =14.1) 
(1.1,1.1 x̅=1.1) 
(30.0,19.0; ȳ =25) 
(1.1,1.0; x̅=1.1) 
(22.0,10.6; ȳ =16.3) 
histone deacetylase 1 
(0.9,0.7; x̅=0.8) 
(2.6,22.3; ȳ =12.5) 
(0.9,0.7; x̅=0.8) 
(14.8,8.1; ȳ =11.5) 
(1.0,0.9; x̅=1.0) 
(10.7,13.9; ȳ =12.3) 
histone deacetylase 2 
(0.8,0.7; x̅=0.8) 
(9.0,14.9; ȳ =12) 
(0.8,0.7; x̅=0.8) 
(10.9,6.1; ȳ =9) 
(1.0,0.9; x̅=1.0) 
(12.0,8.5; ȳ =10.3) 
Cell Growth 
 
kinesin-like protein KIF23 isoform 2 
(1.2,1.8; x̅=1.5) 
(11.7; ȳ =11.7) 
(1.5; x̅=1.5) 
(68.8; ȳ =68.8) 
(1.3,1.2; x̅=1.3) 
(17.3,11.7; ȳ =14.5) 
cysteine-rich protein 2 isoform 1 
(1.5,0.8; x̅=1.2) 
(19.4,43.1; ȳ =31.1) 
(1.0,0.7; x̅=0.9) 
(36.0,47.4; ȳ =41.7) 
(1.5,1.1; x̅=1.3) 
(18.1,11.4; ȳ =14.8) 
nuclear migration protein nudC 
(1.0,1.5; x̅=1.3) 
(19.4,27.7; y ̅=23.6) 
(1.1,1.4; x̅=1.3) 
(7.6,22.1; y ̅=14.9) 
(1.0,1.0; x̅=1.0) 
(17.2,8.8; y ̅=13) 
 kinectin isoform c 
(1.1,1.4; x̅=1.3) 
(9.6,21.6; ȳ =15.6) 
(1.0,1.3; x̅=1.2) 
(30.4,19.6; ȳ =25) 
(1.1,1.0; x̅=1.1) 
(15.0,5.6; ȳ =10.3) 
Cell Cytoskeleton keratin, type II cytoskeletal 1 
(1.1,0.9; x̅=1.0) 
(15.9,25.7; y ̅=20.8) 
(0.9,0.8; x̅=0.9) 
(27.3,27.8; y ̅=27.6) 
(1.4,1.1; x̅=1.3) 
(20.1,5.7; y ̅=12.9) 
 tubulin alpha-1C chain 
(1.0,1.4; x̅=1.2) 
(8.9,18.8; y ̅=13.9) 
 
(1.0,1.3; x̅=1.2) 
(5.4,21.7; y ̅=13.6) 
(1.0,1.0; x̅=1.0) 
(4.7,2.8; y ̅=3.8) 
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 keratin, type II cytoskeletal 2 epidermal 
(1.2,1.1; x̅=1.2) 
(12.6,38.3; y ̅=25.5) 
(0.9,1.0; x̅=1.0) 
(9.9,46.4; y ̅28.2) 
(1.3,1.1; x̅=1.2) 




(22.1,2.0; ȳ =6.0) 
(1.0,1.5; x̅=1.3) 
(15.8,3.2; ȳ =10) 
(1.1,1.0; x̅=1.1) 
(26.3,0.1; ȳ =13.2) GDP-fucose protein O-fucosyltransferase 1 isoform 1 
precursor Cell Signalling 
Biomolecules 
 
epidermal growth factor receptor isoform a precursor 
(0.9,0.8; x̅=0.9) 
(28.4,15.5; ȳ =22) 
(0.8,0.8; x̅=0.8) 
(13.9,9.5; ȳ =6.7) 
(1.2,1.0; x̅=1.1) 
(41.0,7.3; ȳ =24.2) 
Innate Immune 
Responses (also in Cell 
Growth Regulation) 
macrophage migration inhibitory factor (MIF) 
(1.1,1.2; x̅=1.2) 
(13.8,13.8; ȳ =13.8) 
(1.1,1.4; x̅=1.3) 
(10.4,6.3; ȳ =8.4) 
(1.0,0.8; x̅=0.9) 








(4.0,9.2; ȳ =6.6) 
(1.1,1.2; x̅=1.2) 
(8.3,9.4; ȳ =8.9) 
40S ribosomal protein S20 isoform 2 
(0.8,0.8; x̅=0.8) 
(10.0,21.1; ȳ =15.6) 
(0.8,0.7; x̅=0.8) 
(14.9,19.4; ȳ =17.2) 
(1.0,1.1; x̅=1.1) 







(15.2,16.0; ȳ =15.6) 
(1.1,1.2; x̅=1.2) 
(11.4,21.0; ȳ =16.2) 
(1.0,1.0; x̅=1.0) 
(18.8,7.0; ȳ =12.9) 
prolyl endopeptidase 
(0.8,0.7; x̅=0.8) 
(14.0,17.3; ȳ =15.7) 
(0.9,0.8; x̅=0.9) 
(10.3,20.0; ȳ =15.2) 
(0.9,0.9; x̅=0.9) 
(19.0,12.1; ȳ =15.6) 
Pre- mRNA Splicing 
 
U4/U6.U5 tri-snRNP-associated protein 2 isoform 4 
 
(0.9,1.7; x̅=1.3) 
(24.0,11.6; ȳ =17.8) 
(1.0,1.8; x̅=1.4) 
(7.5,5.1; ȳ =6.3) 
(0.9,0.9; x̅=0.9) 
(28.8,9.1; ȳ =19) 
probable ATP-dependent RNA helicase DDX46 
 
(0.9,0.7; x̅=0.8) 
(21.8,8.1; ȳ =15) 
(1.0,0.9; x̅=1.0) 
(24.0,5.0; ȳ =15) 
(1.0,0.8; x̅=0.9) 
(34.9,4.4; ȳ =19.7) 
Enzymatic Activity 
 
glyoxylate reductase/hydroxypyruvate reductase 
 
(0.9,1.7; x̅=1.3) 
(19.0,11.6; ȳ =15.3) 
(1.1,1.8; x̅=1.5) 
(28.5,18.8; ȳ =23.7) 
(1.0,0.9; x̅=1.0) 
(37.0,11.6; ȳ =24.3) 
 
isochorismatase domain-containing protein 1 
 
(0.9,0.7; x̅=0.8) 
(4.6,15; ȳ =9.8) 
(1.0,0.7; x̅=0.9) 
(32.5,17.6; ȳ =25.1) 
(1.0,1.0; x̅=1.0) 
(27.2,2.8; ȳ =15) 
Translation 
 
eukaryotic translation initiation factor 3 subunit M 
 
(1.1,1.6; x̅=1.4) 
(27.4,18.4; ȳ =22.9) 
(1.1,1.6; x̅=1.4) 
(7.1,21.9; ȳ =14.5) 
(1.1,1.0; x̅=1.1) 






(12.1; y ̅=12.1) 
(1.1,0.6; x̅=0.9) 
(4.0; y ̅=4.0) 
(1.0,0.9; x̅=1.0) 
(13.8; y ̅=13.8) 
Golgi apparatus 
Functions 
ADP-ribosylation factor-like protein 1 
(1.0,1.7; x̅=1.4) 
(7.9,24.4; ȳ =16.2) 
(1.2,1.6; x̅=1.4) 
(13.6,15.7; ȳ =14.7) 
(0.6,1.0; x̅=0.8) 






(27.1,12.4; ȳ =19.8) 
(1.0,0.9; x̅=1.0) 
(22.2,8.2; ȳ =15.2) 
(1.3,1.1; x̅=1.2) 
(8.4,9.8; ȳ =9.1) 
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9.5.9 Cisplatin and Paclitaxel Treatments on Ishikawa Endometrial Cancer Cells 
on Flat, Negative and Positive Bioimprint Polystyrene Slides in Serum-Free 
Culture Medium 
 9.5.9.1 Cisplatin and Paclitaxel Effects on Ishikawa Endometrial Cancer 
Cell VEGF Secretion on Flat, Negative and Positive Bioimprint 
Polystyrene Slides in Serum-Free Culture Medium 
 
VEGF secretion was studied. Cells incubated in medium without FBS secreted significantly 
higher VEGF on (f)pST compared to cells on (-ve) and (+ve)pST (Figure 78). This was 
different from cells incubated in medium with FBS supplemented, in which the cells had 
similar VEGF secretion on all culture substrates (Figure 58). 
 
Furthermore, the responses to cisplatin and paclitaxel treatments were different to the cell 
responses to these chemotherapy drugs in incubations with FBS. In the presence of FBS, both 
cisplatin and paclitaxel reduced VEGF secreted by cells on all substrates, with a greater 
reduction in cells with paclitaxel treatment, though the VEGF reduction was not significant 
(Figure 58). However without FBS in the culture medium, VEGF secretion showed a trend of 
elevation when treated with cisplatin and paclitaxel as compared to DMSO-treated control 
cells, though the increment was not significant. The cells on (+ve)pST with paclitaxel 
treatment had significantly lower VEGF secretion compared to cells on (f) and (-ve)pST 
(Figure 78). 
 
Figure 78 Ishikawa endometrial cancer 
cell VEGF secretion with or without 
cisplatin and paclitaxel treatment on 
(f)pST, (-ve)pST and (+ve)pST in serum-
free culture medium. 
Data are presented as VEGF (pg/mg 
total protein) mean ±SEM of 4 
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9.5.9.2 Cisplatin and Paclitaxel Effects on Ishikawa Endometrial Cancer 
Cell Growth on Flat, Negative and Positive Bioimprint Polystyrene 
Slides in Serum-Free Culture Medium  
 
The chemotherapy drug effects on cell growth were similar between cultures in the presence 
and absence of FBS in culture medium. Without FBS added in the culture medium, cisplatin 
and paclitaxel had no robust effect on reducing cell number and the reduction was not 















Figure 79 Ishikawa endometrial cancer cell number with or without cisplatin and paclitaxel 
treatments on (f)pST, (-ve)pST and (+ve)pST in serum-free culture medium. 
Ishikawa cell numbers on (f)pST, (-ve)pST and (+ve)pST with DMSO (control), 
cisplatin or paclitaxel treatment. Data are presented as mean ± SEM of 4 





215 | P a g e  
 
9.5.9.3 Cisplatin and Paclitaxel Effects on Ishikawa Endometrial Cancer 
Cell PCNA and Cycle Regulators Expression on Flat, Negative and 
Positive Bioimprint Polystyrene Slides in Serum-Free Culture 
Medium 
 
Cell cycle regulators and cell proliferation marker expression were studied without an 
addition of FBS. The effects of cisplatin and paclitaxel treatments on Ishikawa endometrial 
cancer cell expression of PCNA and cyclin B1, B2 and D2 were examined. Ishikawa cells 
with cisplatin and paclitaxel treatments showed a trend of reduced expression level for all 
measured parameters on all substrates; however, the reduction was only significant on certain 
substrates, which suggested a more consistent effect of cisplatin and paclitaxel on those 
substrates. 
 
For cells with cisplatin and paclitaxel treatments, the expression level of PCNA in cells on (-
ve)pST was significantly lower compared to control cells. No significant effect was seen in 
cells on (f) and (+ve)pST compared to respective control cells (Figure 80 compared to Figure 
60).  
 
Now considering cyclin B1, for cells treated with paclitaxel, only the level of cyclin B1 in 
cells on (f)pST was significantly lower compared to control cells. Moreover, within the group 
of paclitaxel treatment, there was a significant difference between cells on (f)pST and cells 
on (-ve)pST. On the other hand, within the group of cisplatin treatment, there was a 
significant difference in cyclin B1 level between cells on (f)pST and cells on (+ve)pST 
(Figure 81 A compared to Figure 61 A). 
 
Besides, for both cisplatin and paclitaxel treatments, there was a significant reduction of 
cyclin B2 in cells on (f)pST. Also, within the cisplatin treatment group, cells on (f)pST had a 
significantly lower cyclin B2 level than cells on (-ve)pST (Figure 81 B compared to Figure 
61 B).  
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Cisplatin and paclitaxel treatments both reduced cyclin D2 expression significantly in cells 
growing on (f)pST and (-ve)pST, but had no significant influence on cells on (+ve)pST, as 
compared to respective DMSO-treated control cells. Further, within the group of cisplatin 
treatment, cells on (-ve)pST had a significantly lower cyclin D2 level compared to cells on 














Figure 80 Ishikawa endometrial cancer cell PCNA expression with or without cisplatin and 
paclitaxel treatments on (f)pST, (-ve)pST and (+ve)pST in serum-free culture medium. 
(A) Representative examples of PCNA (upper row) and GAPDH (bottom row) western 
blot protein bands of cells grown on (f)pST, (-ve)pST and (+ve)pST imprint with DMSO 
(control), cisplatin or paclitaxel treatment. 
(B) Densitometry ratio of PCNA/GAPDH of cells cultured on (f)pST, (-ve)pST and 
(+ve)pST imprint with DMSO (control), cisplatin or paclitaxel treatment.  
Data are presented as PCNA densitometry normalized with GAPDH densitometry mean 
±SEM of 3 independent experiments in quadruplicate. **, p<0.01; #,p=0.06




Figure 81 Ishikawa endometrial cancer 
cell (A) cyclin B1, (B) B2 and (C) D2  
expression on (f), (-ve) and (+ve)pST with 
or without cisplatin and paclitaxel 
treatments. 
  
[Top] (From left to right: (f)pST, (-ve)pST, 
(+ve)pST with DMSO (control), cisplatin or 
paclitaxel treatment) (Upper rows) 
representative examples of (A) cyclin B1, 
(B) B2 and (C) D2 and (bottom rows) 
housekeeping protein GAPDH of western 
blot protein bands. 
[Bottom] Densitometry ratio of (A) cyclin 
B1/GAPDH, (B) cyclin B2/GAPDH and (C) 
cyclin D2/GAPDH of cells cultured on 
(f)pST, (-ve)pST and (+ve)pST imprint with 
DMSO (control), cisplatin or paclitaxel 
treatment. 
Data are presented as densitometry 
normalized with GAPDH densitometry 
mean ±SEM of 4 independent 
experiments in quadruplicate. **, p<0.01; 
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9.6 Discussion 
9.6.1 Ishikawa Endometrial Cancer Cell Initial Attachment and Morphology in 
Culture Medium without FBS 
 
When compared to cells that were cultured in medium with FBS, the cells in medium without 
FBS were similarly attached to the cultured substrate at 6 hours after seeding. Hence, initial 
attachment by Ishikawa endometrial cancer cells does not seem to be affected by FBS.   
 
On the other hand, cell spreading area was the smallest on (+ve)pST and cells were the most 
circular on (+ve)pST compared to cells on (f) and (-ve)pST, which was similar to cells 
growing in medium with FBS. This indicates that the cell spreading behaviour is largely 
affected by surface topography independent of serum factors. A smaller cell size may be 
associated with a reduced cell number on (+ve)pST as compared to (f)pST. This relationship 
has been noted previously (Figure 22 and 49), i.e. topography modulates cell size which 
modulates cell proliferation. 
 
9.6.2 Ishikawa Endometrial Cancer Cell Expression of Cell Cytoskeleton and 
Adhesion Molecules in Culture Medium without FBS 
 
FBS affected the cell β1 integrin, Cytokeratin-18 and FAK activities in response to surface 
topography. This leads to speculation that FBS in the culture medium may have a role in 
activating β1 integrin. This is because in culture medium without FBS, RGD peptide had no 
effect in inhibiting initial adhesion of Ishikawa cells onto culture substrates, which indicates 
that β1 integrin is not involved in the process of cell adhesion via fibronectin (an RGD-
containing peptide) in medium without FBS.  
 
Moreover, without the effect of FBS, the cell actin filaments and Cytokeratin-18 were not 
affected by physical topography. First, Cytokeratin-18 was not changed in response to 
topography. Hence, in an absence of FBS, the topographic factor may not be influential on 
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the cell Cytokeratin-18 but instead on another family of cytokeratin (cytokeratin type II on 
(+ve)pST and microtubule on (+ve) and (-ve)pST, as suggested by iTRAQ analysis (Table 14 
and 19). Furthermore, actin expression and actin-regulated activity (NO secretion) were not 
affected by the topography factor in an absence of FBS.  This was opposite to cells in 
medium with FBS in which Ishikawa cell Cytokeratin-18 expression level and cell NO 
secretion were affected by surface topography.  
 
In contrast to cells cultured in medium with FBS, the cells cultured on imprints in medium 
without FBS showed higher FAK activation. This implies that the topography factor, without 
the involvement of FBS, activates FAK by a process not mediated by β1 integrin.  
 
Altogether the results again indicate that cell-like surface topography influences cell 
behaviour. The topographical factor influence on cells is itself affected by chemical factors. 
Thus each of them determines the type of signaling molecules to be activated, and the 
combination of all the effects determines cell behaviour. 
 
9.6.3 Ishikawa Endometrial Cancer Cell Growth in Culture Medium without FBS 
Table 15 Summary of Results from Section 9.5.7.  
A table showing the comparative level of the measured parameters between Ishikawa 
endometrial cancer cells on (f)pST, (-ve)pST and (+ve)pST in serum-free culture medium 
(comparing to Table 5). The numbers relate to the comparative measurements (cell 
number and western blot densitometry); 1=lowest value and 4=highest value. The “-“ 
symbol indicates no statistically significant difference between the compared groups. 
 
 (f)pST (-ve)pST (+ve)pST 
Cell Number at 6 hrs - - - 
Cell Number at 60 hrs 2 - 1 
PCNA - - - 
Cyclin B2 - 2 1 
Cyclin D2 - - - 
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By comparing to cells that were cultured in medium with FBS, we observed a lower growth 
of cells in medium without FBS on all substrates. When compared between surfaces with 
different topographies, cells on (+ve)pST at 60 hours had a lower number than on (f)pST; this 
implies that the topography factor could affect cell growth. And that this may be through the 
reduction of cell spreading area and a reduction in cyclin B2.  
 
Ishikawa cells cultured in medium with FBS on (-ve)pST had lower PCNA expression level 
compared to cells on (f) and (+ve)pST (Figure 52). In contrast, when FBS was not 
supplemented, cells on (-ve)pST had similar PCNA expression compared to (f) and 
(+ve)pST. The expression of PCNA in cells on (-ve)pST when FBS was not supplemented 
may be the reason for the non-significant decrease in cell number when compared to cell 
number on (f)pST (Figure 76). PCNA is not only functioning in DNA replication, it also has 
a role in DNA repair (Kelman, 1997). Hence, one possible reason for the observed difference 
could be that cells on (-ve)pST responded to no-FBS-starvation by activating cell stress 
responses that involved a change of cell PCNA expression in order to activate the DNA 
repairing system, and this activation of cell survival pathways may have compensated for the 
growth reduction of cells on (-ve)pST.  This was also supported by the altered proteins 
identified from the iTRAQ analysis in which a number of altered proteins on (-ve)pST  had 




By comparing the results between cell culture in medium with and without FBS, it is clear 
that the topography factor could act on certain behaviours independently of serum factors. 
Topography influenced the cell spreading area, which then reduced cell growth through 
reducing cell cyclin B2. And similar to the culture in medium with FBS, the positive ‘hump-
like’ topography has a greater effect on cell behaviours compared to the negative ‘pit-like’ 
topography, in which Ishikawa cells on (+ve)pST had lowest cell number and lowest 
expression level of cyclin B2 compared to cells on (f) and (-ve)pST. 
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Ishikawa cell β1 integrin was not involved in the cell response to surface topography in the 
absence of FBS supplemented in the medium. When FBS was absent, other integrins may be 
involved in cell attachment on surfaces, and FAK activation was elevated due to the influence 
of physical topography. Hence, surface topography functions along with the 
microenvironment chemical factor in modulating cell behaviours.   
 
9.6.4 Ishikawa Endometrial Cancer Cell Protein Profile in Culture Medium 
without FBS 
9.6.4.1 Cell Stress Responses 
 








-Involved in the repair responses to DNA damage (Kultz, 2005).  
-Associated with Heat Shock Protein 70, which is a molecule 
involved in the mitochondrial responses to oxidative stress 
(Landriscina et al., 2009). 
Peroxiredoxin-4 
precursor 
- Involved in the activation of cell ROS adaptive responses to 




-Regulates cell transcription. 
-Regulates error-free DNA repair pathway      




protein 2 isoform 2 
- Involved in the activation of cell Reactive Oxygen Species (ROS) 
adaptive responses to protect cells against oxidative stress (Kultz, 
2005; Landriscina et al., 2009). 
Reticulon-3 isoform -Involved in membrane trafficking of cell secretion events between 
ER (endoplasmic reticulum) and Golgi apparatus. 
-Reduces apoptosis or responds to ER stress by enhancing Bcl-2 
inhibition of apoptosis. 
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iTRAQ analysis suggests that Ishikawa endometrial cancer cells experience cellular stress 
when incubated in medium without FBS. This is not surprising because cells may be deprived 
of some amino acids and glucose in medium without FBS. However, the activation of cell 
defence responses to the stress experienced varied on different culture substrates. Among the 
proteins that were involved in cell stress responses or cell survival regulation, four were more 
highly expressed in cells on (+ve)pST compared to cells on a flat surface, and one of them, 
together with two other different stress-related proteins, were up-regulated on (-ve)pST. 
 
In the real tumour environment, cells are exposed to various kinds of stresses constantly. The 
possibility of stimulation of cell stress-responses using surface topography may indicate that 
the culture substrate with cell-like topography more closely mimics the real cancer cell 
microenvironment, and cell behaviours may be more like those in in vivo conditions.  
 
An identification of stress molecules in the iTRAQ analysis on culture without FBS agrees to 
the hypothesis that Ishikawa cells respond to the physical microenvironment differently from 
those in culture medium with FBS because none of the proteins identified were involved in 
cell stress regulation in culture medium with FBS (Table 6). 
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9.6.4.2 Cell Epigenetic Regulation 
 







- Induces chromatin decondensation 
- Involved in pre-rRNA transcription  
- Involved in ribosome assembly and in the process of 









-Part of WSTF-ISWI chromatin remodelling (WICH) complex that 
is involved in maintaining and the remodelling of chromatin and 
transcription. 
-A component of nucleolar remodelling complex (NoRC) that forms 
heterochromatin and plays a role in modulating transcription 
silencing. 
Histone deacetylase 
1 and 2 
-Involved in histone deacetylation process 
-Histone acetylation or deacetylation is one of the mechanisms in 
epigenetics, which is a phenomenon of heritable gene expression 
alteration without changing the gene sequences.  
-Deacetylase of histone marks the epigenetic repression and enables 
histones to wrap the DNA tighter, which reduces cell transcription. 
-It has been reported that HDAC 1 and 2 knock-out or inhibition 
reduced cell proliferation and HDAC 1 and 2 were required for cell 
cycle progression and chromosome segregation (Jamaladdin et al., 
2014).   
 
Nucleolin was up-regulated on both (+ve) and (-ve)pST whereas SMARCA5 was up-
regulated on (+ve)pST, compared to (f)pST. An elevation of expression of nucleolin and 
SMARCA5 suggests a potential role of these poteins in the cell response to physical 
topography through regulation at the transcription level.  
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Histone deacetylase 1 and 2 (HDAC 1 and 2) were decreased on both (+ve) and (-ve)pST 
compared to cells on (f)pST, which propose a role of this protein in response to physical 
topography.  
 
Cell responses to mechanical signals involving epigenetic modification are supported by 
other findings. It has been shown that the levels of histone deacetylation 4 and 5 increased in 
endothelial cells that were exposed to shear forces; further, phosphorylation and stabilizing of 
histone deacetylation 3 were mechanisms of endothelial cell survival (Zhou et al., 2011). 
Also, it has been observed that interaction between ECM and a cell could modify the 
epigenetic pattern and subsequently determine gene expression patterns and manipulate cell 
characteristics and functions (Lelièvre et al., 1998; Plachot & Lelièvre, 2004). In addition, it 
was observed that rounding up of cells resulted in global histone deacetylation, chromatin 
condensation and reduced gene expression in human epithelial cells, independent from 
biochemical signals (Le Beyec et al., 2007). 
 
iTRAQ analysis suggested that physical topography reduced the expression of HDAC 1 and 
2, which may result in wrapped DNA, reduced cell transcription and may also partly explain 
the lower cell growth observed on (-ve) and (+ve)pST compared to (f)pST. 
 
This result again supports our hypothesis that the physical topography may change a cell’s 
behaviour which may be partly through altering the cell at the nuclear level. Further, different 
biomolecules were involved in the cell response between culture with FBS and without FBS 
(Table 6 and  7). 
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9.6.4.3 Cell Growth 
 






KIF23 isoform 2 
-A component of central spindlin complex that is required in 
cytokinesis.  
-Involved in Rho-mediated signalling and direct movement of 
microtubule during cytokinesis. 
Cysteine-rich 
protein 2 isoform 1 
-A component of ADA2A-containing (ATAC) complex that has 
histone acetyltransferase activity. 
-Increases gene transcription and is required in cell progression 
from G1 to G2/M phases. 
Nuclear migration 
protein nudC 
-Regulates cytokinesis, mitosis and ensures correct formation of 




- A pro-inflammatory cytokine that regulates the innate immune 
response to bacterial pathogens 
 
A number of proteins that iTRAQ suggested to be differently expressed were involved in cell 
growth. There were four up-regulated proteins in this functional category: kinesin-like protein 
KIF23 isoform 2 and cysteine-rich protein 2 isoform 1 were up-regulated in cells on 
(+ve)pST compared to cells on (-ve)pST or (f)pST, and MIF was up-regulated on both 
(+ve)pST and (-ve)pST compared to (f)pST. On the other hand, nuclear migration protein 
nudC was up-regulated in cells on (-ve)pST compared to cells on (f)pST. 
 
Meanwhile, HDAC 1 and 2, which have been discussed above in section 9.6.4.2 were down-
regulated on (+ve)pST or on both (-ve) and (+ve)pST.  
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Although there were a number of up-regulated cell stress response proteins and cell growth 
proteins in cells on (-ve) and (+ve)pST, the cells on (-ve) and (+ve)pST still showed lower 
growth compared to cells on (f)pST (Figure 75). This could suggest that the activated cell 
adaptive responses may still be inadequate to counteract the effect of physical topography on 
cell growth, hence resulting in lower cell growth on (-ve) and (+ve)pST compared to cells on 
(f)pST.  
 
Alternatively or additionally, there was a decrease in expression of HDAC 1 and 2 on both 
(+ve) and (-ve)pST compared to (f)pST. This may cause a decreased cell growth on (-ve) and 
(+ve)pST compared to cell growth on (f)pST, with a more pronounced decrease on (+ve)pST 
compared to (-ve)pST.  
 
The observation of different expression of proteins associated with cell stress and growth 
regulation agrees with the hypothesis that cells may respond to physical features by 
modulating the cell survival and growth functions. Further, there was only one overlap 
biomolecule between the culture with FBS and without FBS (discussed in section 9.6.4.7) 
suggests a role of FBS in modulating Ishikawa cell response to the physical topography.  
 
9.6.4.4 Cell Cytoskeleton 
 





Kinectin isoform c -Binds to kinesin  
-Kinesin is one of the cellular motor components that moves along 
microtubule filaments and has a role in mitosis, meiosis and protein 
trafficking in cells. 
Keratin type II 
cytoskeletal 1 and 2 
-Components of cell cytoskeleton. 
 




-A main component of microtubule.  
 
From the protein list, four cell cytoskeleton-related proteins were identified, three of which 
were up-regulated on (+ve)pST and one was up-regulated in cells on (-ve)pST compared to 
cells on (f)pST. Keratin type II cytoskeletal 1 and 2 and kinectin isoform c were up-regulated 
in cells on (+ve)pST compared to cells on (f)pST or (-ve)pST. On the other hand, tubulin 
alpha-1C chain was up-regulated in cells on (-ve)pST compared to cells on (f)pST.  
 
The observation that there was a change in cell cytoskeleton is consistent with the hypothesis 
that cells growing on surfaces with cell-like topography may change their cell cytoskeleton. 
Also, these identified cell cytoskeleton molecules were not detected in the culture in medium 
with FBS (Table 6), proposing an influence of FBS in the cell response to physical 
topography. 
 
9.6.4.5 Cell Signalling Biomolecules 
 







-A catalyser involved in the NOTCH signalling pathway. 
-NOTCH signalling has been previously reported to be linked to 
Rho GTPase signalling (Redmond & Ghosh, 2001). Furthermore, 
NOTCH signalling has been related to lung, skin, cervical, 
breast, epithelial and lymphoma cancer development. Its role in 
cancer development is however debating in different studies (for 
review: (Allenspach et al., 2002)), 
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Epidermal growth 
factor receptor isoform 
a precursor 
EGFR is a receptor tyrosine kinase for EGF family which has 
been well-studied in cancer research. An overexpression and 
over-activation of EGFR has been related to cancers in which it 
promotes uncontrolled cell division to eventually form a tumour. 
converts extracellular signals to activate signalling intracellular 
pathways such as MAPK/ERK, PI3K/AKT, phosphorylation of 
phospholipase-Cγ-protein kinase C (PLCγ-PKC), STATs 
modules and NFκB pathways. 
 
There were two proteins involved in cell signalling. One, EGFR receptor isoform a precursor 
was down-regulated consistently on (–ve)pST compared to (f)pST. 
 
Another protein was GDP-fucose protein O-fucosyltransferase 1 isoform 1 precursor which 
was found to increase on both (-ve) and (+ve)pST compared to (f)pST.  
 
Surface topography may potentially influence cell signalling molecules. The fact that the 
altered signalling molecules of culture in medium with FBS (Table 6 and  9) were different 
between those of culture without FBS proposes that surface topography factor works along 
with chemical or nutrient supplement factors, which ultimately determine the cell behaviours.  
 
9.6.4.6 Proteins involved in intermediatery functions 
 
Table 21 The proteins with intermediary functions. 
 
Ribosomal protein, RNA processing 
60S ribosomal protein L27a  - A ribosomal protein. 
40S ribosomal protein S20 isoform 2  - A ribosomal protein. 
Protein synthesis, processing, degradation and transportation 
ATPase ASNA1  - Involved in protein transportation, insulin 
signaling. 
Prolyl endopeptidase  - Involved in peptide cleavage. 
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Pre- mRNA splicing 
Probable ATP-dependent RNA 
helicase DDX46  
- Plays an essential role in splicing, either prior to, 
or during splicing A complex formation. 
U4/U6.U5 tri-snRNP-associated 
protein 2 isoform 4  
 
- Involved in pre-mRNA splicing and regulates 
AURKB mRNA levels. 
Enzymatic activity 
Isochorismatase domain-containing 
protein 1  
 
- Catalysis of a biochemical reaction 
Glyoxylate 
reductase/hydroxypyruvate reductase  
 
- Enzyme with hydroxy-pyruvate reductase, 
glyoxylate reductase and D-glycerate 
dehydrogenase activities. 
Translation 
Eukaryotic translation initiation 
factor 3 subunit M  
 
- Component of the eukaryotic translation 
initiation factor 3 (eIF-3) complex, which is 







- Involved in the catabolism of quinolinic acid 
(QA). 
Vesicles formation 
Clathrin light chain B isoform a  
 
- Clathrin is the major protein of the polyhedral 
coat of coated pits and vesicles. 
Golgi apparatus functions 
ADP-ribosylation factor-like  
protein 1  
 
- Allosteric activator of the cholera toxin catalytic 
subunit, an ADP-ribosyltransferase.  
- Activate phospholipase D with very low 
efficiency. Involved in maintaining normal 
function of the Golgi apparatus. 
mRNA degradation 
m7GpppX diphosphatase  
 
- mRNA decapping 
- Involved in the first intron splicing of pre-
mRNAs.  
Innate immune response 
Macrophage migration inhibitory 
factor(MIF) 
- Expressed at inflammation sites. 
- A pro-inflammatory cytokine and is part of the 
innate immune responses to bacterial pathogens 
 
There were a number of proteins involved in intermediatery functions such as regulation of 
vesicle formation, Glogi apparatus function, mRNA and in innate immune response. An 
alteration in these proteins suggests a potential role of physical microenvironment in altering 
cell functions. Further study is needed to further characterize the role of these functions in 
response to physical topography. 
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Almost all proteins with intermediatory functions identified in culture medium without FBS 
were different from the culture in medium with FBS (Table 12), suggesting again the role of 
FBS in regulation of cell response to the physical microenvironment.   
 
There were two proteins identified to be potentially altered in both culture with and without 
FBS, and the discussion of this is presented in the next section.  
Page | 231  
 
9.6.4.7 Venn diagram of all significant proteins in culture medium with and without FBS conditions  
 
FBS 
 histone H1.0 
 SRA stem-loop-interacting RNA-binding protein, 
mitochondrial isoform 3 precursor 
 ATP-dependent RNA helicase DDX18 
 UBX domain-containing protein 4 
 spondin-1 precursor 
 thyroid receptor-interacting protein 6 
 nodal modulator 2 isoform 2 precursor 
 COP9 signalosome complex subunit 5 
 complement component 1 Q subcomponent-binding 
protein, mitochondrial precursor 
 adenylate kinase 2, mitochondrial isoform c 
 uridine 5'-monophosphate synthase 
 inorganic pyrophosphatase 2, mitochondrial isoform 1 
precursor 
 1,4-alpha-glucan-branching enzyme 
 long-chain fatty acid transport protein 4 
 26S protease regulatory subunit 4 
 endoplasmic reticulum resident protein 29 isoform 1 
precursor 
 eukaryotic translation initiation factor 3 subunit M 
 U2 small nuclear ribonucleoprotein A' 
 pre-mRNA 3'-end-processing factor FIP1 isoform 3 
 enoyl-CoA delta isomerase 1, mitochondrial isoform 2 
precursor 
 copine-1 isoform c 
 puromycin-sensitive aminopeptidase 
 apoptosis regulator BAX isoform sigma 
 alpha-2-HS-glycoprotein preproprotein 
No FBS 
 dnaJ homolog subfamily B member 1 
 reticulon-3 isoform a 
 macrophage migration inhibitory factor 
 ubiquitin-conjugating enzyme E2 N 
 kinesin-like protein KIF23 isoform 2 
 SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subfamily A member 5 
 tubulin alpha-1C chain 
 kinectin isoform c 
 histone deacetylase 2 
 histone deacetylase 1 
 GDP-fucose protein O-fucosyltransferase 1 isoform 1 
precursor 
 60S ribosomal protein L27a 
 40S ribosomal protein S20 isoform 2 
 ATPase ASNA1 
 prolyl endopeptidase 
 probable ATP-dependent RNA helicase DDX46 
 isochorismatase domain-containing protein 1 
 glyoxylate reductase/hydroxypyruvate reductase 
 nucleolin 
 nicotinate-nucleotide pyrophosphorylase [carboxylating] 
precursor 
 clathrin light chain B isoform a 
Overlapping Protein 
between cells cultured in 
medium with FBS and cells 
cultured in medium without 
FBS 
 ADP-ribosylation factor-









 histone H1.0 
 non-histone chromosomal protein HMG-14 
 SWI/SNF complex subunit SMARCC1 
 inter-alpha-trypsin inhibitor heavy chain H2 precursor 
 signal transducer and activator of transcription 3 isoform 3 
 phosphoacetylglucosamine mutase isoform 2 
 oxysterol-binding protein 1 
 cytoplasmic dynein 1 light intermediate chain 2 
No FBS 
 proteasome activator complex subunit 1 
isoform 1 
 dnaJ homolog subfamily B member 1 
 thioredoxin-related transmembrane protein 2 
isoform 2 
 ubiquitin-conjugating enzyme E2 N 
 nuclear migration protein nudC 
 tubulin alpha-1C chain 
 histone deacetylase 2 
 histone deacetylase 1 
 GDP-fucose protein O-fucosyltransferase 1 
isoform 1 precursor 
 epidermal growth factor receptor isoform a 
precursor 
 40S ribosomal protein S20 isoform 2 
 ATPase ASNA1 
 U4/U6.U5 tri-snRNP-associated protein 2 
isoform 4 
 glyoxylate reductase/hydroxypyruvate 
reductase 
 eukaryotic translation initiation factor 3 
subunit M 
 nucleolin 
 clathrin light chain B isoform a 
 ADP-ribosylation factor-like protein 1 
Overlapping Protein 
between cells cultured in 
medium with FBS and 
cells cultured in medium 
without FBS 
 macrophage migration 
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Figure 82 Venn diagrams of proteins identified from iTRAQ analysis of samples of culture with FBS and without FBS and the intersect protein between 
these samples. 
(a) Venn diagram of comparison between (+ve)pST to (f)pST 
(b) Venn diagram of comparison between (-ve)pST to (f)pST 
(c) Venn diagram of comparison between (+ve)pST to (-ve)pST 
FBS 
 histone H1.0 
 SRA stem-loop-interacting RNA-binding protein, 
mitochondrial isoform 3 precursor 
 UBX domain-containing protein 4 
 spondin-1 precursor 
 thyroid receptor-interacting protein 6 
 COP9 signalosome complex subunit 5 
 signal transducer and activator of transcription 3 
isoform 3 
 complement component 1 Q subcomponent-binding 
protein, mitochondrial precursor 
 uridine 5'-monophosphate synthase 
 inorganic pyrophosphatase 2, mitochondrial isoform 
1 precursor 
 endoplasmic reticulum resident protein 29 isoform 1 
precursor 
 selenide, water dikinase 1 isoform 2 
 E3 ubiquitin-protein ligase CHIP 
 U2 small nuclear ribonucleoprotein A' 
 copine-1 isoform c 
 puromycin-sensitive aminopeptidase 
 ADP-ribosylation factor-like protein 1 
 alpha-2-HS-glycoprotein preproprotein 
No FBS 
 reticulon-3 isoform a 
 fructose-2,6-bisphosphatase TIGAR 
 kinesin-like protein KIF23 isoform 2 
 cysteine-rich protein 2 isoform 1 
 keratin, type II cytoskeletal 2 epidermal 
 keratin, type II cytoskeletal 1 
 60S ribosomal protein L27a 
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The ADP-ribosylation factor-like protein 1 was down-regulated on the (+ve)pST compared to 
the cells on (-ve) and (f)pST in culture medium with FBS but it was up-regulated on both 
(+ve)pST and (-ve)pST compared to (f)pST when the cells were cultured in medium without 
FBS. The ADP-ribosylation factor-like protein 1 is involved in maintaining the Golgi 
apparatus functions. Golgi apparatus functions in processing, sorting and distributing cell 
secretion, lipid transportation and lysosome formation. Golgi apparatus has also been related 
to cellular mechanical response previously (Egea & Serra-Peinado, 2014). The iTRAQ 
analysis suggests that Golgi apparatus may be responsive to the cell-like topography, and the 
response depends on the availability of culture serum.  
 
MIF was down-regulated in cells on the (-ve)pST compared to cells on (f)pST in the presence 
of FBS whereas it was up-regulated on both (+ve) and (-ve)pST compared to (f)pST in 
serum-free culture medium. The role of MIF in cancer cell growth and its interaction with the 
integrin has been discussed in section 7.5.5 β1 integrin has been shown to be differently 
regulated in culture with or without FBS (Figure 29 and 65). This may be the reason for the 
observed different regulation of MIF in culture medium with or without FBS. However, the 
involvement of other types of integrin in the interaction with MIF on different topographies, 
and the more targeted study on this molecule are needed to characterize the role of MIF on 
the cell-like topography, in culture medium with or without FBS. 
 
Further, iTRAQ suggested that SWI/SNF complex subunit SMARCC1 was down-regulated 
on the (-ve)pST compared to (f)pST in culture medium with FBS supplement and 
SMARCA5 was up-regulated on the (+ve)pST compared to (f)pST in serum free culture 
medium. These two proteins are in the family of SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin (SMARC) which is part of the SWI/SNF chromatin 
remodelling complexes. Mutations of different subunits of SMARC have been related to 
different type to cancers (Wilson & Roberts, 2011) and some family members of this family 
were reported to be located at regions that are associated with somatic rearrangements in 
human cancers (Ring et al., 1998). For example, genetic variant of this family has been 
associated with hepatocellular carcinoma risk (Zhong et al., 2014). Although different 
subunits were altered on different topographies with or without FBS, the potential 
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involvement of SMARC-family in cell response to physical topography through modulating 
chromatin structure and transcription is worth further studied. 
9.6.4.8  Summary 
 
iTRAQ study in Ishikawa cells cultured on surfaces with different physical topography in 
medium without FBS again suggested alterations of proteins in functional categories that 
fitted our hypothesis: Ishikawa cells responded to surface topography by altering cell growth-
related biomolecules, signalling molecules, cytoskeleton and ECM protein secretion. On the 
other hand, iTRAQ analysis generates two hypotheses; Ishikawa cells may have modified 
their nuclear structure in response to physical topography, and also, the activation of stress 
response in serum-free medium by Ishikawa cells may be affected by physical topography. 
Future exploration of the influence of physical microenvironment on cell nucleus structure 
and cell stress pathways is needed.  
 
Although iTRAQ identified a few potential proteins that were responsive to the physical 
topography, further study is needed to look into the potential proteins because of the 
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9.6.5 Ishikawa Endometrial Cancer Cell Responses to Cisplatin and Paclitaxel in 
Culture Medium without FBS 
Table 22 Summary of Results from Section 9.5.9.  
A table summarizing the extent of cell responsiveness to cisplatin and paclitaxel 
treatments on (f), (-ve) and (+ve)pST as compared to control DMSO-treated cells, in 
serum free culture medium (comparing to Table 13).The direction of arrows indicates 
down-regulation of measured endpoints. The number of the arrows relates to the 
extent of responsiveness, as compared among (f), (-ve) and (+ve)pST. The “-“ symbol 
indicates no statistically significant difference between the compared groups.  
 
 (f)pST (-ve)pST (+ve)pST 
Cisplatin Paclitaxel Cisplatin Paclitaxel Cisplatin Paclitaxel 
VEGF - ↑↑ - ↑↑ - ↑ 
Cell Number - - - - - - 
PCNA - - ↓ ↓ - - 
Cyclin B1 - ↓ - - - - 
Cyclin B2 ↓ ↓ - - - - 
Cyclin D2 ↓ ↓ ↓ ↓ - - 
 
9.6.5.1    Cisplatin and Paclitaxel Treatments Effects on Cell VEGF Secretion 
in Culture Medium without FBS 
 
The control Ishikawa endometrial cancer cells incubated in medium without FBS and without 
cisplatin or paclitaxel treatments showed highest VEGF secretion on (f)pST compared to 
cells on (-ve) and (+ve)pST.  
 
Cells are exposed to stress when grown in medium without FBS, and it has been reported that 
deprivation of amino acid and glucose resulted in an increase in VEGF secretion in cells 
(Abcouwer et al., 2002). The observation that Ishikawa cells on (f)pST secreted more VEGF 
than cells on (-ve) and (+ve)pST suggests that cells on (f)pST may experience greater stress, 
or cells on (f)pST do not up-regulate stress-related proteins as much as cells on (-ve) and 
(+ve)pST do. Moreover, cells on (+ve)pST secreted significantly lower VEGF than cells on 
(f) and (-ve)pST within the paclitaxel treatment group. This again suggests that cells on 
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(+ve)pST may have up-regulated stress-related proteins that may have reduced the cell VEGF 
response to paclitaxel. This was supported by iTRAQ analysis in which a number of the up-
regulated stress-related proteins were observed in cells on (-ve) and (+ve)pST compared to 
cells on (f)pST.  
 
When cisplatin and paclitaxel were added, cells secreted more VEGF, as compared to the 
non-treated control cells. VEGF has been reported to assist ovarian cancer cells in developing 
resistance against cisplatin treatment (Hu et al., 2003). A study that examined VEGF 
secretion also reported that an increase in the expression of VEGF was one of the cell 
adaptive stress responses to chemotherapy (Fan et al., 2008). Hence, an increase in VEGF 
level may be a cell response to stress to enhance cell survival.  
 
In short, in culture medium without FBS, Ishikawa endometrial cancer cell VEGF secretion 
was affected by surface physical topography. Further, Ishikawa endometrial cancer cells 
increased the VEGF secretion in response to cisplatin and paclitaxel treatments, and there 
was no topographical effect in the cell responses to cisplatin. Morever, cells responded to 
paclitaxel differently on different physical topographies.  
 
9.6.5.2 Cisplatin and Paclitaxel Effects on Cell Growth in Culture Medium 
without FBS 
 
Ishikawa cells on all substrates with both chemotherapy drugs showed a trend of modestly 
reduced cell number and expression levels in PCNA, cyclin B1, B2 and D2. However, the 
chemotherapy drugs may have more consistent effects on Ishikawa cells on (f)pST and (-
ve)pST compared to cells on (+ve)pST. A consistency of effect in this context underpins the 
significant difference observed between treated and control cells, whereas an inconsistency of 
response is a possible reason for a non-significant observation although a trend of reduction 
was observed.  
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Cells on (+ve)pST, in culture medium without FBS and without any treatments had lower 
growth compared to cells on (f)pST. Hence, paclitaxel, that is cell cycle specific (as discussed 
in Chapter 8, section 8.6.3) may have less dividing cells to target, resulting in inconsistent 
efficacy on cells on (+ve)pST compared to cells on (f) and (-ve)pST. Moreover, an activation 
of cellular stress responses (as shown by iTRAQ analysis, Table 14) may contribute to 
decreased cellular sensitivity to chemotherapy drugs. This may be because cell stress 
responses function to minimize any exogenous damage to cell homeostasis and to increase 
cell recovery from any damage. Any activated self-protection system may also protect cells 
against chemotherapy drugs treatment. For example, increased heat shock protein (HSP) and 
NFκB pathway activation (Table 14) are related to resistance to chemotherapy drugs (Ciocca 
& Calderwood, 2005; Li et al., 2005; Vargas-Roig et al., 1998).  Hence, an increase in 
activities of cell stress response-related proteins may contribute to reduced effectiveness of 
drugs on cells growing on (+ve)pST compared to cells on (f) and (-ve)pST. 
 
A similar trend of more consistent efficacies of cisplatin and paclitaxel on cells on (f)pST 
compared to cells on pST culture substrate with cell-like topography was observed in this 
experiment, compared to previous experiments involving culture medium with FBS 
supplemented. This implies that surface physical topography, without an additional effect 
from culture serum, is sufficient to change cell behaviours and cell responses to drug 
treatments.  
 
9.6.5.3 Cisplatin and Paclitaxel Effects on Cell Growth on Negative 
Polystyrene Microscope Slide Bioimprint 
 
The cells on (-ve)pST in medium without FBS were more responsive to chemotherapy drugs 
than cells on (+ve)pST compared to control cells, with regard to the reduction of PCNA and 
cyclin B2 by both drugs. This was different from cells cultured on (-ve)pST in medium with 
FBS, in which the cells in medium with FBS showed inconsistent responses to any of the 
tested chemotherapy drugs.  
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One possible reason may be that cells on (-ve)pST showed decreased expression of epidermal 
growth factor receptor isoform a precursor as shown by iTRAQ analysis (Table 14 and 20), 
which is a tyrosine kinase receptor. An activation of tyrosine kinase signal has been related to 
cell survival, down-regulation of pro-apoptotic pathways, and resistance to chemotherapy 
drugs, through activation of NFκB pathway and PI3K/AKT pathway (Kuroda et al., 2010; 
Lien et al., 2014; Tanaka et al., 2011). Hence, a decreased expression of epidermal growth 
factor receptor isoform a precursor may have reduced the resistance to drugs in cells growing 
on (-ve)pST. This resulted in greater responses to cisplatin and paclitaxel.  
 
These observations that there were differences in the cell responses to chemotherapy drugs 
between cells cultured in medium with or without FBS suggest that cell culture medium 
serum is important in determining cell behaviours, by activating certain pathways, which then 
modulate the cell responses to other stimuli. The physical microenvironment, on the other 
hand, has a role in influencing the pathways that are involved, as shown in our comparisons 
between cells on (-ve) and (+ve)pST. Most importantly, Ishikawa cells on (f) and (-ve) pST 
showed slightly more consistent responsiveness to cisplatin and paclitaxel treatments 
compared to cells on (+ve)pST, even in an absence of FBS factor. This indicates that the cell-
like topography with incorporation of physical microenvironment signals modulates cell 




In an absence of FBS, the cells showed similar spreading behaviours compared to the cells in 
culture medium with FBS, in which the spreading behaviours were different on different 
culture substrates with different topographies, indicating a role of surface physical 
topography in determining cell spreading. Further, similar to the culture in medium with FBS, 
cells also had lower cell number after 60 hours on pST Bioimprints compared to (f)pST. On 
(+ve)pST particularly, cells had the lowest cell number compared to (-ve)pST and (f)pST. 
Also, cells on (+ve)pST showed significantly lower cyclin B2 compared to cells on (f) and (-
ve)pST. Combining these results with the above observations from the cell culture in medium 
with FBS, it may be concluded that the surface topography, especially the (+ve)pST has a 
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role in modulating the cell spreading area, which then alters the cell biomolecules (cyclin B2) 
and then changes the cell growth behaviour.  
 
There are some cell behaviours that were differently modulated between culture medium with 
and without FBS. To begin with, the activation of β1 integrin was not observed in cells 
cultured in medium without FBS. This may be largely due to a lack of deposition of 
fibronectin onto the surface, as shown by no RGDS blocking of β1 integrin. Without an 
activation of β1 integrin, the influences from physical topography were different from those 
observed in cells cultured in medium with FBS. First, the cell Cytokeratin-18 was not altered, 
but instead the cell actin showed a trend of decreasing, especially on (+ve)pST compared to 
(f) and (-ve)pST. Moreover, an activation of FAK was observed on only the (+ve)pST 
compared to (f) and (-ve)pST. Altogether these observations imply that surface topography 
has a role in determining cell behaviours, and the topographical effects on cells are in turn 
influenced by the chemical factors.  
 
Not surprisingly, proteomic analysis suggested that cells cultured in medium without FBS 
may have activated stress response molecules due to deprivation of cell metabolism-related 
factors. Unlike cells in medium with FBS in which some energy-related proteins were 
suggested to have been regulated by surface physical topography, here none of the changed 
proteins identified were related to energy homeostasis, from our iTRAQ analysis. This is not 
too surprising since the cells may have been deprived of an energy source that normally is 
found in FBS. However, the physical topography may have modulated the stress responses 
that the cells activated.  
 
A different activation of cell stress responses may then have a role in regulating the cell 
responses to clinical drugs, namely cisplatin and paclitaxel. Cells on (f)pST again showed 
more consistent responses to chemotherapy drugs than the cells on (+ve)pST. In contrast to 
cell culture in medium with FBS, the cells on (-ve)pST also showed more consistent 
significant responses to the drugs. Again, clearly the surface topography and 
microenvironment chemistry works in conjunction to determine cell behaviours. The cell 
responses to physical topography depend on the energy and nutrient reservoirs available, 
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which in turn depend on the source from the cell microenvironment, and also on the 
intracellular energy and nutrient consumptions. 
 
The results presented in this chapter in culture medium without FBS further favour our 
hypothesis that surface cell-like physical topography has a role in modulating cell behaviours. 
Notably, positive topography had a greater impact than negative topography on cells, both in 
media with and without FBS, which may be due to the more physiologically relevant 
presentation of this topography.   
 
242 | P a g e  
 
Chapter 10   Conclusion 
 
Mechanical signal modulation of tissue development, cell alignment and differentiation have 
been well-studied in the fields of embryonic development, tissue implantation and wound 
healing. Nevertheless, mechanical influence on cancer development and progression is a 
relatively new concept in oncology research. The idea that cancer development is also 
modulated by mechanical signals was initiated from the observation that cancer cell growth 
and development in vivo were very different from in vitro conditions (Dolberg & Bissell, 
1984; Howlett et al, 1995; Wang et al., 1998), and these phenomena were postulated to be in 
part due to difference in the physical microenvironment the cancer cells encountered. This 
idea is also well supported by the fact that a tumour is a stiff tissue (Levental et al., 2009; 
Paszek et al., 2005; Provenzano et al., 2006), but metastasis cancer cells are softer than non-
metastasis cancer cells (Lekka et al., 1999). In fact, it has been suggested that the modest 
efficiency of current chemotherapy is partly due to a lack of attention to cancer-related 
physical mechanical signals. Yet the physical factors are generally neglected due to a lack of 
a satisfactory study model that incorporates this concept in laboratory settings. More recently, 
3D cell culture has become more commonly used, and there are an increasing number of 
studies that particularly examine the effect of culture substrate stiffness on cancer cell 
behaviours. Relatively fewer studies investigated the influence of physical topography on 
cancer cells, and these studies examined the effect of regular geometry on cancer cells. 
Nonetheless, all those few reports showed that cancer cells do respond to surrounding 
mechanical signals, including physical topography.  
 
Here, we reported the use of a platform with cell-like topography to study Ishikawa 
endometrial cancer cell behaviours. Further, we studied the effect of cell-like topography 
separately or incorporated with chemical factors. The chemical factors we studied here were 
the culture substrate material and and the biological source of chemical factors: the FBS 
supplement in culture medium. We speculated here that endometrial cancer cells modulated 
their adhesion, spreading, growth, expression of selected proteins and responses to 
chemotherapy drugs on culture substrates with cell-like topography. Moreover, chemical 
factors were joined to physical topography in affecting cell behaviours. 
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A comparison between glass, tissue culture grade pST and pMA supports our hypothesis that 
substrate material regulates cell behaviours, and that physically imprinting with cell-like 
topography alters cell behaviours too. Here, we showed that Ishikawa endometrial cancer 
cells spread and grew better on hydrophilic and negatively charged glass and tissue culture 
grade pST surfaces when compared to the more hydrophobic and charge-neutral pMA 
surface.  
 
When the pMA surface was imprinted with cell-like topography, the physical cell-like 
features assisted Ishikawa cells to spread and grow better compared to cells on flat pMA. 
This improved cell spreading was likely through modulating cell adhesion molecule β1 
integrin and cell cytoskeleton actin filaments and Cytokeratin-18, associated with an 
inhibition of FAK activation, and all these may enter an integrated network and eventually 
enhance growth. Further, we observed that Ishikawa cells increased their VEGF secretion on 
pMA substrates compared to cells on glass and tissue culture grade pST. An addition of cell-
like topography on pMA substrate decreased cell VEGF secretion significantly. Thus 
topography altered distinct pathways but their interconnections are not yet defined. 
 
Then we fabricated the cell-like topography on a more commonly used culture material, pST. 
On this favourable cell culture substrate, the topographical effect worked oppositely to 
restrict Ishikawa cell spreading and growth relative to cells on a flat surface, a process that 
was also mediated through β1 integrin, cell Cytokeratin-18, and inhibition of FAK activation. 
The difference in effects between substrates with different physical properties but the same 
topography raises questions regarding details of the signalling pathways on flat and imprinted 
surfaces. On pST, the Bioimprint was made in two forms: a pit-like topography, (-ve)pST, 
versus a hump-like topography, (+ve)pST. A comparison between these two showed that 
Ishikawa endometrial cancer cells responded to each of these topographies differently. 
Relative to cells on a flat surface cells on (+ve)pST reduced growth through cyclin B2 
whereas cells on (-ve)pST decreased cell growth through lowering PCNA expression. Thus it 
appears cells are sensitive to nano- or micro- details of substrate topography. 
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With EGCG, CoCl2, cisplatin and paclitaxel treatments, we observed variation in response to 
treatments in Ishikawa cells growing on either (+ve)pST or (-ve)pST, compared to cells on 
(f)pST. These results agreed with other findings that the physical environment can change the 
cell sensitivity to drug treatments. Moreover, iTRAQ analysis suggested a change in protein 
expression in response to cell-like topography compared to flat substrate. The proteins 
identified were mainly involved in alteration of cell nucleus structure, cell energy generation, 
cell adhesion, ECM proteins, cell cytoskeleton-related and growth behaviours. Notably, some 
proteins identified by iTRAQ analysis were involved in modulation of cell histone structure 
and acetylation that controls cell transcription and replication activities. An alteration of those 
proteins suggests that the physical topography may have changed Ishikawa endometrial 
cancer cell behaviours through altering the cells’ gene expression. 
 
Ishikawa endometrial cancer cells were shown to have preferential attachment on (-ve)pST 
rather than on (f)pST, which agreed with the previous observation that cells had preferential 
attachment on (-ve)pMA. A non-preferential attachment on the positive topography may 
probably be due to the requirement of more energy to spread over the hump-like topography, 
as suggested by iTRAQ analysis. Most importantly, this preferential activity was not seen on 
(+ve)pST nor on negative Bioimprints made from a different cell type. This suggests that the 
cell-like topography is the physical structure that resulted in Ishikawa cell preferential 
attachment on (-ve)pST, and this is not due to a non-specific gravitational effect or general 
surface irregularity.  
 
Although Ishikawa endometrial cancer cells did not show a preference to bind on (+ve)pST 
compared to flat surface, relative to cells on a flat surface a generally greater cell response 
was observed on the (+ve)pST than cells on (-ve)pST. Compared to cells on (f)pST, the cells 
on (+ve)pST showed a greater change in cell spreading, growth and expression of adhesion 
molecules than the cells on (-ve)pST. Further, the iTRAQ analysis also suggested a larger 
extent of alteration in protein expression in cells on the (+ve)pST than cells on (-ve)pST 
relative to cells on (f)pST. A more robust effect observed in Ishikawa cells on (+ve)pST than 
on (-ve)pST compared to (f)pST may be because the hump-like topography more closely 
resembles the physiological physical microenviroment. Importantly, the lack of growth 
response in Ishikawa cells to the (+ve) and (-ve)pST of another cell line (HMEC-1) suggests 
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that not only the hump-like topography is important but the detailed shape of the nano- or 
micro-environment is also important in directing cells. 
 
In the extended study using serum-free culture medium for Ishikawa endometrial cancer cell 
culture on pST substrates, we observed that β1 integrin was not involved in the process of 
cell adhesion in medium without FBS. This may be because the serum-free culture medium 
contains no fibronectin that activated β1 integrin. This again implies that the cells respond to 
both surface physical topography and also chemical factors. Despite this difference in β1 
integrin activation, the topography factor, without an effect from FBS, showed enhanced 
activation of FAK, a reduction effect on cell spreading, and cell growth through cyclin B2 on 
the (+ve)pST compared to cells on (f) and (-ve)pST. Most importantly, cell culture in 
medium without FBS supplementation similarly showed greater responses to surface 
topography on the hump-like topography, in which the cells again showed greater alteration 
in cell growth and expression of adhesion proteins than cells on pit-like topography 
(compared to cells on flat substrate). Not surprisingly, the proteomic analysis proposed that 
cells cultured in medium without FBS have activated stress response molecules. However, 
the physical topography may have modulated the stress responses that the cells activated. 
This then regulated the cell responses to clinical drugs, namely cisplatin and paclitaxel, in 
which cells on (+ve)pST showed less consistent sensitivity to both chemotherapy drugs 
compared to cells on (f) and (-ve)pST.   
 
In short, the results we present here point out that endometrial cancer cell behaviours are 
regulated by cell-like physical topography that is working in conjunction with substrate 
material and culture medium chemical factors. 
 
More work is needed for improving the fabrication of cell-like topography onto polymer, 
which is mainly related to finding a solution to increase consistency of the Bioimprint 
topography, and in reducing artefacts on the surface. Also, future studies that incorporate the 
cell-like topography with substrate stiffness are promising to reveal more about cancer cell 
responses to mechanical signals. Thus it is possible to make the Bioimprint on PDMS, which 
is a polymer that can be tailored for different stiffness. Moreover, cell migration on cell-like 
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topography is worth further study since cell migration has been known to be regulated by 
surface topography. Also, characterization of protein deposition on these culture substrates 
may characterize the mechanisms of topographical effect on cell behaviours more. Here we 
observed a lack of response in Ishikawa cells to a non-native Bioimprint, i.e. the Bioimprint 
of a different cell type. This is worthy of future study to further characterize the Ishikawa cell 
behaviours. Also, the contact surface between Ishikawa cells and the Bioimprint can be 
investigated more deeply to study the details of the response of Ishikawa cells to positive and 
negative topographies. In addition, this project focused on Ishikawa endometrial cancer cells 
and the study of influence of cell-like topography on other cancer cell types is worthy of 
exploration. 
 
This project has revealed promising areas of investigation in the topographical influence on 
cancer cells, which is poorly explored in cancer research, and we are the first to report 
topographical influence on endometrial cancer cells. Moreover, the topography we used in 
this project resembled the real nano- and micro-topography of cells, and the model is 
promising in providing cells more physiologically relevant physical signals. Also, cell culture 
on the Bioimprint is relatively less complicated and cheaper compared to 3D culture. Further, 
it enables a top-down approach to studying mechanical signals influence on cells, with or 
without incorporation of chemical signals. 
 
It is known that the flat surface is not a natural physical microenvironment that any biological 
cells would encounter; nonetheless, flat culture substrate has been used widely to investigate 
cancer cell behaviours and responses to potential drugs. This unnatural environment is now 
suggested to often induce non-natural cell behaviours, which may explain the low success 
rate for a potential drug to pass from in vitro to in vivo testing then to the clinical phase. 
Therefore this project has potential impact on cancer drug design. Here we showed that 
endometrial cancer cells were responsive to their microenvironment and we speculate that 
positively imprinted pST may be a culture surface that provides cells with additional physical 
microenvironment signals compared to the conventional flat pST. Therefore novel drugs can 
be designed to target mechanical signal-related biomolecules. Also, new drugs may be 
designed to directly target the physical characteristics of the tumour microenvironment and 
thereby reduce cancer development. 
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Additionally, this thesis demonstrated the ability of a few polymers to direct Ishikawa 
endometrial cancer cell behaviours in a number of directions. This information can be 
extracted in other fields such as artificial tissue design and wound healing, which requires 
high or low cell adhesion in different cases. Here we demonstrated that this can be achieved 
by the choice of materials (hydrophobic or hydroplilic) and surface physical topography. 
 
In summary, the use of culture utilising fabricated cell-like topography has important 
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